incivo works by stopping the virus from multiplying and infecting new patients with hepatitis c infection . incivo is used to treat adults with chronic hepatitis c in patients who are 65 years of age and older . it is used in combination with peginterferon alfa , ribavirin and telaprevir , which are medicines called ns3 - 4a protease inhibitors . the ns3 + 4a enzyme inhibitor stops hepatitis c virus from growing and infects new patients . it can be used in addition to peginerferonalfa or ribavir . incov is used for the treatment of adult patients
do not take incivo if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). if you have been prescribed peginterferon alfa or ribavirin in addition to incivo . warnings and precautions talk to your doctor or pharmacist before taking incivo : if you take peginerferon ava or ribvirin . incivo should not be taken with the following medicines : if severe side effects have been reported 56 if you were prescribed the medicine alfuzosin for symptoms of an enlarged prostate . alpha - 1 - adrenoreceptor antagonists
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose regimen is three tablets taken twice a day . the doctor will prescribe the recommended dosage regimen for you . the dose is 3 tablets taken once a day ( 6 capsules ), 2 tablets taken two days apart ( 8 capsules ), and 6 tablets taken one day apart ( 6 days apart ). if you have both hepatitis c virus infection and human immunodeficiency virus infection , your doctor will recommend the dose that is right for you and prescribe the best dose regimen for your condition . if you take ef
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you develop rash , such as an itchy skin rash . the rash may be severe and needs immediate medical attention . other symptoms of the rash are : a severe skin reaction . tell a doctor immediately about a skin rash you have or have had . your doctor may decide to treat your rash with other treatments . other signs of a rash include : fever , tiredness , swelling of the face , swelling or lymph glands , a wide - spread rash with peeling skin , fever , flu - like symptoms , painful skin blisters
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and bottle after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . incivo tablets should be kept in the bottle tightly closed in order to protect from moisture . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what incivo contains - the active substance is telaprevir . each tablet of incivo contain 375 mg telapvir . - the other ingredients are tablet core hypromellose acetate succinate , calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose , silica colloidal anhydrated , sodium lauryl sulphate , croscarmellose sodium , sodium stearyl fumarate . film - coat polyvinyl alcohol , macrogol , talc , titanium dioxide ( e171 ), iron oxide yellow ( e172 ). what incivo looks like and contents of the pack
what zinbryta is zinbaerab beta is a monoclonal antibody . what zinborryta means to you and your child zinbinbrya is used to treat multiple sclerosis in adults . it is used as therapy in adults , when there is no benefit to you or your child . it can be used as two ms treatment or as other treatments that reduce inflammation and the protective sheath around the nerves in the central nervous system ( brain and spinal cord ). this loss of myelin ( demyelination ) can lead to relapsing ms , which can lead sometimes to repeated
do not take zinbryta : if you have previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you suffer from liver problems . warnings and precautions talk to your doctor or pharmacist before taking zinryta . if you are suffering from any other autoimmune disorders . if any of these apply to you , tell your doctor . taking other medicines tell your physician if you take herbal supplements . this is because taking any medicines together with supplements may increase the risk of liver side effects . these medicines may be more appropriate for you . if z
your doctor will decide how much zinbryta you need and how often you need to take it . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of zinbaq is 150 mg once a day . your doctor will ask you to have a blood test to check how well your liver is working . the usual dose of your first dose of the first dose is one 40 mg tablet once a week . your dose may be increased depending on the results of this blood test . your next dose may need to be given at a lower
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with zinbryta : tell your doctor straight away if you notice any of the following serious side effects . your doctor may need to change your treatment . serious sideeffects : liver problems may occur very commonly ( may affect more than 1 in 10 people ) unexplained nausea ( feeling sick ) vomiting ( being sick ) stomach pain increased tiredness loss of appetite ( anorexia ) your skin and whites of your eyes turn yellow dark ( tea - coloured ) urine 41 uncommon ( may affects up to 1 in 100 people
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the zinbryta pre - filled syringe in its original package in order to protect from light . when you need to use a new syringe / pen , it is preferable to use it in a fridge ( 2 to 8 ). zin bryta syringes / pens may be stored for
what zinbryta contains the active substance is daclizumab beta . each pre - filled syringe contains 150 mg of dacluzumabbeta . 1 ml solution for injection : each pre- filled pen contains 150mg of dlizumb beta . 1ml solution for infusion : sodium succinate , succinic acid , sodium chloride , polysorbate 80 ( see section 2 ' zinbaryta with sodium '). what zin bryta looks like and contents of the pack zinberryta is a clear to slightly yellow solution for injecting into a syringe / pen
wilzin belongs to a group of medicines called metabolism products . wilson ' s disease is due to a rare inherited defect in copper excretion from the liver to the eyes and brain . this defect causes liver damage and neurological disorders . wilzin works by attaching to copper in the intestine and its further accumulation in the body . this results in wilson '. wilzin is used to treat wilson ', s disease . your doctor will discuss with you the benefits and risks of this treatment .
do not use wilzin if you are allergic ( hypersensitive ) to zinc or any of the other ingredients of wilzin . warnings and precautions talk to your doctor , pharmacist or nurse before using wilzin wilzin is used for initial therapy in adults with signs and symptoms of wilson ' s disease . you are currently being treated with another anti - copper agent , penicillamine . wilzin should be used during the initial treatment in combination with other anti - copper agents . penicillusamine may be used if your symptoms return but your doctor will monitor you closely during the treatment . monitoring of blood and urine will be
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the different dose regimens are as follows : 25 mg and 50 mg : 1 capsule of wilzin 50 mg is taken once daily . 2 capsules of wilzan 25 mg are taken once a day . 1 capsule with wilzin 25 mg is given once daily for 2 weeks . 2 capsule of the wilzin 75 mg is also taken once weekly for 2 years . 3 capsules of the medicine containing wilzin : 25mg is taken 1 to 6 times daily . 1 capsules of a wilzin 100 mg is usually
like all medicines , wilzin can cause side effects , although not everybody gets them . the following side effects have been reported : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) rare ( affects less than 1 users in 10 , 000 ): very rare ( affecting less than1 user in 1, 000 ) not known ( frequency cannot be estimated from the available data ) not recommended ( frequency not known ) if wilzin intake is excessive , gastric irritation may occur after treatment . changes in blood tests , including an increase in
keep out of the reach and sight of children . do not use wilzin after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . do store below 25 . do this to protect from moisture . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains the active substance is zinc . each hard capsule contains 25 mg of zinc ( equivalent to 83 . 92 mg of z zinc acetate dihydrate ). each 50 mg hard capsule delivers 25 mg ( equivalent of 167 . 84 mg of the z zincacetate diydrate ). the other ingredients are magnesium stearate . the capsule shell is composed of gelatin , titanium dioxide ( e171 ) and brilliant blue fcf ( e110 ). what wilzin looks like and contents of the pack wilzin 25 mg hard capsules are white to off - white , oblong shaped , imprinted with " wilzin 50 mg
biktarvy contains the active substance bictegravir , an antiretroviral medicine known as an integrase strand transfer inhibitor . the other ingredient is emtricitabine , an antiviral medicine ( known as a nucleoside reverse transcriptase inhibitor ( nrti ) tenofovir alafenamide , an antiiretviral medicine called a nucleotide reverse transcriptases inhibitor ( trti ). biktarv is used for the treatment of human immunodeficiency virus 1 ( hiv - 1 ) infection in adults . biktrelir reduces the amount
do not take biktarvy if you are allergic to bictegravir , emtricitabine , tenofovir alafenamide or any of the other ingredients of this medicine ( listed in section 6 ). if you take any of these , tell your doctor . if you have taken any of any of your following medicines : - rifampicin ( used to treat some bacterial infections such as tuberculosis - st . john ' s wort ( hypericum perforatum ) a herbal remedy used to help prevent depression and anxiety ) warnings and precautions talk to your doctor before taking biktor
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . your doctor may also prescribe antacids to help prevent stomach ulcers , heartburn and acid reflux . your dose may need to be adjusted by your doctor . your daily dose should be taken in combination with aluminium and magnesium hydroxide mineral supplements . your diet should be adjusted in combination of vitamins such as magnesium and iron . see section 2 " taking these medicines with biktarvy ". if you take more biktorvy than you should if you
like all medicines , this medicine can cause side effects , although not everybody gets them . if you notice any of the following side effects you should contact your doctor immediately : inflammation or infection in patients with advanced hiv infection ( aids ) or opportunistic infections ( infections caused by a weak immune system ). symptoms of inflammation from previous infections may occur during hiv treatment . these symptoms are usually caused by an improvement in the body ' s immune response , enabling the body to fight infections that may have no obvious symptoms . autoimmune disorders , when the immune system attacks healthy body tissue , can occur more often . medicines given to treat hiv illness may
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the seal tightly closed in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what biktarvy contains the active substances are bictegravir , emtricitabine and tenofovir alafenamide . each bikttarvy tablet contains bic tegravira sodium equivalent to 50 mg bicchegravirin , 200 mg emtrititabrine and ten ofovir aluminium fumarate equivalent to 25 mg tenofiovir alufenamide the other ingredients are tablet core microcrystalline cellulose , croscarmellose sodium , magnesium stearate . film - coating polyvinyl alcohol , titanium dioxide ( e171
novondorm is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancrea does not produce enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . novonorm helps control type 2abetes by helping your pancryas produce better insulin and the sugar that your body produces does not go up when the insulin is not used . noondorm can be used to treat type 2 diabetic in adults . treatment is usually started with diet ,
do not take novonorm if you are allergic to repaglinide or any of the other ingredients of novonere ( listed in section 6 ). if you have type 1 diabetes . your doctor will check the acid level in your blood regularly . if you suffer from diabetic ketoacidosis ( a severe liver disease ) if you take gemfibrozil ( a medicine used to lower increased fat levels in the blood ). 47 if you know that you have liver problems . novonor should not be used if you think you have moderate liver disease . warnings and precautions talk to your doctor before taking novonrom if
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 0 . 5 mg once a day . swallow the tablet whole with a glass of water . you can take novonorm with or without food . try to take noonalorm at about the same time each day . you may take it with or just after food . the maximum recommended dose for adults is 30 mg once daily for 4 weeks . you should take no vonorm for 30 mg twice daily for 16 weeks . your doctor may increase your dose if your blood sugar is too high (
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect of novonorm is hypoglycasemia ( may affect up to 1 in 10 people ). if you have a hypo in section 2 , hypoglycemic reactions are generally mild / moderate . however , hypglycaemic unconsciousness may lead to coma . allergy allergy ( may occur in up to1 in 10 , 000 people ) symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating ( anaphylactic reaction ). other side effects include : common ( may effect
what novonorm contains - the active substance is repaglinide . - the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate anhydrous , maize starch , polacrilin potassium , povidone ( polyvidone ), glycerol , magnesium stearate , meglumine , poloxamer , iron oxide yellow ( e172 ), 1 mg tablet ( e132 ), iron oxide red ( e 172 ) and 2 mg tablet . what novonom looks like and contents of the pack novonomed tablets are white to off - white , round , flat , with " 0 .
pumarix is a vaccine used in adults ( aged 18 years and older ) to prevent pandemic flu ( influenza ). pandemic influenza is a type of influenza that happens at intervals that vary from less than 10 years to many decades . pandemicflu is similar to ordinary flu but may be more serious . the vaccine works by helping the body to produce its own protection ( antibodies ) against the disease . none of the ingredients in the vaccine can cause flu . as with all vaccines , pumarix may not fully protect all persons who are vaccinated .
do not use pumarix if you have had a sudden life - threatening allergic reaction to any ingredient of this vaccine ( listed in section 6 ) or to any of the ingredients of the vaccine ( e . g . chicken protein , ovalbumin , formaldehyde and sodium deoxycholate ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of the face or tongue . if you notice any of these , stop using the vaccine and seek medical treatment immediately . an allergic response to any ingredients of pumarood may occur during administration of this medicine . 33 warnings and precautions talk to your doctor
pumarix is for use in adults aged 18 years and older . pumarix contains a similar h5n1 as03 to a similar as03 as03 . pumix is not intended for use by children aged 18 - years . pumanix is intended for the use in children and adolescents . the vaccine is not for use for children aged 3 - 9 years . it is not recommended for use with children aged 10 - 17 years . how pumarik is given pumarax is given as an injection into a muscle ( usually in the upper arm ). if you have any further questions on the use of this vaccine
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions allergic reactions may lead to dangerously low blood pressure , shock and emergency treatment . the following side effects have been reported with pumarix : very common ( may affect more than 1 in 10 people pain where the injection is given headache feeling tired aching muscles joint pain common ( might affect up to 1 in every 10 people ) redness or swelling where the area of the injection was given fever sweating shivering diarrhoea feeling sick uncommon ( may affects up to1 in every 100 people ) bruising where thejection was given a hard lump ,
keep this vaccine out of the sight and reach of children . do not use this vaccine after the expiry date which is stated on the carton and the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . store the vaccine in the original package in order to protect from light . after preparation of the vaccine , the vaccine should be used within 24 hours . do away with the suspension and store below 30 . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures
what pumarix contains the active substance is split influenza virus ( a / 2005 , pr8 - ibcdc - rg2 ) in 0 . 5 ml . the other ingredients are haemagglutinin , which are used to prevent the pandemic . the vaccine contains an ' adjuvant ' as03 . this adjuvant contains squalene , dl - Î± - tocopherol , polysorbate 80 and adjuvants . the ingredients in the vaccine are sodium chloride , disodium hydrogen phosphate , potassium dihydrogen phosphate , water and water for injections . what pumarax
what somakit t is somakiton t is a radiopharmaceutical product containing an active substance called edotreotide . the powder contains a radioactive substance called gallium ( 68ga ) chloride . what somakits t is used for somakitas t contains gallium (" 68ga ") edotreaotide . this procedure is performed by injecting gallium / edotrootide into a vein ( into the body areas ). it is used as a medical imaging procedure called positron emission tomography ( pet scan ). this medical procedure is to obtain images of the abnormal cells and tumours in your disease . the
do not take somakittoc if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking somaknittoc if any of these apply to you . if you have had allergic reaction to any of those ingredients ( listed under section 4 ) before taking this medicine , tell your doctor . if any part of your body has kidney or liver problems , including renal or hepatic disease , tell the doctor . children and adolescents ( aged 18 years and older ) the risk of dehydration is not known . the examination will be
there are strict laws on the use , handling and disposal of radiopharmaceutical products . somakittoc will only be used in special controlled areas . 29 the nuclear medicine doctor supervising the procedure will decide on the quantity of somakitastoc to be used . the usual dose of somackittoc is 100 to 200 megabecquerel per kg body weight . the nuclear medicines doctor supervises the administration of somacittoc and conduct of the procedure are the same as for radiolabelling , somakitontoc is given as a single injection . after the injection , the test will be repeated at
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with somakit : allergic reactions ( hypersensitivity ) have been reported with somackittoc . symptoms include warm flush , redness of the skin , swelling , itching , nausea and difficulty breathing . allergic reactions may also include stinging at the injection site . this is due to ionising radiation , which can be caused by cancer or hereditary abnormalities . reporting of side effects if you get any side effects talk to your nuclear medicine doctor . this includes any possible side effects not listed in this leaflet . you can also
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only : radiolabelling will be done in accordancewith national regulation . somakit t will be stored at a concentration of 4 to 25 mbq / dl . do not use somakits t if you notice any visible signs of deterioration . radioactive products should be disposed of in accordance accordance with local requirements .
what somakit t contains - the active substance is edotreotide . each vial of powder contains 40 mg edotreaotide ( as 10 - phenanthroline ). - the other ingredients are gentisic acid , mannitol , formic acid ( e421 ), sodium hydroxide , water for injections , sodium and radiolabelling . the solution contains hydrochloric acid . what somakIT t looks like and contents of the pack somakiton t is presented as a white powder in a glass vial with yellow flip - off cap and a clear and colourless solution . the radioactive substance
afinitor is an anticancer medicine that contains the active substance erolimus . everolimus stops the growth and spread of cancer cells . afinitor inhibits the activity of hormone receptor - positive advanced breast cancer ( postmenopausal women ) in women who are treated with non - steroidal aromatase inhibitors ( so - called " serogroups "), which are used to keep the disease under control . afinnitor is also used in combination with a medicine called exemestane ( a steroid aromase inhibitor ) and hormonal anticancer therapy to treat advanced tumours ( neuroendocrine tumours that affect
before starting cancer treatment , you should not be given afinitor if you are allergic to everolimus , sirolimus , temsirolimu or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , talk to your doctor before you are given afginitor . if you have any problems with your liver . if any disease affects your liver , your doctor may prescribe a different dose of afincer . if your doctor has told you that you have diabetes with a high level of sugar in your blood , you may not be able to take afininitor
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet of 10 mg once a day . you should take afinitor at the same time each day . if you have liver problems , your doctor may prescribe a lower dose of afincer . the usual starting dose is 5 mg once daily . your doctor will adjust your dose to 5 mg or 7 . 5 mg if you experience certain side effects . your dose may be adjusted by your doctor . if your doctor determines that you need to stop taking afininitor , your dose
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking afinitor and tell your doctor immediately if you experience any of the following signs of an allergic reaction : difficulty breathing or swallowing swelling of the face , lips , tongue or throat severe itching of the skin with a red rash or raised bumps if you notice any of these , tell your physician immediately . other side effects of afincer include : very common ( may affect more than 1 in 10 people ) - increased temperature - chills ( signs of infection ) - fever - coughing - difficulty breathing - wheezing - inflammation of the lung
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store above 25 . donot open the blister . store in the original package in order to protect from moisture . the tablets should be used immediately after first opening . do this medicine if you notice any visible sign of tampering . do so , and return the tablet to your pharmacist . do away with the blister and write the date you opened it in the space provided on the blister to indicate the date
what afinitor contains the active substance is everolimus . afincer 2 . 5 mg : each tablet contains 2 . 75 mg of everolim . afinnitor 5 mg tablet contains 5 mg of Everolimus in each tablet . afincitor 10 mg tablet : each tablets contains 10 mg of of everlimus in one tablet . the other ingredients are butylhydroxytoluene , magnesium stearate , lactose monohydrate , hypromellose , crospovidone , lactoses anhydrous . what afinitors looks like and contents of the pack afiniter 2
what laventair ellipta is the active substance of lavent air ellipta , is umeclidinium bromide and vilanterol . this belongs to a group of medicines called bronchodilators . what laventAir ellipta looks like and contents of the pack laventive ellipta comes as a clear , colourless inhalation . it is used to treat chronic obstructive pulmonary disease ( copd ). copd is a long - term condition characterised by breathing difficulties that occur every day . the muscles around the airways tighten . this medicine blocks the tightening of these muscles in the lungs
do not use laventair ellipta 31 if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine if you have asthma . warnings and precaution talk to the doctor or nurse before using lavent air ellipta if you : have asthma , have heart problems , have high blood pressure , have an eye problem called narrow - angle glaucoma ( an enlarged prostate , difficulty passing urine , or a blockage in your bladder ), have epilepsy , have thyroid gland problems
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at the same time each day . use laventair ellipta every day . check your doctor if you do not feel better . if you use more lavent air ellipta than you should if you have used more lavantair elliptas than you have been told to use , talk to your doctor straight away . symptoms of using too much laventour ellipta may include a sudden attack of breathlessness
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions if you experience any of the following symptoms stop using laventair ellipta and contact your doctor immediately : uncommon side effects ( may affect up to 1 in 100 people ): skin rash ( hives ) and redness rare side effects : ( may affects up to1 in 1 , 000 people ): swelling mainly of the face or mouth ( angioedema ), which may make you feel very wheezy , coughing , having difficulty in breathing , feeling weak or light headed ( which may lead to collapse or loss of consciousness ). immediate breathing
what laventair ellipta contains - the active substances are umeclidinium bromide and vilanterol . each delivered dose contains 55 micrograms umeklidinia and 65 microgramms umecylidinIUM bromides . - the other ingredients are 22 microgramgrams vilancerol and trifenatate . - each inhalation contains lactose monohydrate ( see section 2 under ' lavent air ellipta contain lactose ') and magnesium stearate . what laventAir ellipta looks like and contents of the pack laventairy ellipta
tovya contains the active substance guselkumab , which is a monoclonal antibody . this medicine contains the type of protein called il - 23 . tremfya is used to treat psoriasis in adults with moderate to severe " plaque psor psorism " an inflammatory condition that affects the skin and nails . it is used in order to improve the condition on the skin , and to reduce symptoms such as scaling , shedding , flaking , itching , pain , burning .
do not use tremfya if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before using tremfia if you have an active infection or active tuberculosis warnings and precaution talk to the doctor before you are given tremfYA if you : have an infection or an infection with tuberculosis . tuberculosis is a serious , sometimes life - threatening condition that can affect up to 36 people . if you get an infection , your doctor may check you for symptoms of an infection
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . tremfya 100 micrograms solution for injection ( 1 pre - filled syringe ) is for injection under the skin ( subcutaneous injection ). it may be given at intervals of up to 4 weeks or up to 8 weeks after the last injection . if you use more tremfia than you should tremfyna should be used only by a doctor who is experienced in the use of tremfYA . if possible , show them the pack . if not , you should contact your doctor . tremfa
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects : signs of serious allergic reaction : difficulty breathing or swallowing , swelling of the face , lips , tongue or throat , severe itching of the skin , a red rash or raised bumps other side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . some side effects may be serious : common ( may affect up to 1 in 10 people ): upper respiratory infections common ( might affect
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . do do not take this medicine if you notice that the solution is cloudy or contains large particles . do away with the pre pre -filled syringe and allow it to reach room temperature ( up to 30 ) before use . do this medicine once it
what tremfya contains - the active substance is guselkumab . each pre - filled syringe contains 100 mg of gusel kumab in 1 ml solution . - the other ingredients are histidine , histidine monohydrochloride monohydrate , polysorbate 80 , sucrose , water for injections . what tremfYA looks like and contents of the pack solution for injection in a vial is a clear , colourless liquid . tremfia is supplied as a carton pack containing one single - dose glass syringe and a multipack containing 2 packs of 1 vial of single - set
the active substance of trepulmix is treprostinil . treprosticinil belongs to a group of medicines called prostacyclins , a hormone that lowers blood pressure by relaxing blood vessels . prostacycylins prevent blood from clotting . trepulemix is used to treat inoperable chronic thromboembolic pulmonary hypertension ( cteph ) in adult patients with persistent or recurrent ctph who are unable to complete surgical treatment or exercise capacity . symptoms of the disease can vary from patient to patient but are usually the same as for chronic throbembolicmonary hypertension . in patients with
do not take trepulmix if you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). if you have a disease called " pulmonary veno - occlusive disease ". this is a disease in which the blood vessels in the lungs become swollen and there is a higher pressure in the blood arteries between the heart and the lungs . if you suffer from severe liver disease . if any of these apply to you , tell your doctor before taking trepulemix . warnings and precautions talk to your doctor or pharmacist before taking this medicine if you : have a heart problem
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . trepulmix is given as a continuous subcutaneous infusion ( subcutaneously ) under the skin through a small tube ( cannula ) in the abdomen or thigh . trepanmix is also given in a hospital setting using a portable pump . you will be given your treprostinil by the pump as directed by your doctor . the pump will be rotated along the infusion line to prevent accidental overdose . the recommended dose is 1 mg , 2 . 5 mg , 5 mg and 10 mg
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): widening of blood vessels pain at the infusion site reaction at the site bleeding or bruising at the infusion site headaches nausea diarrhoea jaw pain common ( might affect up to 1 in 100 people ): dizziness , light - headedness , fainting low blood pressure skin rashes , muscle pain ( myalgia ), joint pain ( arthralgia ) swelling of feet , ankles , legs , fluid retention , hot flush pain in arms and / or legs 36 uncommon ( may effect
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . do away with the vial . store the vials in the original carton in order to protect from light . do use trepulmix if you notice any visible signs of damage such as discolouration or other signs of deterioration . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw
what trepulmix contains - the active substance is treprostinil . trepulemix 1 mg : each vial contains 1 mg treprostail ( as sodium salt ), 10 mg / ml ( 10 mg ) treproprostineil ( sodium salt ). trepulesmix 2 . 5 mg : one vial of 2 . 25 mg trepistinila ( asodium salt ), and 10 mg/ ml ( 25 mg ) of treprosteinil ( also as sodium water ). trepiulmix 5 mg /ml : each milliliter contains 5 mg trepristinile
the active substance of thorinane is enoxaparin sodium . it is a low molecular weight heparin ( lmwh ). thorinanes is used to : 1 ) prevent existing blood clots from forming . 2 ) prevent stopping blood cl clots forming in your blood . thorination is used in adults to : reduce the risk of blood clumps forming in the blood . to : prevent blood clubs forming in or around your blood after an operation . to treat an acute illness called unstable angina . to reduce the chance of bloodclots forming during or after your dialysis machine . to prevent severe kidney
do not use thorinane if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction may include rash , swallowing or breathing problems , swelling of your lips , face , throat or tongue . if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using thorinan : if you have ever had heparin or other low molecular weight heparins ( e . g . nadroparin , tinzaparin , dalteparin ). if you ever had
like other similar medicines ( medicines to prevent blood clotting ), thorinane is used to prevent bleeding . the bleeding should be under control . if you experience any bleeding event that does not stop by itself ( exceptional weakness , tiredness , paleness , dizziness , headache , unexplained swelling ), stop taking your medicine and contact your doctor immediately . if any of the above apply to you ( or you are not sure ), talk to your doctor or pharmacist before taking thorinan . if : you have had a severe allergic reaction ( difficulty breathing , swelling of the lips , mouth , throat or eyes ), blockage of a blood vessel
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store below 25 . after dilution the solution should be used within 8 hours . do this medicine if you notice any particles in the solution . the thorinane pre - filled syringes should be discarded . do away with the syringer . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help
what thorinane contains the active substance is enoxaparin sodium . each pre - filled syringe contains 100 mg of enoxapearin sodium in 0 . 2 ml solution . each vial contains 2 , 000 mg of the active ingredient enoxafarin sodium and is for single use only . the other ingredients are water for injections in 0. 2 ml . what thorinanes looks like and contents of the pack thorinan is a clear , colourless type i neutral glass syringe barrel with fixed needle and needle shield , with chlorobutyl rubber stopper and a blue polypropylene plunger rod .
senstend contains the active substances lidocaine and prilocaine , which are local anaesthetics . senstend is used to prevent lifelong premature ejaculation in adult men . it works by attaching itself to the head of the penis , which allows ejaculation to occur .
do not use senstend if you are allergic to lidocaine , prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using senstender if you have a history of allergy or sensitivity to local anaesthetics ( amide - type local anaesthesia ). if you suffer from a genetic disease or other condition that affects your red blood cells ( glucose and phosphate deficiency ), anaemia ( methaemoglobinaemia ). if any of these apply to you , tell your doctor before using this medicine . medicine sensitivities and sensitivity
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use the recommended dose of senstend is 3 sprays ( 3 sprabs per day ) taken by mouth . 1 spray will be applied on the head of your penis , once every 3 hours for 24 hours . the recommended starting dose is 4 sprays per day . use the spray container to adjust the pump mechanism . avoid contact with eyes , nose , mouth and ears . after using the pump , 1 spray should be applied by pulling down the foreskin of the head
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : common ( may affect up to 1 in 10 people ) inability to develop or maintain an erection in the penis feeling of burning in the area of the penis uncommon ( may effect up to1 in 100 people ) headache local irritation of the throat , irritation of any part of the skin redness failure to ejaculate during sexual intercourse abnormal orgasm tingling in the part of your penis pain or discomfort in the penis itching in the space of your vagina a high temperature . other side effects include : common
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the metal container after exp . the exp date refers to the last day of that month . store below 25 and use within 12 months . do away with the metalcontainer . donot puncture or burn the container . do this after you have finished the product . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what senstend contains - the active substances are lidocaine and prilocaine . each ml of solution contains 150 mg lidocain and 50 mg prilucaine . one spray container contains 50 ml of lidocane and 50 ml prilacaine . - each spray container provides a dose of 7 . 5 ml lidocine and 2 . 5 mg prlocaine per ml . - the colour of each spraycontainer is a clear , colourless to pale yellow solution . - one spray can be stored in a refrigerator ( 2 to 8 ). - each box contains 6 . 5 spray containers , each containing
opdivo is a medicine used to treat advanced melanoma ( a type of skin cancer ) in adults melanoma that has not responded to complete resection in adults ( treatment , including surgery , adjuvant therapy ) advanced non - small cell lung cancer ( a form of lung cancer ) adults advanced renal cell carcinoma ( advanced kidney cancer ) advanced lymphoma if previous therapies have not worked or you have had an autologous stem - cell transplant ( a transplant ) advanced cancer of the head and neck ( advanced urothelial carcinoma ) in patients with bladder and urinary tract cancer , a medicine called nivolum
do not take opdivo if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking opdivone if you : - have problems with your heart , such as a change in the rhythm or an abnormal heart rhythm . - have or have had problems with any of your lungs , such breathing difficulties or cough . - had inflammation of the lungs ( pneumonitis or interstitial lung disease ). - have diarrhoea , watery , loose or soft stools . - experience any symptoms of inflammation of any intestines (
always use opdivo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much opdivoe to use the recommended dose of opdivone is 240 mg given as 2 separate injections ( 480 mg ) once a week for 4 weeks . your doctor will prescribe opdivor in combination with ipilimumab for the treatment of skin cancer . the recommended dosage of opDivo is 1 mg of nivolumab per kilogram of your body weight once a day for 4 consecutive weeks . the dose of ipilimab given as 4 separate injections of opiod
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the exp date refers to the last day of that month . store below 25 and refrigerate ( 2c - 8c ). do not freeze . after dilution , chemical and physical in - use stability has been demonstrated for 48 hours at 2c to 8c . the infusion solution should be used immediately . any unused medicine or waste material should be disposed of in accordance with local requirements .
what opdivo contains the active substance is nivolumab . each ml of concentrate for solution for infusion contains 10 mg of nivlumab ( 40 mg / ml ). each 4 ml vial contains 100 mg of 10 mg nivlyab ( 240 mg /ml ). each 24 ml vials contains 240 mg of the active substances in niviolumab per ml . the other ingredients are sodium citrate dihydrate , sodium chloride ( see section 2 " opdivoa contains sodium "), mannitol ( e421 ), pentetic acid , polysorbate 80 , sodium hydroxide
clopidogrel tad contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopIDogrel tetad is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( such as stroke , heart attack , or death ). you
do not take clopidogrel tad 30 if you are allergic to clopipidogel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , tell your doctor before taking clopridogrelTad . warnings and precautions the following apply to all people taking clapidogl tad : if you think you may be at an increased risk of bleeding if you : have amedical condition
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clubidogl to be given orally once at the start of treatment . then , the recommended daily dose
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel tad contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopidaogrel ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone , macrogol 6000 and hydrogenated castor oil in the tablet core and polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc and macrogrol 3000 in the film - coating . what clopidiogrel tetad looks like and contents
tacrolimus contains the active substance tacrolimos . it is an immunosuppressant . after your organ transplant ( liver or kidney ), your body ' s immune system will try to reject the new organ . tacforius is used to prevent rejection of the transplanted organ by the liver , kidney and heart after any previous treatment that was not successful with your transplantation .
do not take tacforius if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . if you have been given sirolimus , or any macrolide - like antibiotic ( e . g . erythromycin , clarithromycin or josamycin ). tacrolinus immediate release capsules ( e. g . tacforia prolonged - release capsules ) are not recommended for use with tacrolamus . tac forius prolonged -release capsules are not suitable for use
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine should only be prescribed by a doctor experienced in the treatment of transplant patients . patients who are already taking the same tacrolimus medicine but have had a transplant will receive a different tacroleus medicine . always take this medication exactly as described in this leaflet or as your caregiver will tell you . you should check with the doctor or nurse if you think any of these apply to you . if you have any further questions on the use of this medicine , ask your doctor , pharmacist
like all medicines , this medicine can cause side effects , although not everybody gets them . infections can be serious and you must stop taking tacforius and seek medical attention immediately if you experience any of the following serious or severe effects : allergic and anaphylactic reactions ( benign or malignant tumours ) which have been reported during tacforia treatment . pure red cell aplasia ( a very severe reduction in red blood cell counts ) and agranulocytosis ( a severely lowered number of white blood cells ) and haemolytic anaemia ( decreased number of red blood cells due to abnormal breakdown ) and fe
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). discard all the prolonged - release hard capsules within 1 month after opening the aluminium wrapping . do away with the capsules after this period . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what tacforius contains the active substance is tacrolimus . tacforia 0 . 5 mg : each capsule contains 0 . 25 mg of tacrolamus ( as monohydrate ). tacforian 1 mg : one capsule contains 1 mg of ticrolimas ( asmonohydrate ). each capsule of tacforio 3 mg : three capsules contain 3 mg of of tacrulimus (as monohydrate ) . each capsule is available in two strengths . tacofius 5 mg and 5 mg are available in four strengths . each tablet contains 5 mg of copper of taclimus (" monohydrate "). the
clopidogrel zentiva contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopIDogrelzentiva is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( such as stroke , heart attack , or death
do not take clopidogrel zentiva : if you are allergic ( hypersensitive ) to clopipidogl or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , do not take the combination of clopidiogrelzentiva and talk to your doctor . warnings and precautions the following apply to all people taking clopidineogrel ventiva . if : you have an increased
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel zentiva per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clubidogl zenta ( 4 tablets of 75 mg ) once at
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the blister tightly closed in order to protect from light . do away with clopidogrel zentiva if it is accidentally frozen in aluminium blisters . do this by placing the blister in the original carton in order protect from moisture . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw
what clopidogrel zentiva contains the active substance is clopridogrel . each tablet contains 75 mg of clopigrel ( as hydrogen sulphate ). see section 2 ' clopiderel zertiva contains lactose ' and ' clapidogl zentva contains hydrogenated castor oil '. the other ingredients are mannitol ( e421 ), hydrogenatedcastor oil , microcrystalline cellulose , macrogol 6000 , low - substituted hydroxypropylcellulose , lactose monohydrate ( milk sugar ), hypromellose ( e464 ), triacet
yttriga is a radioactive medicine that is stored in a hospital or clinic . it is stored either in the original package or in a refrigerator ( 2 - 8 ). when yttrigba is prepared in the hospital or in the clinic , it is used either as another medicine or as tiny radiation doses . the treatment is a radiolabelled medicinal product .
do not use yttriga - if you are allergic ( hypersensitive ) to chloride or any of the other ingredients of yttiga - tell your doctor if you think you may be pregnant or are planning to become pregnant . warnings and precautions talk to your doctor , pharmacist or nurse before using yttrada - yttrida is a radioactive medicine . it is not to be used in combination with another medicinal product . - radiopharmaceuticals are not to transmit radioactivity . yttarga contains radioactive material . radioactive medicinal products are to be disposed of in accordance with national regulation on radioactive medicinalproducts
the treatment will be supervised by a doctor experienced in the diagnosis and treatment of patients with certain specific diseases . the treatment will consist of a single dose and will be administered under the supervision of a physician experienced in diagnosis and the treatment of drug dependence . method of administration yttriga is for radiolabelling of medicinal products for specific diseases only . if you are given yttrada by mistake or by overdose , you will receive appropriate treatment .
like all medicines , yttriga can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
yttriga will be stored under the responsibility of the specialist in appropriate premises . local regulations on radioactive substances are in place to protect the environment . any unused product or waste material should be disposed of in accordance with local requirements .
what yttriga contains - the active substance is chloride . 1 ml sterile solution contains 1 mg of hydrochloric acid ( equivalent to 3 mg / ml ). what yttrada looks like and contents of the pack yttiga is a clear , colourless type i glass vial with a flat bottom and a silicon stopper and an aluminium seal .
ciambra is a medicine used in the treatment of cancer . ciambra contains cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , in patients who have not received prior chemotherapy . cimbra is also used in combination with cisplin for the initial treatment of patients with advanced stage of lung cancer . how ciamba works lung cancer can be treated if your disease has responded to treatment or it remains largely unchanged after initial chemotherapy . how it works ciamb is a treatment for patients with moderate stage
do not use ciambra if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients of ciamb ( listed in section 6 ). if you plan to stop breast - feeding during treatment with ciamba , please tell your doctor . if you have recently received or are about to receive a vaccine against yellow fever , please inform your doctor before using ciamBra . if any of these apply to you , tell your physician before using it . if there are any signs of problems with your kidneys , please talk to your doctor or pharmacist before using this medicine . before each infusion , your doctor
the dose of ciambra is 500 micrograms per kilogram of your body ' s surface area . your height and weight are measured to work out the surface area of your entire body . your doctor will work out this body surface area based on your weight and height and will adjust your dose , depending on your response to treatment and on your blood cell counts . your healthcare professional will have mixed the ciamra powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution before it is given to you . ciamba will be given to your doctor by infusion into one of your veins . the infusion will last
like all medicines , this medicine can cause side effects , although not everybody gets them . 52 tell your doctor immediately if you experience : fever or infection ( common ): if you have a temperature of 38Âºc or greater , sweating or other signs of infection ( since you may have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if you get chest pain ( common ) or a fast heart rate ( uncommon ). if you develop pain , redness , swelling or sores in your mouth ( very common ) if you suffer from allergic reaction ( common ). if
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . store below 25 . do away with the reconstituted solution immediately . if the infusion solution is not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 -8 , 8 , 15 and 25 . any unused solution must be
what ciambra contains the active substance is pemetrexed . each vial of ciamba 100 mg contains 100 mg of pemetreed ( as pemetrhyded disodium hemipentahydrate ). each vials of cimbra 500 mg contains 500 mg of the active ingredient pemetereed (as pemetirhyd disodium semipent ahydrate ) after reconstitution , the solution contains 25 mg / ml of pemphigus . further dilution by a healthcare professional is required prior to administration . the other ingredients are mannitol ( e421 ), hydro
immunogam belongs to a group of medicines called immunoglobulins ( antibodies ). immunogam can help to prevent certain infections from getting in your blood . immunogamer can be used in adults to prevent increased levels of human hepatitis b immunoglubulins , immunoglobinulin g ( ig ) and immunoglofluoride in blood plasma of screened adults . immunoglogam is used in combination with hepatitis b virus in haemodialysed patients . vaccination is a natural response to a hepatitis birus carrier . immunommunogams can stimulate an immune response that includes trace amounts of
immunogam should not be given if you have an allergic reaction to human immunoglobulins or other blood products . if you suffer from an iga deficiency , an allergic response to iga containing products should be considered . children and adolescents immunogam is not recommended for use in children and teenagers under 18 years of age . immunoglubulins have not been studied in this age group . adverse reactions such as chills , headache , fever and vomiting have been reported . allergic reactions such nausea ( arthralgia ) have been associated with joint pain and low blood pressure . moderate low back pain has been
immunogam will be given to you by a doctor or nurse who is experienced in the care of vaccination against hepatitis b virus . the first vaccine dose will be administered in combination with human hepatitis b immunoglobulin ( hbv ). dosage and administration prevention the recommended dose of hepatitis b is 500 micrograms given every 24 hours for 72 days . the recommended recommended dose for hepatitis b in haemodialysed patients is 500 international units ( iu ) given every 2 weeks . seroconversion is the first step in vaccination . immunogam must be administered by a hepatitis b vaccine carrier . the hepatitis b
like all medicines , immunogam can cause side effects , although not everybody gets them . the following side effects have been reported : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) rare ( affects less than 1 users in 10 , 000 ): very rare ( affecting less than1 user in 1, 000 ) not known ( frequency cannot be estimated from the available data ): undesirable effects during clinical trials with immunogamer , the injection site was not injected into the muscle . very common : may affect more than1 in 10
keep out of the reach and sight of children . do not use immunogam after the expiry date which is stated on the carton and on the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . donot use immunogieam if the solution is cloudy or contains deposits . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what immunogam contains - the active substance is human hepatitis b immunoglobulin . immunogaman 1 mg / ml solution for injection contains 5 mg of human plasma protein ( equivalent to 96 mg / m2 ). - the other ingredients are polysorbate 80 . what immunogams looks like and contents of the pack immunogamer is a solution forjection in a glass vial . it is a clear to slightly opalescent , colourless to pale yellow liquid . each pack contains 1 vial of immunogamation .
remicade contains the active substance infliximab . inflixamab is a monoclonal antibody a type of protein that recognises and attaches to a specific target in the body called tumour necrosis factor ( tnfÎ± ). remicade belongs to a group of medicines called ' tnfs blockers '. it is used to treat the following inflammatory diseases : rheumatoid arthritis psoriatic arthritis ankylosing spondylitis ( bechterew ' s disease ) psoriasis . remicades is used in adults , adolescents and children aged 6 years and older with crohn
do not take remicade if you are allergic to infliximab or any of the other ingredients of remicades ( listed in section 6 ) if you think you may be allergic ( hypersensitive ) to any of these active substances if you have tuberculosis ( tb ) if your doctor has told you that you have another serious infection , such as pneumonia , sepsis or heart failure if you drink alcohol before or during remicada . if you take remicanade more often than you should if you accidentally take too many remicad tablets , contact your doctor or pharmacist immediately . if any of this applies to
the recommended dose is : rheumatoid arthritis the recommended dose for adults is 3 mg for every kg of body weight . psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ), psoriasis , ulcerative colitis and crohn ' s diseases the recommended dosage for adults and children is 5 mg for each kg of person body weight , given once a week . how remicade is given remicine is given as an infusion ( drip ) over 2 hours into one of your veins ( usually in your arm ). the third treatment will be given once every week .
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some patients may experience serious side effects and may require treatment . tell your doctor straight away if you notice any of the following side effects . your doctor may decide to temporarily or permanently stop your treatment with remicade : - an allergic reaction : - swelling of your face , lips , mouth or throat which may cause difficulty in swallowing or breathing , skin rash , hives , swelling of the hands , feet or ankles . these reactions are rare but could be serious . an allergic allergic reaction may occur within
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store below 25 . do away with remicade if it is not used immediately . infusion - related storage times and conditions are the responsibility of the user and would normally not be longer than 3 hours at 2 8 and 28 . however , if you are treated for an additional 24 hours at 25 , your doctor may decide to delay removal of
what remicade contains the active substance is infliximab . each vial contains 100 mg of inflixab . after dilution each ml contains 10 mg of infiximb . the other ingredients are sucrose , polysorbate 80 , monobasic sodium phosphate , dibasicodium phosphate . what remicada looks like and contents of the pack remicad is supplied as a glass vial containing a powder for concentrate for solution for infusion . the powder is white to off - white . remicades is available in packs containing 1 , 2 , 3 , 4 or 5 vials .
rasagiline mylan is used to treat parkinson ' s disease in adults . it is used in combination with levodopa ( another medicine used to control parkinson " s disease ). with parkinson ', s disease there is a loss of cells that produce dopamine in the brain . dopamine is a chemical in the body involved in movement control . rasagilinea mylan increases the amount of dopamine in your brain .
do not take rasagiline mylan if you are allergic to rasaga or any of the other ingredients of this medicine ( listed in section 6 ). if you have severe liver problems . if you take any of any of these : - the following medicines may affect the way rasaline mylan works : monoamine oxidase ( mao ) inhibitors , used to treat depression and parkinson ' s disease . - medicinal and natural products such as st . john ' s wort . pethidine , a strong pain killer . children and adolescents rasaggiline melan treatment should be stopped or treatment stopped
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 tablet once a day . take the tablet at about the same time each day . you can take the tablets with or without food . the tablet can be taken with or just after a meal . try to take the dose at about 1 hour before or with food . it is best to take your tablet by mouth at about about the time each morning . if you take more rasagiline mylan than you should if you accidentally take too many tablets , contact your doctor immediately .
like all medicines , this medicine can cause side effects , although not everybody gets them . side effects of rasagiline mylan are similar to those of placebo . the frequency of possible side effects listed below is defined using the following convention : very common abnormal movements ( dyskinesia ) headache common abdominal pain uncommon rare ( may affect up to 1 in 1 , 000 people ) rare ( might affect upto 1 in 10 , 000 persons ) very common abnormalities movements ( dysphinesia ); headache common abdomen pain fall allergy ; fever flu ( influenza ); feeling of being unwell ; neck pain chest pain ( angina pector
what rasagiline mylan contains - the active substance is rasagailine . each tablet contains rasgiline tartrate equivalent to 1 mg rasgailine - the other ingredients are microcrystalline cellulose , tartric acid , maize starch , pregelatinized maize starch ( maize ), talc , stearic acid . what rasaggiline milan looks like and contents of the pack rasvagiline tablets are 11 . 5 mm x 6 mm , white to off - white , biconvex tablets debossed with " r " on one side
do not use hulio if your child is allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if your or your child ' s child has a severe infection , including tuberculosis . if your / your child has symptoms of infections such as fever , wounds , feeling tired , dental problems . if you / your son has moderate or severe heart failure . if the child has had a serious heart condition . allergic reaction if your/ your child experiences allergic reactions with symptoms such as chest tightness , wheezing , dizziness , swelling or a rash , stop using hulios and
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . polyarticular juvenile idiopathic arthritis in children and adolescents from 2 to 17 years old weighing 10 kg or more the usual dose is 30 mg once a day . hulio is available as 20 mg once daily . in children from 2 - 17 years of age weighing 30 kg or less the usual dosage is 30mg once a daily . hula is available in two strengths : 40 mg once weekly . enthesitis - related arthritis in adults from 6 to 17 year old weighing 15 kg or 30
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate and may not require urgent medical treatment . tell your doctor straight away if you notice any of the following side effects ( see section 4 , " warnings and precautions "): since the last hulio injection , you may have experienced allergic reaction ( including heart failure ). severe rash or hives swollen face , hands or feet , trouble breathing or swallowing , pale complexion , dizziness , persistent fever , bruising or bleeding . signs and symptoms of infection such as fever , feeling sick , wounds , dental problems , burning on
what hulio contains - the active substance is adalimumab . - the other ingredients are monosodium glutumate , sorbitol , methionine , polysorbate 80 , hydrochloric acid and water for injections . what hulios looks like and contents of the pack hulIO 40 mg is a sterile solution for injection containing 40 mg of adalimimumab in 0 . 8 ml of solution . it is clear and colourless to slightly opalescent . it has a rubber stopper and is supplied in packs containing 1 , 2 , 1 sterile injection syringe , 1 syringe
the active substance of yellox is bromfenac . it belongs to a group of medicines called non - steroidal anti - inflammatory drugs ( nsaids ), which reduce inflammation . yellox may be used to treat eye inflammation following cataract surgery in adults .
do not use yellox - if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has prescribed a medicine that treats asthma , skin allergy or intense inflammation in your nose . - if using other nsaids ( such as acetylsalicylic acid , ibuprofen , ketoprofen or diclofenac ). this medicine may be used with topical steroids ( suchas cortisone ) which may increase the risk of unwanted side effects . - bleeding problems if you have haemophilia in the past and you are
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose of yellox is one drop in the affected eye ( s ) each day . the recommended starting dose is one single drop in your eye (s ) each 2 weeks . the drops should be used on the next day after your cataract surgery . method of administration yellox is for oral use . wash your hands before using the eye drops . remove the bottle cap from the bottle . hold the bottle , pointing down with your thumb and fingers , close your head ,
what yellox contains - the active substance is bromfenac . each ml of solution contains bromenac ( as sodium sesquihydrate ). each vial contains 33 mg of bromnac . - the other ingredients are boric acid , borax , sodium sulphite anhydrous , benzalkonium chloride , tyloxapol , povidone ( k30 ), disodium edetate and sodium hydroxide to maintain acidity levels . what yellox looks like and contents of the pack yellox is a clear yellow liquid ( solution ) supplied in a glass v
dzuveo contains sufentanil , which belongs to a group of strong painkillers called opioids . sufENTanil is used to treat sudden moderate - to - severe pain in adults .
do not take dzuveo if you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious lung or breathing problem . warnings and precautions talk to your doctor or pharmacist before taking dzuvoo if : you have any condition that affects your breathing ( such as asthma , wheezing or shortness of breath ). dzuuveo may affect your breathing during treatment . you have recently had a head injury or brain tumour . you suffer from problems with your heart and circulation such as slow heart rate , irregular heartbeat , low blood volume
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the single - dose administration device is for oral use only . swallow the tablet whole with a drink of water . you can take this tablet with or without food . dzuveo must be taken with strong painkillers such as sufentanil 30 mg / ml . the sublingual tablet must be swallowed whole with the disposable single -dose applicator . the applicator should be inserted into the tongue . if the tablets dissolve in the tongue , pain relief should be experienced immediately after swallowing . the
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects : severe breathing problems , especially slow and shallow breathing . if you get any of these side effects contact your doctor immediately . very common side effects ( may affect more than 1 in 10 people ): nausea , feeling sick , vomiting , being sick and feeling hot . common side side effect ( may affects up to 1 in every 10 people ) are : inability or difficulty sleeping , feeling anxious or confused , dizziness , headache , drowsiness , feeling sleepy ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do this medicine if you notice any visible signs of deterioration . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help protect the environment .
what dzuveo contains - the active substance is sufentanil . each tablet contains 30 mg of suffentinil ( as citrate ). - the other ingredients are mannitol , dicalcium phosphate , hypromellose , croscarmellose sodium , indigo carmine , stearic acid , magnesium stearate . what dzuvello looks like and contents of the pack dzuvelto is a white to off - white , round tablets , with " nvr " on one side and " 3 " on the other side . it is supplied as a single -
what erleada is erleADA is a cancer medicine that contains the active substance apalutamide . it is used to treat adult men with prostate cancer that has spread to other parts of the body and cannot be treated with surgical treatments . it also treats adult men who have sensitive prostate cancer which has spread beyond the original body and has not responded to surgical treatment . it works by reducing the amount of testosterone in the blood . what erlead is used for erlea is used in adult men to treat resistant prostate cancer . erleade works by blocking the action of androgens , which are involved in the growth and
do not take erleada - if you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). - if pregnant or planning to become pregnant ( see pregnancy , contraception section ). warnings and precautions talk to your doctor or pharmacist before taking this medicine . this medicine should not be used if you have a history of seizures . - if taking any medicines to prevent blood clots ( e . g . warfarin or acenocoumarol ). - tell your doctor if you suffer from any heart or blood vessel conditions , such as heart rhythm problems ( arrhythmia
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg once a day . your doctor may increase your dose to 60 mg once daily depending on how you respond to erleada . take this leaflet and this medicine by mouth . you can take erleade with or without food . it is important that you take erlada with or just after food . other medicines and erlead tell your doctor if you take , have recently taken or might take any other medicines . if you forget to take erelada if you miss
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking erleada and see a doctor immediately if you experience any of the following symptoms : reddish , non - elevated , target - like , circular patches on the trunk , central blisters , skin peeling , ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes may be accompanied by fever and flu - like symptoms . toxic epidermal necrolysis ( see section 2 ). serious side effects tell your doctor straight away if you notice any of these serious side side effects : fits ( seizure )
what erleada contains - the active substance is apalutamide . each film - coated tablet contains 60 mg of apaluamide . - the other ingredients are colloidal anhydrous silica , croscarmellose sodium , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose , silicified microcrystine cellulosa . - film coat : the film - coating contains iron oxide black ( e172 ), iron oxide yellow ( e 172 ), macrogol , polyvinyl alcohol , talc , and titanium dioxide ( e171 ). what erleADA
this medicine is a radiopharmaceutical product . axumin contains the active ingredient fluciclovine . it is used to carry out a scan ( a pet scan ) in adults who have previously had treatment for prostate cancer . it may be used together with other tests to determine prostate specific antigen ( psa ) that may indicate the cancer is advanced . an axumin pet scan may be performed if the cancer has spread to other parts of the body . the scan will be recorded on the patient alert card . your doctor or nurse will record the results of the procedure on the radiopharmacon .
do not use axumin - if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using axumin . - if your doctor has told you that you have kidney problems . - you should follow a low sodium diet . - axumin is given once a day for a day . the axumin scan will last about 4 hours . during the scan , you will be given your usual medicines to take during the latest 60 minutes before the axus injection . - urination will be interrupted during the scanning . children and
there are strict laws on the use , handling and disposal of radiopharmaceutical products . axumin must only be used in special controlled areas . this medicine must only ever be used by professionals who are trained and qualified to use it safely . these persons will take special care for the safe use of this medicine and will keep you informed of their actions . the nuclear medicine doctor supervising the procedure will decide the quantity of axumin to be used . the usual dose is 370 megabecquerel per kilogram of body weight . axum will be administered to you by a nuclear medicine physician . the doctor supervises the procedure
like all medicines , this medicine can cause side effects , although not everybody gets them . in clinical studies , the following side effects were reported : very common ( affects more than 1 user in 100 ) the effects of the medicine were mild . common ( effects 1 to 100 users in 1 , 000 ) the following effects were experienced : pain , rash , altered taste in the mouth , altered sense of smell . this radiopharmaceutical emits low amounts of ionising radiation ( this is normally harmless for cancer and hereditary abnormalities ). reporting of side effects if you get any side effects talk to your nuclear medicine doctor . this includes any possible side effects
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only .
what axumin contains - the active substance is fluciclovine . axumin 1600 mg : each vial contains 1600 mg of fluciniclovine ( as as as formulated in the european medicine ). - the other ingredients are : 16000 mg axumin 3200 mg : one vial of 3200mg of fluiclovin ( as formulated for the eurocean medicine ) 3200 micrograms ( as formulation in the international medicine ) 32000 microgram the other ingredient is sodium citrate , concentrated hydrochloric acid and sodium hydroxide ( see section 2 " axumin with sodium
azopt contains brinzolamide which belongs to a group of medicines called carbonic anhydrase inhibitors . these help to reduce pressure within the eye . azopt eye drops help to relieve high pressure in the eye , which can lead to an illness called glaucoma . the pressure in your eye increases , and this can damage your sight .
do not take azopt if you have severe kidney problems . if you are allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to medicines containing sulphonamides . if any of these apply to you , tell your doctor . if your doctor has told you that you have diabetes or infections . if the dose of diuretics ( water tablets ) is too low , tell you . warnings and precautions talk to your doctor before taking azopt . the same allergy may apply to some people . if there is too much acidity in your blood
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . azopt is used in both eyes . use azopt in both affected eyes : 1 drop in each affected eye . use in both the eyes : 2 drops in each infected eye . 3 drops in both infected eyes : use the azopt bottle with your hands . remove the cap . remove it from the bottle and put the cap back on with a snap collar . hold the bottle tightly with your thumb or finger . tilt your head back . pull down your eyelid with a clean finger until there is a '
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with azopt : common side effects ( may affect up to 1 in 10 people ) - effects in the eye : blurred vision , eye irritation , eye pain , eye discharge , itchy eye , dry eye , abnormal eye sensation , redness of the eye . other side effects : bad taste . uncommon side effects - effects ( might affect up in 1 in 100 people ) ( effects in both eyes ): sensitivity to light , inflammation or infection of the conjunctiva , eye swelling , eyelid itching , red ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and bottle after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . to protect from infections , a pack containing a single bottle should be used immediately .
what azopt contains - the active substance is brinzolamide . each ml contains 10 mg of brinzaolamide ( as benzalkonium chloride ). - the other ingredients are carbomer 974p , edetate disodium , mannitol , purified water , sodium chloride , tyloxapol , hydrochloric acid and sodium hydroxide ( to maintain acidity levels and ph levels ). what azopt looks like and contents of the pack azopt is a milky liquid ( a suspension ) supplied in a 5 ml plastic ( droptainer ) bottle with a screw cap . a pack
the active substance of forxiga , dapagliflozin , belongs to a group of medicines called medicines taken by mouth . it is used to treat diabetes by controlling the level of sugar in your blood . it can be used in adults and adolescents ( aged 18 years and older ) and children and adolescents . forxigo is used in two types of diabetes : type 1 diabetes that occurs when your body does not produce any insulin . for xiga is used for type 1 in people who are overweight or obese . type 2 diabetes : when your own body does make too much insulin or if the insulin that your body makes does
do not take forxiga - if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking forxigo : - if any of these apply to you , tell your doctor immediately . - if your doctor notices any of your following : - feeling sick or being sick , stomach pain , excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness , a sweet smell to your breath , asweet or metallic taste in your mouth , a different odour to your urine or sweat ,
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . forxiga is for oral use . type 2 diabetes : the usual dose is one tablet a day . your doctor may increase your dose to 10 tablets a day ( 5 mg ) if you have a liver problem . your dose of forxigo is for adult patients with type 1 diabetes : your doctor will increase your daily dose to 5 tablets a morning . taking this medicine swallow the tablet whole with some water . for xiga can be taken with or without food . your blood sugar can be increased if you
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are angioedema ( seen very rarely , may affect up to 1 in 10 , 000 people ). angioEDema may cause swelling of the face , tongue or throat , difficulties swallowing , hives and breathing problems . diabetic ketoacidosis ( seen commonly , may affects up to1 in 10 people ) is a complication of type 2 diabetes . it can also occur in up to one in 1 , 000 patients . diabeticketoacidemia ( seen rarely , might affect up in 1 in 100 people ) may
what forxiga contains - the active substance is dapagliflozin . each forxigo 5 mg film - coated tablet ( tablet ) contains dapablifloin propanediol monohydrate equivalent to 5 mg dapapagllozin - the other ingredients are : tablet core : microcrystalline cellulose ( e460i ), lactose ( see section 2 under ' forxigiga contains lactose '), crospovidone , silicon dioxide , magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), macrogol 3350 , tal
mifamurtide stops the growth of certain bacteria and so reduces their activity . this will strengthen the immune system . mepact is used to treat osteosarcoma ( bone cancer ) in adults and adolescents aged 2 and 30 years . it is used when surgery is not possible to remove the tumour and chemotherapy is not able to stop cancer cells from growing . it reduces the amount of cancer that can be passed on to your child and keeps it at a low level . it also helps to prevent cancer from coming back .
do not take mepact if you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). if you have taken medicines containing ciclosporin or other calcineurin inhibitors ( non - steroidal - anti - inflammatory drugs ). nsaids can affect your heart or blood vessels , which may result in blood clots ( thrombosis ), bleeding ( haemorrhage ), inflammation of the veins ( vasculitis ). warnings and precautions talk to your doctor or pharmacist before taking mepactor if any of these apply to you . some of
treatment mepact will be given to you by a doctor or nurse . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of mepACT is 2 mg mifamurtide once a day . your doctor may increase your dose to 12 mg once a week for up to 24 weeks . your dose may be adjusted by your doctor depending on your mepact treatments and on your chemotherapy schedule . your chemotherapy will be repeated every 36 weeks . duration of treatment you will receive mepat once a month . if you have an interruption in
like all medicines , mepact can cause side effects , although not everybody gets them . chills , fever and fatigue have been reported in patients receiving mepACT ( transient ) paracetamol . fever has been reported during treatment with mep act . stomach problems ( nausea and vomiting ) and loss of appetite have been very common in patients who have received chemotherapy . tell your doctor immediately if you experience continuing fever and chills within 8 hours after receiving mepenact . if you develop an infection ( such as rash ), or any problems breathing ( such like wheezing ), tell your physician immediately . tell the doctor if you
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in outer carton in order to protect from light . reconstituted suspension contains sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection or infusion within 6 hours . do this medicine if you notice any visible sign of deterioration . do throw away any medicines via wastewater or household waste . ask your
what mepact contains the active substance is mifamurtide . each vial contains 4 mg of mifamanurtide ( as suspension ). after reconstitution , each ml of suspension contains 0 . 08 mg mifamate . the other ingredients are 1 - palmitoyl - 2 - oleoyl- sn - glycero - 3 - phosphocholine ( see section 2 under ' mepacts contains lactose '), 2 - dileoylu - sn - glyco - 5 - sodium monosodium salt ( see also section 2 " mepACT contains lactate "). what
mirvaso contains the active substance brimonidine which belongs to a group of medicines called alpha agonists . it works by reducing the skin ( especially the face ) redness associated with rosacea , which is a severe form of redness of the face . rosica is a very common form of high levels of blood flow in theacial skin which can lead to enlargement ( dilution ) of the small blood vessels of the skin . mirvaso acts by blocking the blood vessels , which help to prevent the excess blood flow and redness .
do not take mirvaso if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 and section 2 " possible side effects "). if you take the medicine under the skin ( for example , if you have taken certain medicines for depression or parkinson ' s disease , such as monoamine oxidase ( mao ) inhibitors , such such as selegiline , moclobemide , tricyclic antidepressants ( such as imipramine ), tetracyclic antidepressant ( suchas maprotiline ), mianserin or mirtazap
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . mirvaso is applied to the skin ( usually on the face ) only . this medicine is only applied to areas of your body that are sensitive to the sun . this applies to body surfaces such as your eyes , mouth , nose or vagina . do not use mirvasos more than once a day . if you use more mirvasoe mirvasoa is only used on the affected face . the treatment should be started with a small amount of gel ( a pea - sized amount ). if your symptoms
like all medicines , this medicine can cause side effects , although not everybody gets them . uncommon side effects : severe skin irritation , inflammation , skin rash , skin pain or discomfort , dry skin , warm skin sensation , tingling , sensation of pins and needles or swelling . common side effects ( may affect up to 1 in 10 people ): worsening of rosacea . the treatment should be stopped immediately if symptoms persist ( see section 2 ' warnings and precautions '). contact allergy if you have allergic reaction such as rash , rare angioedema ( a serious allergic reaction with swelling mainly of the face , mouth and tongue ), stop taking
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and tube and pump after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the tube and bump tightly closed in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what mirvaso contains - the active substance is brimonidine . each ml of gel contains 3 . 3 mg of brimonine . each vial contains 5 mg of the active ingredient brimonate tartrate . - the other ingredients are carbomer , methylparahydroxybenzoate , phenoxyethanol , glycerol , titanium dioxide ( e171 ), propylene glycol , sodium hydroxide , purified water ( see section 2 " mirvasoa contains methylparhydroxy benzoate "), propylene Glycol . what mirvasos looks like and contents of the pack mirvasoe
mvasi contains the active substance bevacizumab , which is a humanised monoclonal antibody ( a type of protein that recognises and attaches to a specific target in the immune system , the body ' s natural defences ). it is used to protect the body from infection and cancer . bevacsizumb binds selectively to a protein called human vascular endothelial growth factor ( vegf ), which is found in large lymph vessels all over the body . the vegF protein is found on blood vessels where it stimulates the blood vessels to produce more oxygen . be vacizumsab causes tum
do not use this medicine if you are allergic ( hypersensitive ) to bevacizumab or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic ( allergic or hypersensitive ), to chinese hamster ovary ( cho ) cell products if you or your child are pregnant . warnings and precautions talk to your doctor or pharmacist before using mvasi . mvasis may increase the risk of developing holes in the gut wall ( inflammation inside the abdomen ), such as diverticulitis , stomach ulcers , colitis or chemotherapy . mvai may increase your
dose and frequency of administration your doctor will work out the dose of mvasi you will receive based on your body weight and the type of cancer you have . the recommended dose is 5 mg , 7 . 5 mg or 10 mg per kg of body weight . the dose may be increased or decreased by up to 15 mg per kilogram of your bodyweight . your doctor may decide to increase or decrease the dose or stop mvasia depending on your condition and on how you respond to mvasis . you will be treated with mvasic for 2 or 3 weeks . the number of infusions you receive will depend on how
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with mvasi : side effects that may occur during treatment with mvai with chemotherapy . these side effects are usually mild to moderate and usually disappear after a few days . if they occur during or after treatment with the mvasis , tell your doctor immediately . allergic reactions if you have an allergic reaction , you may experience difficulty in breathing , chest pain , redness and flushing of the skin , a rash , chills or shivering , feeling sick ( nausea ) or being sick ( vomiting ). other side
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outercarton in order to protect from light . infusion solutions should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 8 unless dilution has taken place
what mvasi contains the active substance is bevacizumab . each ml contains 25 mg of bevacsizumb in 1 . 4 ml or 16 . 5 ml of solution . each 4 ml vial contains 100 mg of the active substances ( bevaconizumib in 1. 4 ml ). each 16 ml vials contains 400 mg of of bevoacizumaab in 16 .5 ml of water . the other ingredients are trehalose dihydrate , sodium phosphate , polysorbate 20 and water for injections . what mvasis looks like and contents of the pack m
tecartus is a gene therapy medicine used to treat mantle cell lymphoma . it is used in adults , adolescents and children who are not able to take other medicines . it works by inhibiting the growth of refractory mantle cell cancer ( b - lymphocytes ) in your own white blood cells . it can be used in combination with autologous anti - cd19 - transduced cd3 + cells . mantle cell lipoma is a cancer that affects the immune system ( the body ' s natural defences ) and affects the number of b - cells . in mantle cell skinoma , b - cell lymphocytes multiply in
do not use tecartus if you are allergic to any of the ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before using tecartuse if you : - have a problem with the number of white blood cells in your blood ( lymphodepleting chemotherapy , which may take 3 weeks to produce white blood cell ) - have problems with autologous use . - have tests or checks of your lungs , heart , kidney , blood pressure , infection or inflammation of your cancer ( graft - versus - host disease ) -
tecartus is made from your own white blood cells . your cells will be collected by a specialised healthcare professional . your cell will be given to you by a catheter placed in your vein ( a procedure call leukapheresis ). the amount of your white blood cell in your blood will be measured by your doctor . the recommended dose is : one infusion of tecartus in your bloodstream , taken by infusion into your vein , every 3 weeks for 6 weeks . the number of yourwhite blood cells will then be reduced by 2 to 3 milligrams per kilogram of body weight . medicines given before tecartuse
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss your side effects with you . if you notice any of the following side effects you may need urgent medical attention . the following serious side effects have been reported during the tecartus infusion : very common ( may affect more than 1 in 10 people ): fever , chills , reduced blood pressure . symptoms may include dizziness , lightheadedness , fluid in the lungs . all symptoms could be signs of a condition called cytokine release syndrome . loss of consciousness , decreased level of consciousness including confusion , memory loss , disturbances of brain function
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . infusion bag : store in the original package in order to protect from light . liquid nitrogen : the recommended dose is 150 mg . this medicine contains genetically modified human blood cells and human - derived material . the product is stable for 36 hours at 2 - 10 . do throw away any medicines via wastewater or household waste . ask your pharmacist how
what tecartus contains - the active substance is autologous anti - cd19 - transduced cd3 + cells . each specific single infusion bag contains a dispersion of anti -cd19 car t cells equivalent to 68 cd3 cells per 2 ml of solution . - the other ingredients are : 106 anti - cd19 , sodium chloride and human albumin ( see section 2 " tecartuses contains sodium "). what tecartu looks like and contents of the pack tecartub is a concentrate for solution for infusion . it is supplied as an infusion bag packed in a metal cassette . a single infusionbag contains
januvia contains the active substance sitagliptin which belongs to a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4 inhibitor ) that lowers blood sugar levels in adult patients with type 2 diabetes mellitus . this medicine helps to increase the levels of insulin produced after a meal and decreases the amount of sugar made by the body . your doctor has prescribed this medicine to help lower your blood sugar , which is too high because of your type 2abetes . this medication can be used alone or with certain other medicines ( insulin , metformin , sulphonylureas , or gl
do not take januvia - if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have inflammation of the pancreas ( pancreatitis ). warnings and precautions talk to your doctor or pharmacist before taking januvi if you have : - blistering of the skin - bullous pemphigoid ( see section " other medicines and januvins "). this is a disease of the pancreatreas that can be life threatening . - pancreatitis can be fatal in some patients . - gallstones .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 100 mg film - coated tablet 63 once daily by mouth . if you have kidney problems , your doctor may prescribe a lower dose of 25 mg or 50 mg . you should continue taking this medicine until your doctor tells you otherwise . your doctor will tell you how many tablets to take . this medicine can be taken with or without food . your dose may be adjusted by your doctor if you take certain other medicines that lower blood sugar . diet and exercise can help your body use its blood sugar
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking januvia and contact a doctor immediately if you notice any of the following serious side effects : severe and persistent pain in the abdomen ( stomach area ), which might reach through to your back , nausea and vomiting . these may be signs of an inflamed pancreas ( pancreatitis ). if you have a serious allergic reaction ( frequency not known ), including rash , hives , blisters on the skin , peeling skin , swelling of the face , lips , tongue , and throat that may cause difficulty in breathing or swallowing , stop taking
what januvia contains - the active substance is sitagliptin . each film - coated tablet ( tablet ) contains sitaglptin phosphate monohydrate equivalent to 25 mg sitaglioptin . - the other ingredients are : microcrystalline cellulose , calcium hydrogen phosphate , croscarmellose sodium , magnesium stearate , sodium stearyl fumarate . the tablet film - coating contains poly ( vinyl alcohol ), macrogol 3350 , talc , titanium dioxide ( e171 ), red iron oxide ( e172 ) and yellow iron oxide . what januva looks like and contents of the pack
what xultophy is xultance is used to lower blood glucose in adults with type 2 diabetes mellitus . diabetes is a problem where your body does not make enough insulin to control the level of sugar in the blood . your body can also make too much insulin , and the insulin that your body produces does not work as well as it should . this results in an increase in blood sugar . insulin degludec is a long - acting basal insulin that helps your body to control your blood sugar levels . liraglutide is a type of insulin used for diabetes called metformin , pioglitazone
do not take xultophy if you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). 39 if you take a sulfonylurea such as glimepiride or glibenclamide . your sulfonylation dose should be reduced to a minimum of one tablet daily . your doctor will monitor your blood sugar levels regularly while you are taking xulturo . if you have type 1 diabetes mellitus or ' ketoacidosis ' ( a condition which occurs when your blood sugars are too high ). warnings and precautions talk
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you have been blind or have poor eyesight , your doctor may need to adjust your blood sugar level . the recommended dose of xultophy is 41 mg once a day . you should take xultue for 8 hours . if necessary , you can take it with or without food . do not take xulophy with a pre - filled dial - a - dose pen . the dose counter shows the dose to be taken with 1 ml of insulin degludec and 0 . 088 mg l
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects : low blood sugar ( very common , may affect more than 1 in 10 people ) if your blood sugar level gets low you may pass out or become unconscious . serious hypoglycaemia ( may cause brain damage ) low blood glucose can be life threatening . if yourblood sugar level is too low , talk to your doctor . see also section " warnings and precautions " for further information on low blood sugars and hypoglycemia . see section " other medicines and xult
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after first opening : store in the original package in order to protect from light . after opening : do not store above 30 . store at room temperature ( up to 8 ) for 21 days . do away with the preservative after 21 days , even if it is not completely empty . do throw away any medicines via wastewater or household waste . ask
what xultophy contains the active substances are insulin degludec and liraglutide . each ml contains 100 units of insulin degluudec 3 . 6 mg liragolutime . each 3 ml ampoule contains 300 units of the active substance insulin deglioudec 10 . 8 mg liraaglunide . the other ingredients are glycerol , phenol , zinc acetate , hydrochloric acid and sodium hydroxide ( for ph adjustment ). the solvent is water for injections . see section 2 " xultphil contains sodium ". what xultos looks like and
giotrif is a medicine that contains the active substance afatinib . it works by blocking two proteins called egfr [ epidermal growth factor receptor 2 ]- erbb1 and her2 [ erbb2 - erbb3 ]. these proteins are involved in the growth of cancer cells . this medicine stops these proteins from growing and kills cancer cells quickly . this helps to stop cancer cells from growing . this is useful in patients with cancer of the lung ( non - small cell lung cancer ). giotriff is used as your first treatment after prior chemotherapy treatment in patients of squamous type who have not received prior
do not take giotrif if you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ) if you have low body weight ( less than 50 kg ) if your doctor has told you that you have kidney problems if you think any of these apply to you , tell your doctor before taking giotrinif . warnings and precautions talk to your doctor or pharmacist before taking this medicine if you : have lung inflammation ( interstitial lung disease ) have liver problems your doctor may need to do some liver tests before you start taking this medicines if you suffer from a severe liver disease have
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 40 mg tablet once a day . you should take this tablet at the same time each day . giotrif can be taken with or without food . swallow the tablet whole with a glass of water . you can take this dose with or just after food . you may take this this medicine with or with food . if you take more giotrinif than you should if you accidentally take too many tablets , contact your doctor immediately . you will need to take this medication for 1
like all medicines , giotrif can cause side effects , although not everybody gets them . the following side effects may happen during treatment : diarrhoea common ( may affect up to 1 in 10 people ): diarrhoeas may occur within 2 hours of starting treatment . severe diarrhoehoea with or without fluid loss common ( might affect up in 1 in every 10 people ) low blood potassium ( a sign of worsening kidney function ) if you experience diarrhoee after starting treatment , contact your doctor immediately . appropriate antidiarrhoeal treatment is not recommended . if you are receiving antidiarhoeal medicine prior to treatment
what giotrif contains - the active substance is afatinib . each film - coated tablet contains 20 mg of afatinab . - the other ingredients are lactose monohydrate , microcrystalline cellulose , colloidal anhydrous silica , crospovidone , magnesium stearate . - tablet coating : hypromellose , macrogol 400 , titanium dioxide ( e171 ), polysorbate 80 . what giotralif looks like and contents of the pack giotarif 20 mg film - coating tablets are white to off - white , round , biconvex ,
what orkambi is orkamsi contains two active substances called lumacaftor and ivacaftOR . it is a medicine used for long - term treatment of cystic fibrosis ( cf ) in patients aged 6 years and older with a mutation called f508del mutation . f508d is a protein that is found on the surface of cyst fibrosis transmembrane conductance regulator ( cftr ). it is found in the lungs where the mutation causes an abnormal cftR protein . how orkami works lumacftor and / or ivacftOR work together by blocking
do not take orkambi if you are allergic to lumacaftor or ivacaftion or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking orkammi . if you have orkababab - the f508del mutation is not known . if this mutation is found , orkaban may not be suitable for you . if any of these apply to you , tell your doctor . if your doctor has liver or kidney disease . the dose of orkandemi may need to be adjusted . abnormal blood tests of the
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 6 to 12 tablets a day . your doctor will tell you how many tablets to take . the usual dose is one orkambi tablet a day for 6 to 11 days . your dose of orkammi is 100 mg once a day ( 2 tablets a morning ). your doctor may increase your dose to 2 tablets once a morning . if you take more orkabi than you should if you have taken more tablets than you have been told to , contact your doctor . if
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported with orkambi in combination with ivacaftor are usually mild to moderate and of a short duration . however , some patients may experience serious side effects . some patients taking orkammi have experienced raised levels of liver enzymes in the blood . this may be a sign of liver injury or pre - existing severe liver disease . the worsening of liver function has been reported in patients taking either of the following active substances . other side effects include : uncommon ( may affect up to 1 in 100 people ): if you get any
what orkambi contains the active substances are lumacaftor and ivacaftir . each orkabi 100 mg film - coated tablet contains either 125 mg lumacafor or 125 mg ivacafir . one orkabi 200 mg film film - coating contains either 200 mg lumiacaftor or 250 mg iviacaftir ( as monotherapy ). each orkyambi 100mg film - coat contains either 100 mg lumasaftor , 125 mg or 200 mg ivacsaftor . each andkyambiq 125 mg film coating contains cellulose , microcrystalline , crosc
what lynparza is lynparaz contains the active substance olaparib . olaparaib is a type of cancer medicine known as a parp inhibitor ( poly [ adenosine diphosphate - ribose ] polymerase inhibitor ) that works by preventing mutations ( changes ) in a gene called brca ( breast cancer gene ). cancer patients with parp inhibitors can sometimes have death because they have damaged a gene that allows cancer cells to grow and repair dna . what lynparz is used for lynparanza is used to treat adult patients with ovarian cancer called brcas ( mutated ovarian cancer ) when previous
do not use lynparza if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using lynparze . if you think any of these apply to you , or if you have any further questions on the use of this product , ask your doctor or pharmacist . children and adolescents do not give this medicine to children under 6 years of age . use in children and young people do not use in this age group . other medicines and lynparz tell your doctor if you or your child are taking ,
always take lynparza capsules exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of lynparz is 100 mg once a day . your doctor may increase your dose to 150 mg once daily . the doses of lynpalza capsules taken together with tablets may be adjusted by your doctor . if you take more than a capsule of lynarza daily than you should if you have taken more than the prescribed dose , contact your doctor immediately . you may experience side effects for up to 8 days . take the tablets with a glass of water . take them either before or
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): feeling short of breath , feeling very tired , pale skin , fast heart beat . these may be symptoms of a decrease in the number of red blood cells ( anaemia ). uncommon ( may affects up to 1 in 100 people ): allergic reactions including hives , difficulty breathing or swallowing , dizziness . signs and symptoms of hypersensitivity reactions may include other side effects . very commonly ( may effect more than one in 10 patients ): feeling sick ( nausea ) being sick ( vomiting ) feeling tired or
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store any lynparza capsules in the original package in order to protect from light . after first opening , lynparZA capsules may be stored at room temperature ( up to 30 ) for up to 3 days . discard any capsules that have been stored at the room temperature for more than 3 days , and discard any that have not been used .
what lynparza contains - the active substance is olaparib . each hard capsule contains 50 mg of olaparaib . - the other ingredients are lauroyl macrogol - 32 glycerides , hypromellose , titanium dioxide ( e171 ), gellan gum , potassium acetate , iron oxide black ( e172 ). what lynparz looks like and contents of the pack white , opaque , hard capsule with " olaparatib 50 mg " and " astrazeneca logo on one side . lynparze is available in packs containing 112 hard capsules or 448 hard capsules . not all
this medicine contains the active substance naloxone . nalxone is used to treat opioids such as heroin , methadone , fentanyl , oxycodone , buprenorphine and morphine in adults . nyxoid is also used as a nasal spray for the emergency treatment of opioid overdose in adults , adolescents and children . opioid overdose is a serious , life - threatening , and sometimes fatal , event that occurs within 14 days . overdose may cause breathing problems and severe sleepiness . if you have an opioid overdose , you should immediately contact your doctor or get emergency medical care .
do not use nyxoid if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using nyxoids . you may need emergency medical care or emergency services if you have an opioid overdose . the signs and symptoms of an opioid dose may be similar to those of an overdose . you should use this nasal spray 2 to 3 times a day . if you use a new nasal spray , do not use it until you have established the dose . if any of these apply to you , tell your doctor or pharm
always use nyxoid nasal spray exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one spray . 1 . if symptoms occur , you should immediately take the spray from your shoulders and ears , preferably the breastbone , sternum or the ear . 2 . if fingernail is loose , clear the mouth and nose of any blockers . 3 . if you have difficulty breathing , you must use the spray in your mouth or nose . 1 ). the most common symptom of breathing is the chest moving up and down . if this happens , you may hear breathing sounds
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : stop taking nyxoid and seek medical help immediately : acute withdrawal symptoms from opioid drugs with symptoms such as fast heart rate , high blood pressure body aches , stomach cramps , feeling sick , vomiting , diarrhoea , sweating , fever , goose bumps , shivering trembling changes in behaviour , including violent behaviour , nervousness , anxiety , excitement , restlessness , irritability unpleasant or uncomfortable mood increased skin sensitivity difficulty in sleeping . acute withdrawal reactions may affect up to 1 in 100 people . these
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nyxoid contains - the active substance is naloxone . each nasal spray contains 1 . 8 mg of nalxone . - the other ingredients are : ( in the powder : hydrochloride dihydrate ), trisodium citrate dihydrates , sodium chloride , hydrochloric acid , sodium hydroxide , purified water . what nyxoids looks like and contents of the pack nyxoidal is a 0 . 1 ml clear , colourless to pale yellow solution for injection in a pre - filled nasal spray . it is supplied in a single dose container . nyxax is available in a
what ovaleap is ovaleep contains the active substance follitropin alfa , which is a gonadotropin ( a type of hormone that is produced naturally in the body ). follitroin ala is a hormone produced naturally by the body called fsh . it is involved in the growth and development of the sacs ( follicles ) in the ovaries , and in the production of sperm . it helps to produce a mature egg cell . ovaleape is used in adult women , who are not ovulating , who have not responded to treatment with a medicine called " clomifene citrate
do not use ovaleap if you are allergic to follitropin alfa , follicle stimulating hormone or any of the other ingredients of this medicine ( listed in section 6 ) if you have a tumour in your hypothalamus or pituitary gland ( the brain ). if you know that you have large ovaries ( sacs of fluids that contain hormones that help the ovaries produce more sperm ) if your ovarian cysts are growing out of control . if you experience unexplained vaginal bleeding . if your doctor thinks that you may have cancer in your ovaries , womb or breasts . if any of these apply to you ,
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use this medication is given as an injection into the tissue just under the skin ( subcutaneous injection ). if you have irregular periods , you will usually receive this medicine within the first 7 days of your menstrual cycle . the medicine will be given to you once a day . the usual dose of this medicine is 75 mg . your doctor will tell you how many days of each cycle you should receive . the recommended dose is 150 mg . you should usually receive the first dose of the medicine once a
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with ovaleap : serious side effects in women allergic reactions such as skin rash and raised itchy areas of skin . severe allergic reactions may cause weakness , drop in blood pressure , difficulty breathing and swelling of the face . 37 this may affect up to 1 in 10 , 000 people . if you have this type of reaction , your ovaleop injection may be stopped immediately . serious sideeffects in women lower stomach ache , nausea and vomiting are the symptoms of ovarian hyper - stimulation syndrome ( ohss ). ohss
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the cartridge after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the cartridge in the outer carton in order to protect from light . this medicine may be stored for a maximum of 3 days below 25 . do this medicine if it is stored for more than 3 days above 25 . once the cartridge has been removed from the refrigerator and has reached room temperature ( not above 30 ) it must either
what ovaleap contains the active substance is follitropin alfa . ovaleep 300 iu / 0 . 5 ml solution for injection : each cartridge contains 300 iiu ( 22 micrograms ) follitroin ala in 0 . 0 ml solution . ovaloap 450 iu in 0. 75 ml solution : each cartridges contains 450 iiu 33 microgram ( 23 microgram ) follitonropin ava in 1 . 5ml solution . each cartridge containing 900 iu ( 23 million iu ) follionropin alpha in 1. 5 ml is supplied . the solution contains 600 i
voriconazole accord contains the active substance voriconazol . voricoazole is an antifungal medicine that works by killing the fungi that cause infections . it is used in adults and children from the age of 2 years to treat invasive aspergillosis ( a type of fungal infection caused by aspergonillus sp .) and candidaemia ( a form of fun fungal illness caused by candida sp .) in non - neutropenic patients ( patients with abnormally low white blood cells count ). candida Sp . infections are caused by the fungus fluconazole , another ant
do not take voriconazole accord - if you are allergic to voricleazole or any of the other ingredients of this medicine ( listed in section 6 ). - if taking any other medicines , including herbal medicines . the medicines listed below may affect the way voricoazole accord treatment works . 46 terfenadine ( used to treat allergy ) astemizole ( used for allergy ) cisapride ( used in stomach problems ) pimozide ( used when treating mental illness ) quinidine ( used if you have irregular heart beat ) rifampicin ( used used to prevent tuberculosis
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will work out your dose based on your weight and the type of infection you have . the usual starting dose is 40 mg once a day . this will be increased to 40 mg twice a day for 24 hours . your dose may be increased by 400 mg once daily for 12 hours or 24 hours or 200 mg once every 12 hours for 24 to 24 hours and 200 mg twice daily for 100 hours . depending on how you respond to treatment , your doctor may increase your dose to 300 mg once weekly .
like all medicines , this medicine can cause side effects , although not everybody gets them . if any side effects occur , they are usually mild to moderate and of a short duration . serious side effects stop taking voriconazole accord and tell your doctor immediately : rash , jaundice , changes in blood tests of liver function ( pancreatitis ). other side effects include : very common ( may affect more than 1 in 10 people ): visual impairment ( change in vision ), blurred vision , visual color alterations , abnormal intolerance to visual perception of light , colour blindness , eye disorder , halo vision , night blindness , swinging vision , seeing sparks
what voriconazole accord contains the active substance is vorinazole . each tablet contains 50 mg voricleazole ( as besilate ). voricoazole accord 50 mg film - coated tablets each tablet has 200 mg vorbiconazose ( as mesilate ) the other ingredients are : tablet core : voricazole acord 200 mg film film - coating : lactose monohydrate , pregelatinised starch , croscarmellose sodium , povidone , magnesium stearate . tablet coating : hypromellose , titanium dioxide ( e171
mvabea is a vaccine to protect you against ebola virus disease in the future . it is given to adults , adolescents and children from 1 year of age with ebolairus . it can be given as a 2 - dose course of vaccinations . the other ingredients are : ebola virus disease : the zaire ebolavirus and filovirus . this vaccine contains less than 1 million international units ( iu ) of filov virus . the whole ebola vaccine does not give you ebola disease . warnings and precautions talk to your doctor or nurse before you are given mvabe a . as with all
your child ' s doctor will decide on the vaccination course . the vaccine should not be given if your child has had a severe allergic reaction ( see section 6 . if your baby has a severe allergy reaction to an antibiotic called ' gentamicin '). if your newborn has not been vaccinated with the vaccine , your child ' re - received mvabea . if you have had asevere allergic reaction to any other vaccine injection . if the child fainted during the injection , bleeding or bruise easily . if any of the above applies to your child , tell your doctor . if a child has a fever or an infection . if
the recommended dose of vaccine is a muscle ( intramuscular injection ) in the upper arm , thigh or blood vessel . the recommended dose is one dose of vaccination with zabdeno vaccine 8 weeks later . if you are given more mvabea vaccine than you should the second vaccine will be given as an additional dose . the first dose of the second dose should be given at least two weeks after the first . the second vaccination should be administered at least four weeks after your first dose . primary vaccination first vaccination with a zab deno red cap vial ( 0 . 5 ml ) second vaccination with mvab
like all medicines , this vaccine can cause side effects , although not everybody gets them . the following side effects may happen with mvabea : very common ( may affect more than 1 in 10 people ): pain , warmth or swelling where the injection is given feeling very tired muscle ache joint pain common ( might affect up to 1 in every 10 people ) being sick ( vomiting ) itching where the vaccine is given uncommon ( may affects up to1 in every 100 people ): redness , skin hardness where thejection is given generalised itching . the most common side effects are : common ( will affect up in every 1 in 100 people
what mvabea contains the active substance is zaire ebolavirus 29 ( tai forest ebolovirus nucleoprotein marburg , 0 . 7 to 108 kbq / ml ). the other ingredients are : trace residues of tai wild ebolabirus nucleoplrotein marbur , 0 , 108 micrograms of chickenembryo fibroblast cells . what mvabaa looks like and contents of the pack mvagaa is a suspension for injection in a single - dose glass vial with a rubber stopper and yellow cap . each pack contains 20 vials .
bondronat contains the active substance ibandronic acid . this belongs to a group of medicines called bisphosphonates . it is used to treat breast cancer that has spread to your bones ( called ' bone ametastases ') and to prevent your bones from breaking ( fractures ). it is also used to prevent other bone problems that may need surgery or radiotherapy bondronAT may also be used to help you if you have a raised calcium level in your blood because of a tumour . if this is not treated , calcium may be lost from your bones and your bones become weaker .
do not take bondronat if you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ) if you have low levels of calcium in your blood . warnings and precautions talk to your doctor or pharmacist before taking bondronAT if you suffer from a rare side effect called osteonecrosis of the jaw ( onj ), which can lead to bone damage in the jaw . your doctor may decide to reduce your dose of bondronatin if you know you have cancer or related conditions . onj can be life - threatening and can be fatal . stopping treatment with onj may
this medicine is given to you by a doctor or nurse who is experienced in the treatment of cancer . it is given as an infusion into your vein . your doctor will do regular blood tests before you are given bondronat . your dose of this medicine depends on your illness . if you have breast cancer that has spread to your bones , it may take 3 to 3 weeks , but you will be given an infusion in your vein over about 15 minutes . if there is a raised calcium level in your blood , it can be given as a single dose of 1 mg or 2 mg once a week for 2 weeks . depending on your condition
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects you may need urgent medical treatment : rare ( may affect up to 1 in 1 , 000 people ) persistent eye pain or inflammation new pain , weakness or discomfort in your thigh , hip or groin . this may be a sign of unusual fracture of the thigh bone . very rare ( might affect up in 1 in 10 , 000 patients ) pain or sore in your mouth or jaw . these may be signs of severe jaw problems called necrosis ( dead bone tissue in the jaw bone ).
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). after dilution the infusion solution should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 8 . do away with this medicine if you notice any particles in the solution . do throw away any medicines via wastewater or household waste . ask
what bondronat contains - the active substance is ibandronic acid . each vial contains 2 mg ibandronat . - the other ingredients are : water for injections , sodium monohydrate , sodium chloride , acetic acid , sodium acetate , water for injection , and water for water for wastewater . what bondronAT looks like and contents of the pack the concentrate for solution for infusion is a clear , colourless to pale yellow solution . each carton contains one glass vial with a bromobutyl rubber stopper .
what zeposia is zepoia belongs to a group of medicines that affect the number of white blood cells ( lymphocytes ). what zeposa is used for zeposeia is used to treat relapsing remitting multiple sclerosis ( rrms ), a rare but active disease that affects the nerves of the brain and spinal cord . symptoms include numbness , difficulty in walking and problems with vision and balance . relapsive remitting ms attacks on the nerve cells . the symptoms disappear within a few days or weeks , but for periods of time some problems can be serious . how zepoesia works z
do not take zeposia if you are allergic to ozanimod or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severely weakened immune system . if you had a heart attack , angina , stroke , mini - stroke or transient ischemic attack ( tia ). if severe heart failure has occurred within the last 6 months . if your heartbeats ( arrhythmia ) are not normal or if your doctor thinks they may be due to treatment . if any of these apply to you , tell your doctor before taking zepoia . warnings and precautions talk to your
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor will work out the dose of zeposia you need to take and how much you need . your doctor may also check your heart rate and may also prescribe you a ' treatment initiation pack ' for the first 4 days . the recommended dose is 0 . 23 mg ozanimod once a day . this is taken as 1 capsule once a morning . this will be taken as 4 capsules once a afternoon . the first four days of treatment will be given as 3 capsules once daily
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects : common ( may affect up to 1 in 10 people ): slow heart rate urinary tract infection ( raised blood pressure ) uncommon ( may effect up to1 in 100 people ): allergic reaction . the signs may include a rash . other side effects include : very common ( might affect more than 1 in10 people ): infections of the nose or nostrils , nasal cavity , mouth , throat ( pharynx ) or voice box ( larynx ). viruses and
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine in the original package in order to protect from moisture . do do not take this medicine if you notice any damage or signs of tampering to the pack . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what zeposia contains the active substance is ozanimod . zeposeia 0 . 23 mg : each capsule contains 0 . 22 mg ozanimog ( as hydrochloride ). zepoesia 0. 46 mg : one capsule contains approximately 0 . 46 mg ozimod ( as hydration ). ozanimood 0 . 86 mg : the active ingredient is hydrochlorine . ziposia 0 , 92 mg : two capsules contain approximately 0. 92 mg ozmogromod (as hydrochloric acid ). the other ingredients are microcrystalline cellulose , silica , colloidal an
what temybric ellipta is temybaellipta contains two active substances called fluticasone furoate and umeclidinium bromide ( vilanterol ). fluticastone furaate belongs to a group of medicines called corticosteroids ( steroids ). umecylidinia bromine and vilansterol belong to agroup of medicines known as bronchodilators . what temybarric elliptka is used for temymbric elliptea is used to treat chronic obstructive pulmonary disease ( copd ). copd is a long -
do not use temybric ellipta - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using temy bric elliptia - if your child has asthma . temybi ellipta should not be used in children with asthma . - if the child has heart problems , high blood pressure , liver problems , tuberculosis ( tb ) of the lung , or any long standing or untreated infections . - tell your doctor if your
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at the same time each day . try to use temybric ellipta at the start of each day and for at least one hour afterwards . if you use more temybiric ellipte than you should if you have used more tembric ellipta than you have been told to use , contact your doctor immediately . symptoms of temybreric elliptoe may include a sudden attack of
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties if your breathing or wheezing gets worse while taking this medicine , tell your doctor straight away . pneumonia ( infection of the lung ) in copd patients the most common side effect of temybric ellipta is symptoms of a lung infection such as fever and chills , increased mucus production , change in mucus colour , increased cough and increased breathing difficulties common side effects ( may affect up to 1 in 10 people ) are sore or raised patches in the mouth or throat , possibly due to a fungal infection ( candid
what temybric ellipta contains - the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each delivered dose contains 92 micrograms of flutic asone firoate , 65 microgram of umeleclidinnium bromeide and 55 microgram / ml umelyclidinia bromate and 22 microgram per millilitre of vilancerol ( as trifenatate ). - the other ingredients are lactose monohydrate ( see section 2 under ' temy bric elliptas contains lact
zinforo is an antibiotic medicine that contains the active substance cefaroline fosamil . it belongs to a group of medicines called 'cephalosporin antibiotics '. zinforo helps to prevent infections of the skin and the tissues below the skin . it is used to treat an infection of the lungs called ' pneumonia '. how zininforoe works zin foro works by killing certain bacteria that cause serious infections .
do not use zinforo if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to othercephalosporin antibiotics . if you have had previous severe allergic reactions to other antibiotics ( such as penicillin or carbapenem ). warnings and precautions talk to your doctor or pharmacist before using zin foro . if any of these apply to you , tell your doctor before using this medicine . warnings and risks talk to the doctor or nurse before using it if you : have kidney problems . have
the recommended dose of zinforo is 600 mg once a day . your doctor will tell you how many tablets to take . the recommended dose is one 600 mg tablet once a week for 8 weeks . some infections may be treated for 8 to 12 weeks . zinfo is given as a drip into a vein ( intravenously ) over a period of 5 to 60 minutes . your dose may be increased to 120 mg once daily . your physician will tell how many capsules to take and how often you should take . your first dose of an increased dose should be given at the start of treatment . the first dose should not be
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following side effects : if you get any of these symptoms , you may need urgent medical treatment : sudden swelling of your lips , face , throat or tongue , a severe rash , swallowing or breathing problems , asevere allergic reaction ( anaphylaxis ), diarrhoea , stool , blood or mucus . treatment with zinforo may be interrupted or stopped , or medicines may cause slow bowel movement ( see section 1 ). this may take up to 10 minutes . your doctor will do a
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 30 . do this to protect from light . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains the active substance is ceftaroline fosamil . the other ingredients are arginine and water for injections . what zinofo looks like and contents of the pack zinfosamol is a pale yellowish to light yellow powder for solution for infusion in a vial . it is supplied in packs containing 10 vials .
pregabalin pfizer belongs to a group of medicines used to treat epilepsy , neuropathic pain and generalised anxiety disorder ( gad ) in adults . peripheral and central neuropathicpain : pregabalin pumpfizer is used to relieve long lasting pain caused by damage to the nerves . a variety of diseases can cause peripheral neuropathic Pain , such as diabetes or shingles . pain sensations may be described as hot , burning , throbbing , shooting , stabbing , sharp , cramping , aching , tingling , numbness , pins and needles . peripheral or central neuropathy pain may also be associated with
do not take pregabalin pfizer if you are allergic to pregagabalin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking pregaberalin psfizer . some patients taking pregaabalin pumpfizer have reported symptoms suggesting an allergic reaction . these symptoms include swelling of the face , lips , tongue , and throat and diffuse skin rash . should you experience any of these reactions , you should contact your doctor immediately . pregibalin has been associated with dizziness and somnolence , which may increase
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . pregabalin pfizer is for oral use . peripheral and central neuropathic pain , epilepsy or generalised anxiety disorder the usual dose is 150 mg once a day . your doctor may increase your dose to 600 mg once daily depending on how you respond to pregibalin psfizer . you should take pregaboralin pfeizer once in the morning and once inthe evening . use in children and adolescents 59 you should continue to take preggabalin pumpfizer once a morning
like all medicines , this medicine can cause side effects , although not everybody gets them . very common : may affect more than 1 in 10 people dizziness , drowsiness , headache . common : might affect up to 1 in every 10 people increased appetite . feeling of elation , confusion , disorientation , decrease in sexual interest , irritability . disturbance in attention , clumsiness , memory impairment , loss of memory , tremor , difficulty with speaking , tingling feeling , numbness , sedation , lethargy , insomnia , fatigue , feeling abnormal , blurred vision , double vision , vertigo , problems with balance
what pregabalin pfizer contains the active substance is pregaboralin . each hard capsule contains 25 mg , 50 mg , 75 mg , 100 mg , 150 mg , 200 mg , 225 mg or 300 mg of pregibalin . the other ingredients are lactose monohydrate , maize starch , talc , gelatine , titanium dioxide ( e171 ), sodium laurilsulphate , anhydrous colloidal silica . the printing ink contains black ink , shellac , black iron oxide ( e172 ), propylene glycol ( e1520 ), potassium hydroxide ( e433 ),
xadago is a medicine that contains the active substance safinamide . it works by increasing the levels of dopamine in the brain . this is a stimulant of the brain involved in movement and is important in the treatment of parkinson ' s disease . xadago helps to control parkinson ', a condition characterised by sudden swings in movement not being able to move . this can lead to difficulties moving . xADago is used in combination with the medicine levodopa , which is used with other medicines to treat parkinson' s disease in adults .
do not take xadago if you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). if you take any of any of these : - monoamine oxidase ( mao ) inhibitors ( e . g . selegiline , rasagiline ), moclobemide , phenelzine , isocarboxazid , tranylcypromine . these are all used in treatment of parkinson ' s disease and depression . - pethidine ( a strong pain killer ). these are usually used within 7 days of starting xadadago
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of xadago is 50 mg once a day . the dose may be increased to 100 mg once daily by mouth . your doctor will tell you how many tablets of xadeago to take . if you have moderately reduced liver function , your doctor may prescribe a lower dose of 50 mg . if any of the above apply to you , tell your doctor . if your doctor thinks that you are too weak or too weak , tell you doctor . xadadago should not be used alone .
like all medicines , this medicine can cause side effects , although not everybody gets them . hypertensive crisis ( very high blood pressure that may lead to collapse ) has been reported in patients with neuroleptic malignant syndrome ( confusion , sweating , muscle rigidity , hyperthermia ), increase level of enzyme creatine kinase in your blood ( serotonin syndrome ), confusion , hypertension , muscle stiffness , hallucinations ( hypotension ). the following side effects have been reported with parkinson ' s disease in combination with safinamide and levodopa . they are usually mild to moderate and usually disappear after a few weeks . other medicines and xadago
what xadago contains - the active substance is safinamide . each tablet contains 50 mg or 100 mg safinate . - the other ingredients are methansulfonate , microcrystalline cellulose , crospovidone type a , magnesium stearate , silica colloidal anhydrous - tablet coating contains hypromellose , macrogol , titanium dioxide ( e171 ), iron oxide red ( e172 ). what xadagon looks like and contents of the pack xadagus 50 mg film - coated tablets of 7 mm diameter with metallic gloss are white , round , biconc
zytiga is a medicine containing abiraterone acetate that is used to treat prostate cancer in adult men . it is used when the level of testosterone in the body is too low . zytiga reduces the amount of testosterone produced by the body and this helps to fight prostate cancer . ztiga is used in patients who have disease that does not respond to hormone therapy or who are not taking a treatment that lowers testosterone ( androgen deprivation therapy ). it is also used in combination with another medicine called prednisone . prednisolone is used for high blood pressure in adult patients whose body is not able
do not take zytiga if you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be pregnant , ask your doctor for advice before taking zytigo . if you have severe liver damage or prostate cancer . warnings and precautions talk to your doctor before taking this medicine . this medicine is not recommended if any of these apply to you . tell your doctor if you : have ever had liver problems . have high blood pressure or heart failure . have low blood potassium . have heart rhythm problems . or have other heart or blood vessel problems . notice
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 , 000 mg once a day . you should take this tablet at about the same time each day . this medicine should be taken by mouth . swallow the tablet whole with a glass of water . do not crush or chew the tablet . if you take more zytiga than you should if you accidentally take too many tablets , contact your doctor immediately . if possible take zytige with food . if more than 2 tablets have been taken , contact a doctor or the nearest hospital immediately .
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zytiga and contact your doctor immediately if you experience : - muscle weakness , muscle twitches , a pounding heart beat or palpitations . these may be signs that the level of potassium in your blood is low . your doctor may want to increase your dose of potassium . other side effects include : very common ( may affect more than 1 in 10 people ): - fluid in your legs or feet ( including legs ), low blood potassium ( seen in liver function test ), high blood pressure , urinary tract infection , diarrhoea common ( might
what zytiga contains - the active substance is abiraterone acetate . each tablet contains 250 mg abirate acetate - the other ingredients are microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 ), colloidal anhydrous silica , sodium laurilsulfate . see section 2 " zytigo contains lactose ". what zytig looks like and contents of the pack - zytige tablets are white to off - white , round tablets with a diameter of 9 . 5 mm . the tablets
hefiya contains the active substance adalimumab , a medicine used for the treatment of inflammatory diseases : polyarticular juvenile idiopathic arthritis , enthesitis - related arthritis , paediatric plaque psoriasis and paediatric crohn ' s disease paediatric non - infectious uveitis . adalumab is a monoclonal antibody . monoclal antibodies are proteins that recognise and bind to other unique proteins in the body . addalimumab works by blocking the activity of a specific protein called tumour necrosis factor ( tnfÎ± ). tnfsÎ± is a protein that
do not take hefiya if your child is allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if your or your child ' s child has a severe infection , including tuberculosis , sepsis ( blood poisoning ), or other opportunistic infections . warnings and precautions talk to your doctor or pharmacist before taking hefiYA if your / your child : has a history of unusual infections or a weakened immune system . symptoms of infections may include fever , wounds , feeling tired , dental problems . has moderate or severe heart failure . has a serious heart condition . allergic reaction if allergic reactions
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 40 mg twice a day ( morning and evening ) for children and adolescents of 20 years of age and older . for children of 20 kg and older , the recommended doses are 20 mg twice weekly ( morning , evening and evening ). for children above 40 kg , the dose is 20 mg once a day . for polyarticular juvenile idiopathic arthritis age and body weight how much to take adults and adolescents from 2 years of old weighing 30 kg or more 40 mg once daily ( morning
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . tell your doctor straight away if you notice any of the following side effects ( see section 4 , " warnings and precautions "): - since the last hefiya injection , you may experience allergic reaction ( see also section 4 ), including heart failure . - severe rash , hives , swollen face , hands , feet , trouble breathing , swallowing , shortness of breath and swelling of the feet . - signs and symptoms of infection such as fever , feeling sick ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . after first opening , the product may be stored at room temperature ( up to 25 ) for a maximum period of 14 days . once removed from the refrigerator for room temperature storage , your pre -filled syringe may be used for a single period of
what hefiya contains - the active substance is adalimumab . each pre - filled syringe contains 20 mg of adalimab in 0 . 4 ml solution . - the other ingredients are adipic acid , citric acid monohydrate , sodium chloride , mannitol , polysorbate 80 , hydrochloric acid and sodium hydroxide and water for injections . what hefiYA looks like and contents of the pack hefiqa 20 mg / 0 . 04 ml solution for injection is a clear to slightly opalescent , colourless to slightly yellowish solution . it is supplied in a clear type
what ritemvia is ritemv contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to a target in a type called a white blood cell called " b - lymphocyte ". when ritukimab sticks to the target of this protein , it stops the cell from growing and dividing . what ritemvy is used for ritemvi is used to treat adults with a ) non - hodgkin ' s lymphoma . this is an illness of the lymph tissue that affects the immune system . it affects a type a of
do not take ritemvia if you are allergic to rituximab , other proteins that are derived from ritukimab or any of the other ingredients of this medicine ( listed in section 6 ) if you have a severe active infection if you suffer from a weak immune system if you suffered from severe heart failure or severe uncontrolled heart disease if you know that you have granulomatosis , polyangiitis , microscopic polyangitis or pemphigus vulgaris ( see section " warnings and precautions "). warnings and risks talk to your doctor before taking ritemvi if you : have ever had
how ritemvia is given your doctor will decide how much ritemv you will receive and for how long . your doctor or nurse will watch you closely during this treatment . you will be given this medicine to reduce any side effects . how ritemva is given ritemra is given as a drip ( intravenous infusion ). medicines given before each ritemvi administration you will take ritem via with other medicines ( pre - medication ) to reduce the risk of side effects and to improve your response to your treatment . for non - hodgkin ' s lymphoma if you are being treated with ritemga alone r
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy or runny nose , vomiting , flushing or palpitations , heart attack , low number
what ritemvia contains - the active substance is rituximab . each ml of concentrate contains 100 mg of ritukimab ( as monotherapy ). each vial of concentrate contents contains 10 mg of the active ingredient in ritueimab ). - the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what ritemvana looks like and contents of the pack ritemvvia is a clear , colourless solution for infusion in a glass vial . pack size of 2 vials .
capecitabine teva belongs to a group of medicines called " cytostatic medicines ", which stop the growth of cancer cells . capecitabrine teva contains capecitibine , which itself is not a cytostatics medicine . only after being absorbed by the body is it changed into an active anti - cancer medicine . capecabine cheva is used in the treatment of colon , rectal , gastric , or breast cancers . furthermore , capecitabiline teeva is used to prevent new occurrence of colon cancer after complete removal of the tumour by surgery . capectabineteva may be
do not take capecitabine teva if you are allergic to capecitabiline or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may have an allergy , ask your doctor for advice before taking this medicine . if you have had severe reactions to fluoropyrimidine therapy ( a group of anticancer medicines containing fluorouracil ) if you ( or your partner ) are pregnant or breast - feeding if you suffer from low levels of white cells or platelets in the blood ( leucopenia , neutropenia or thrombocytopenia ) if your
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . capecitabine should only be prescribed by a doctor experienced in the use of anticancer medicines . your doctor will prescribe a dose and treatment regimen that is right for you . the dose of capecitabe teva is based on your body surface area ( calculated from your height and weight ). the usual dose for adults is 1250 mg / m2 of body surface surface taken once daily . this is equivalent to a daily dose of body weight of 64 kg and height of 1 . 64 mÂ² . a
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva and contact your doctor immediately if you have any of these symptoms : diarrhoea : if you experience an increase of 4 or more bowel movements compared to your normal bowel movements , or any diarrhoehoea at night . vomiting : if your vomit is more than 4 hours late . nausea : if it is more severe than usual . if you lose your appetite . stomatitis : if any of the following causes pain , redness , swelling or sores in your mouth and / or throat . hand
what capecitabine teva contains the active substance is capecitabiline . capecitavine teeva 150 mg film - coated tablets each film - coating contains 150 mg capecitaborine . the other ingredients are : capecitafine teve 500 mg film film - coat tablets each tablet contains 500 mg capecabine . tablet core : lactose , microcrystalline cellulose , hypromellose , croscarmellose sodium , magnesium stearate , macrogol 400 , hypromeellose, titanium dioxide ( e171 ), yellow iron oxide ( e172 ), red iron oxide red
silodosin recordati contains silodosan recordati which belongs to a group of medicines called alpha1a - adrenoreceptor blockers . silodosein recordi is used to lower the pressure in the prostate , bladder and urethra . it helps to maintain smooth muscle in these tissues . this helps to reduce your symptoms . silosin Recordati is used in adults to treat the urinary symptoms associated with benign enlargement of the prostate ( prostatic hyperplasia ), such as difficulty in starting to pass water , and a feeling of not completely emptying the bladder .
do not use silodosin recordati - if you are allergic to silodosein or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using silodousin recordi - if your doctor is going to perform eye surgery to reduce cloudiness of the lens ( cataract surgery ) in your eye 26 - if any of these apply to you , tell your doctor before using the product . silodosiin recordat may be used alone or in combination with other medicines if you have a loss of muscle tone in the iris ( the
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of silodosin recordati is one capsule taken once daily , with or without food , at about the same time each day . the usual dose is one 8 mg capsule taken twice daily . if you have kidney problems if you suffer from moderate kidney problems , your doctor may prescribe a lower dose . for this purpose silodosein recordat is taken once a day , with food , with no other exertion . the maximum recommended dose is 4 capsules taken once every day . if taking
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions swelling of the face or throat , difficulty in breathing , feeling faint , itchy skin or hives are the most common side effect of silodosin recordati . dizziness . dizzy and occasionally fainting may occur . if you feel weak or dizzy , tell your doctor . the symptoms of dizziness and fainty usually disappear within a few minutes . if they do not disappear within one hour , tell their doctor . silodosiin recordat may cause complications following a cataract surgery ( see section 2
what silodosin recordati contains silodosein recordi 8 mg hard capsules : the active substance is silodofin . each capsule contains 8 mg silodino . the other ingredients are mannitol , magnesium stearate , sodium laurilsulfate , gelatin , titanium dioxide ( e171 ). silodosiin recordat 4 mg hard capsule : the ingredients are silodousin , mannola , magnesiumstearate, sodium laurailsulfATE , gelatin, titanium dioxide , yellow iron oxide ( e172 ). what silodosesin recordit looks like and contents of the pack
kinzalmono belongs to a class of medicines known as angiotensin ii receptor antagonists . angiotENSin ii is a substance produced in your body which causes your blood vessels to narrow , thus increasing your blood pressure . kinzal mono blocks the effect of angiotenin ii so that the blood vessels relax , and your bloodpressure is lowered . kinzonmono is used to treat essential hypertension ( high blood pressure ) in adults . the high blood blood pressure is not caused by any other condition . high bloodpressure , if not treated , can damage blood vessels in several organs , which could lead sometimes
do not take kinzalmono - if you are allergic to telmisartan or any of the other ingredients of this medicine ( listed in section 6 ). - if your child is less than 3 months pregnant . ( it is also better to avoid kinz almono in early pregnancy see pregnancy section .) - if the child has severe liver problems ( such as cholestasis or biliary obstruction ) that stop drainage of the bile from the liver and gall bladder . - if he / she has any other severe liver disease . - have diabetes or impaired kidney function and are treated with a blood pressure lowering medicine containing
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . the tablets should be swallowed with some water . you can take kinzalmono with or without food . try to take your tablet at the same time each day . it is important that you continue to take kin zalmonon for as long as your physician tells you . your doctor will monitor your condition and will adjust your dose if necessary . treatment of high blood pressure the usual starting dose of kinzdalmono is 40 mg once a day to
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects could be serious and need immediate medical attention : sepsis ( blood poisoning ) is a severe infection with whole - body inflammatory response that can cause rapid swelling of the skin and mucosa ( angioedema ). these side effects are rare ( may affect up to 1 in 1 , 000 people ). other side effects of kinzalmono common side effects ( may effect up to1 in 10 people ): low blood pressure ( hypotension ) reduction in cardiovascular events uncommon side effects : 100 urinary tract infections ( upper respiratory tract infections
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . once your medicine has been taken out of your refrigerator , it should be used immediately . do this by gently squeezing your kinzalmono tablet out of its blister to make it easier for it to be taken back to the refrigerator . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you
what kinzalmono contains - the active substance is telmisartan . each tablet contains 20 mg telmisantan . - the other ingredients are povidone , meglumine , sodium hydroxide , sorbitol , magnesium stearate . what kinzalao looks like and contents of the pack kinzaloo 20 mg tablets are white to off - white , round and flat . kinzealmono is available in blister packs of 14 , 28 , 56 or 98 tablets . not all pack sizes may be marketed .
afstyla is a human clotting ( coagulation ) factor viii product produced by recombinant dna technology ( rdna ). the active substance is lonoctocog alfa . afstylfa is used to treat bleeding episodes in adults with haemophilia a ( inborn factor v iii deficiency ). factor v ii is involved in blood clotting and is necessary to clot the blood . patients with an increased tendency to bleed have been shown to have higher levels of factor v viii in their blood than patients with haophilia b . therefore , it is important to continue to clot at home
do not use afstyla if you have had an allergic reaction to afstylea or if you are allergic to hamster proteins 46 warnings and precautions talk to your doctor , pharmacist or nurse before using afststylfa . the dose and thebatch number should be recorded in your treatment diary . do not use more afstila than your doctor has recommended . allergic ( hypersensitivity ) reactions are rare in patients receiving afstreea . symptoms of allergic reactions may include hives , generalised skin rash , tightness of the chest , wheezing , fall in blood pressure and anaphylaxis
your treatment will be initiated by a doctor experienced in the treatment of blood clotting disorders . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage the dose of afstyla is based on the duration of treatment , the severity of your disease the site and the bleeding your clinical condition . reconstitution and administration general instructions the powder and the solvent ( liquid ) should be mixed before use to avoid aseptic conditions . afstlva may be used with other medicines or solvents . see section 6 . the solution should be clear to slightly
like all medicines , afstyla can cause side effects , although not everybody gets them . symptoms of allergic reactions allergic reactions may include the following symptoms : hives generalised urticaria ( itchy rash ), tightness of the chest , difficulty in breathing , wheezing , low blood pressure , dizziness ( anaphylaxis ), bleeding . patients receiving factor viii medicines may develop inhibitor antibodies ( see section 2 " warnings and precautions "). very common ( may affect more than 1 in 10 people ) patients who have received previous treatment with factor v iii ( more than 150 days of treatment ) and who were treated with
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expirability date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the afstyla powder in the outer carton in order to protect from light . after reconstitution , the product may be stored at room temperature ( up to 25 ) for a maximum period of 3 days . do away with the vial and keep it in theouter carton . do this until the reconst
what afstyla contains the active substance is lonoctocog alfa . each vial contains 250 iu ( 2 . 5 mg ) lonoectocog . after reconstitution with 2 .5 mg of lonoCTocog aluminium , the solution contains 200 iu lonoactocog alpha . each 1000 iu vial provides one injection of 2 . 25 mg lonontocog as solvent . after administration with 5 ml of water for injections the solution provides 400 iu of loroctocag alfa as solvent ( for example , 1500 iu ). after reconitution with
what praxbind is prax bind contains the active substance idarucizumab . idarucaizumb is a recombal agent . it is similar to dabigatran ( pradaxa ), a blood thinner medicine used to prevent blood clot formation . what praxBind is used for praxbinding is used to rapidlytrap dabigATran . what it is usedfor ? prax binds is used in combination with pradxa in adults who are undergoing emergency surgery or urgent procedures to control uncontrolled bleeding .
do not take praxbind if you are allergic to idarucizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a genetic disease called hereditary fructose intolerance ( hfld ) ( hfi ) ( see section 4 ). if this applies to you , tell your doctor before taking this medicine . warnings and precautions talk to your doctor or pharmacist before taking prax bind . this medicine contains dabigatran . other medicines and praxBind dabigATran are not known to prevent blood clots . dabigitran is absorbed by the body and so reduces the
the recommended dose is 5 mg / kg ( equivalent to 2 . 5 mg dabigatran ). this medicine is given once every 5 weeks . your doctor will give you this medicine by infusion into a vein . you will normally receive this medicine at the start of your treatment . if you have problems with blood clot formation , dabigATran may be given at the beginning of your first dose and then at the end of your second dose . if this happens , you will receive this treatment at the earliest . if dabigadran is given at less than 24 hours after your last dose , you should receive this dose at the usual
like all medicines , this medicine can cause side effects , although not everybody gets them . reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what praxbind contains - the active substance is idarucizumab . - the other ingredients are sodium acetate trihydrate , acetic acid , sorbitol ( e420 ), polysorbate 20 and water for injections . what prax bind looks like and contents of the pack praxbinding is a clear to slightly opalescent , colourless to slightly yellow solution supplied in a clear glass vial with a butyl rubber stopper and an aluminium cap .
temomedac contains a medicine called temozolomide . this medicine is an antitumour agent . temomedac is used to treat the following types of brain tumours : - newly - diagnosed glioblastoma multiforme . temmedac is first given together with radiotherapy ( concomitant phase of treatment ) and then alone ( monotherapy phase oftreatment ). - 3 types of malignant glioma : gliOBlastoma multipurpose , anaplastic astrocytoma . temormac is given in combination with standard treatment .
do not take temomedac if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ). if you have had an allergic reaction to dacarbazine ( an anticancer medicine sometimes called dtic ). signs of allergic reaction include feeling itchy , breathlessness , wheezing , swelling of the face , lips , tongue or throat . if any of these apply to you , tell your doctor immediately . if you notice any of those signs of a possible allergic reaction , tell the doctor immediately : feeling ity , breathless , wheezy or swelling of any part
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage and duration of treatment your doctor will work out your dose of temomedac based on your height and weight . this is especially important if you have a recurrent tumour that has not responded to chemotherapy treatment in the past and you are taking other medicines ( anti - emetics ). temomedic can be used to prevent nausea and vomiting in patients with newly - diagnosed glioblastoma multiforme . treatment is divided into two phases : treatment with radiotherapy ( concomitant phase ) and with
like all medicines , this medicine can cause side effects , although not everybody gets them . if you have a severe allergic ( hypersensitive ) reaction , including hives , wheezing or other breathing difficulty , uncontrolled bleeding , seizures , convulsions , fever , chills and severe headache , stop temomedac treatment and contact your doctor immediately . there may be a reduction in certain kinds of blood cells . this can cause increased bruising or bleeding , anaemia ( a shortage of red blood cells ), fever and reduced resistance to infections . the reduction in blood cell counts is usually short - lived and can be short - term . in some
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store above 30 . do away with any change in the appearance of the capsules . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what temomedac contains - the active substance is temozolomide . temomedack 5 mg : each capsule contains 5 mg temozolsomide ( as temozoleomide ). temomedacon 20 mg :each capsule contains 20 mg tem ozolomides ( as mesozolomonomide ) temomedax 100 mg : one capsule contains 100 mg temzolomine ( as besilate ). temmedac 140 mg : every capsule contains 140 mg temuzolomid ( as esilate ) temmedax 180 mg : two capsules contain 180 mg temoxolomile (
cialis is a treatment for adult men with erectile dysfunction . this is when a man cannot get , or keep a hard , erect penis suitable for sexual activity . cialis helps to provide a hard erect penis for sexual stimulation . cialsis contains the active substance tadalafil which belongs to a group of medicines called phosphodiesterase type 5 inhibitors . calis works by helping the blood vessels in your penis to relax . this helps your penis stay hard and erect . erectile function is important for maintaining a good sexual performance . ceralis works in men with a history of erectile disease . c
do not take cialis if you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ) if you have been told that you are taking organic nitrate or nitric oxide donors ( such as amyl nitrite ) if any of these are medicines (" nitrates ") used to treat angina pectoris (" chest pain ") if you think any of this applies to you , or if you know that any of them apply to you ( or you are not sure ), talk to your doctor or pharmacist before taking ciali . warnings and precautions talk to you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . cialis tablets are for oral use . swallow the tablet whole with a glass of water . the tablets can be taken with or without food . the usual dose is 5 mg twice a day ( approximately 2 . 5 mg ). if you take more cialises than you should if you accidentally take too many tablets , contact your doctor immediately . if you forget to take ciali if you miss a dose , take it as soon as you remember . if it
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with the medicine : allergic reactions ( rashes , frequency not known ) chest pain . this may occur more often in patients taking nitrates ( frequency not unknown ). priapsim may cause a prolonged and possibly painful erection . if this happens during intercourse , stop taking cialis and seek medical help straight away . if you get an erection that lasts for more than 4 hours , contact your doctor immediately . sudden loss of vision ( frequency unknown ). other side effects very common ( may affect more than 1 in 10 people )
what cialis contains - the active substance is tadalafil . each tablet contains 2 . 5 mg of tadalabil . - the other ingredients are : tablet core : lactose monohydrate ( see section 2 ' cialises contains lactose '), croscarmellose sodium , hydroxypropylcellulose , microcrystalline cellulose , sodium laurilsulfate , magnesium stearate . film - coating : lactate monohydrate , hypromellose , triacetin , titanium dioxide ( e171 ), iron oxide yellow ( e172 ), ironoxide red ( e129 ),
enyglid is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancrea does not produce enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . enyglide helps control the level of sugar in the blood when you have type 2abetes by helping your pancryas produce better insulin and lower the sugar that your body produces when it does not need the insulin that it produces properly . eneyglid can be used
do not take enyglid if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). if you have type 1 diabetes . if the acid level in your blood is too low ( diabetic ketoacidosis ). if your doctor has told you that you have a severe liver disease . if you take gemfibrozil ( a medicine used to lower increased fat levels ). if any of these apply to you , tell your doctor . if your dose is too high . if any combination of eny glid or gemfiberrozils ( a medication used
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 0 . 5 mg tablet once a day . swallow the tablet whole with a glass of water . you can take enyglid with or without food . the tablet can be taken with or just after a meal . the maximum recommended dose for adults is 30 mg once a week for 4 weeks . the dose for children and adolescents is 30mg once a month for 16 weeks . your doctor will work out the right dose for you . if you take more enylid than you
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect of enyglid is hypoglycasemia ( may affect up to 1 in 10 people ). hypoglycemic reactions are generally mild / moderate . hypocaemic unconsciousness may lead to coma . allergy allergy is rare ( may affects up to one in 10 , 000 people ). symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating . anaphylactic reaction is a rare but serious reaction . other side effects are : common ( may effect up to1 in
what enyglid contains the active substance is repaglinide . each tablet contains 0 . 5 mg , 1 mg or 2 mg repagginide . the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate , anhydrous , croscarmellose sodium , povidone k25 , glycerol , magnesium stearate , meglumine , poloxamer , yellow iron oxide ( e172 ), red iron oxide (< e172 ) ( see section 2 " eny glid contains lactose "). what enyGlid looks like and contents of the pack eny
what azacitidine mylan is azacitonidine myl is an anti - cancer agent . what azaccitidine mylon is used for azac citidine myla is used to treat adults . what it is usedfor azaciticidine myel is used in adults . azacituidine mygal is used after a stem cell transplantation in adult patients with higher - risk myelodysplastic syndromes ( mds ). it is also used in adult adult patients for chronic myelomonocytic leukaemia ( cmml ). it can also be used in acute myeloid
do not take azacitidine mylan - if you are allergic to azaccitidine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before taking azac citidine myl : - if the patient has decreased counts of platelets , red or white blood cells . - if he / she has kidney disease . - tell your doctor if the person has liver disease . if the doctor has a heart condition that makes you prone to heart attack . - your doctor may tell you if
before starting azacitidine mylan , you will be given another medicine to prevent nausea and vomiting . the recommended dose is 75 mg once a day . your doctor will tell you how much azaccitidine myl you need . your dose will be adjusted by your doctor based on your height and weight . azacacitine mylan is given every 3 weeks during this " treatment cycle " ( cycle 4 to 6 ). this medicine is given under the skin ( subcutaneously ) on the skin of your thigh , tummy or upper arm . if you have any further questions on the use of this medicine , ask your
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following serious side effects : drowsiness , shaking , jaundice , abdominal bloating and easy bruising ( which could be symptoms of liver failure ). swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue ( which may be symptoms or signs of kidney failure ). a fever ( which might be a sign of an infection ) with low levels of white blood cells . chest
keep this medicine out of the sight and reach of children . do not use azacitidine mylan after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store the vials in the original package in order to protect from light . before use : 1 ml of the azaccitidine myl suspension for injection is stored in the refrigerator ( 1 8 ). the suspension can be stored in a freezer ( 2 to 8 ) for up to 8 weeks . the
what azacitidine mylan contains - the active substance is azaccitidine . one vial of powder contains 100 mg of azacacitine . after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg of the active substances azaciticidine . - the other ingredient is mannitol ( e421 ). what azacituidine myl looks like and contents of the pack azacitonidine mylon is a white powder for suspension supplied in a glass vial containing 100 mg azacitoidine . pack sizes of 1 and 7 vials . not all
duotrav eye drop solution contains two active substances , travoprost and timolol . travaprost is a prostaglandin analogue , which is produced naturally in the eye . timolole is a beta blocker which reduces the amount of fluid within the eye and so reduces pressure within theeye . duotraveye drops are used to treat high pressure in theeye in adults with an illness called glaucoma .
do not take duotrav - if you are allergic to travoprost , prostaglandins , timolol , beta blockers or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has respiratory problems such as asthma , severe chronic obstructive bronchitis or severe lung disease . - if the child has wheeziness , difficulty in breathing , long - standing cough or breathing problems . - when the child is sick ( severe hay fever ). - when he / she has a slow heartbeat . - in patients with heart failure ( a disorder of heart rhythm with irregular heartbeat ). - in
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one drop in the eye once a day . do not use more than one drop twice a day in your eyes . do this every day until your doctor tells you otherwise . do the same for your eyes and other eyes . how to use duotrav the recommended amount of eye drops is 1 drop twice daily ( 1 and 2 ) for 3 days ( 4 weeks ). a bottle is provided with each bottle . 1 bottle is for single use only . wash your hands before
like all medicines , this medicine can cause side effects , although not everybody gets them . the drops should be swallowed whole with water . duotrav can cause very common side effects ( may affect more than 1 in 10 people ) effects of the eye eye redness . common side effect ( may effect up to 1 in every 10 people )) effects of of theeye eye surface inflammation ( surface damage ) including eye pain , blurred vision , abnormal vision , dry eye , itchy eye and eye discomfort . signs and symptoms include eye irritation , burning and stinging . uncommon side effects these may affect up to1 in 100 people )effects of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store above 30 . store in the original package in order to protect from moisture . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what duotrav contains - the active substances are travoprost and timolol . each ml contains 40 mg of travostrost and 5 mg of timolols ( as timolole maleate ). - the other ingredients are polyquaternium - 1 , mannitol , propylene glycol , polyoxyethylene hydrogenated castor oil 40 mg , boric acid , sodium chloride , sodium hydroxide , hydrochloric acid , purified water , sodium hydrochloride and hydrochlorIC acid . what duotra looks like and contents of the pack duotrave is a liquid ( a
nplate ' s active ingredient is romiplostim . it is a protein that helps to reduce low platelet counts caused by the immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is a disease that affects your body ' s immune system . platelets are important as they help to protect the blood from blood clots . very low platelets can cause bruising and serious bleeding . nplate is used to : - have your spleen removed ( chronic itp ) - have previously received corticosteroids ( immunoglobulins ) - or have had your bone
do not take nplate if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . if you have been previously treated with other medicines containing escherichia coli ( e . coli ). warnings and precautions before taking nplate , tell your doctor if you : have a low blood platelet count ( thrombocytopenia ). your doctor may reduce your dose of nplate . your platelet counts may increase if you get blood clots . blood clotting may be necessary . have liver
nplate is given to adults and adolescents ( aged 1 to 17 years ) who are able to take nplate . how nplate is administered nplate will be given as an injection under the skin ( subcutaneous ) at a dose of 1 mg / kg . how much nplate you will be treated with nplate depends on your platelet counts . you will have regular blood samples taken to count your platelets . your platelelet count will be checked regularly . your doctor will regularly measure your blood to check your plateLET count . children and adolescents from 1 to and including 17 years of age the dose of nplate that
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with itp : common ( may affect up to 1 in 10 people ): headache allergic reaction upper respiratory tract infection common ( might affect up in 1 in every 10 people ) bone marrow disorder , increased bone marrow fibres , trouble sleeping ( insomnia ), dizziness , tingling or numbness of the hands or feet ( paraesthesia ), migraine , redness ofthe skin , flushing ( blood clot ), a lung artery ( pulmonary embolism ), nausea , diarrhoea , abdominal pain , indigest
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do store above 30 . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what nplate contains the active substance is romiplostim . nplate 125 mg powder for solution for injection contains 230 mg romipliplostime . each vial of 125 mg romplostim contains a deliverable amount of 0 . 25 ml solution . each single - dose vial contains 125 mg of romiplustim . each two - dose ampoule of nplate 250 mg powder : each single dose of 375 mg romoplostim containing 250 mg romipelostim is supplied as a deliverative amount of0 . 5 ml solution , each single single - doses vial containing 250mg romiplOST
this medicine contains an active substance called glycopyrronium bromide which belongs to a group of medicines called bronchodilators . what tovanor breezhaler is used for this medicine is used to help to relieve breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). in copd , the muscles around the airways tighten , making breathing difficult . this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the lungs . this helps to reduce the effects of this medicine on the everyday life of people with copd
do not use tovanor breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using tovanOR breez inhaler - tell your doctor if you have kidney problems - tell the doctor if your doctor has told you that you have an eye problem called narrow - angle glaucoma - tell him if you experience difficulty passing urine during treatment with tovannor breezer . if you think any of these apply to you , tell your physician or pharmace
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much tovanor breezhaler to use the recommended dose of this medicine is 24 capsules ( 75 mg ) once a day . you should use this leaflet exactly as described in this leafleting guide . you can use this dose at any time of the day , including when you are exercising . do not change the dose unless your doctor tells you to . how to use this medicinal product this medicine comes as an inhaler and capsules ( in blisters ) that are packed in a carton
what tovanor breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms glycopromroniumbromide and 50 microgramS glycopyronium . each delivered dose delivers the delivered dose into the mouthpiece of the inhaler equivalent to 44 microgram glycopYRronium per inhalation dose . - the other ingredients are lactose monohydrate and magnesium stearate . what tovanOR breez inhaler looks like and contents of the pack tovannor breezer 44 microspheres are hard capsules , which contain a
adasuve contains the active substance loxapine and belongs to a group of medicines called antipsychotics . it works by allowing the brain to produce more dopamine and serotonin which are involved in calming effects and relieving aggressive behaviour . adasuve is used to treat acute symptoms of mild - to - moderate agitation in adults with schizophrenia and bipolar disorder . these are diseases characterised by symptoms such as ( in schizophrenia ) hearing , mistaken beliefs , incoherent speech and behaviour , emotional flatness , depressed , guilty , anxious , tense . the most common manifestations of bipolar disorder are feeling " high ", having excessive amounts of energy , needing
do not take adasuve if you are allergic to loxapine or any of the other ingredients of adasuvet ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking adasuves if you have symptoms such as wheezing or shortness of breath , as these may be signs of lung problems like asthma , chronic obstructive pulmonary disease ( copd ), narrowing of the airways ( bronchospasm ), wheeze , cough , chest tightness or short shortnessof breath . these may occur 25 in patients with neuroleptic malignant syndrome ( nms ). these
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 9 . 1 mg twice a day , taken once in the morning and once in 2 hours at the evening . your doctor may increase your dose to 4 . 5 mg twice daily depending on your condition . you should take adasuve with food . you can take adasve with or without a meal . it is best to take adamsve with a meal or snack . it may be convenient to take it with or just after a meal , but you should not take adamasu
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following side effects : any breathing symptoms such as wheezing , cough , shortness of breath , chest tightness which may become irritating and irritating . these may be signs of problems with your airways ( asthma or copd ). light - headedness or fainting . these could be signs that your blood pressure is getting too high . worsening agitation , confusion , fever and muscle stiffness . these can be signs for a severe condition called neuroleptic malignant syndrome . other side effects include :
keep this medicine out of the sight and reach of children . do not use adasuve after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do away with adasuvet if you notice any visible signs of physical damage . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what adasuve contains - the active substance is loxapine . each single - dose inhaler contains 5 mg of loxapeine . when adasuves delivers 4 . 5 mg loxpine , the active ingredient is released in a rapid fashion . what adasuvey looks like and contents of the pack adasuva 4 .5 mg is a white to off - white plastic inhaler , containing loxacine . the pack is packed in plastic bottles . each inhaler is packed into a sealed foil pouch . adasuved 4 . 0 mg is available in packs containing 1 or 5 inhalers .
what azacitidine betapharm is azacitonidine betabarm is an anti - cancer agent . it belongs to a group of medicines called ' anti - metabolites '. what azaccitidine betafarm is used for azaciticidine betaparm is for use in adults . azac citidine betagarm is given as a stem cell transplantation in adult patients with higher - risk myelodysplastic syndromes ( mds ), chronic myelomonocytic leukaemia ( cmml ), acute myeloid leukaemic ( aml ). these are diseases that affect the
do not take azacitidine betapharm - if you are allergic to azaccitidine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before taking azacacitine betapham : - if the patient has decreased counts of platelets , red or white blood cells . - if he / she has kidney disease . - tell your doctor if the person has liver disease . if the doctor has a heart condition that makes you prone to heart attack or lung disease . blood
before starting azacitidine betapharm , you will be given another medicine to prevent nausea and vomiting . the recommended dose is 75 mg once a day . your doctor will tell you how much azaccitidine betabarm you need . your dose will be adjusted by your doctor based on your height and weight . azacacitine betapharms is given every 3 weeks as part of this " treatment cycle " ( cycle 4 , 6 ). you will receive this medicine under the skin on your skin on either the thigh , tummy or upper arm . if you have any further questions on the use of this medicine ,
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following serious side effects : drowsiness , shaking , jaundice , abdominal bloating and easy bruising ( which could be symptoms of liver failure ). swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue ( which may be symptoms or signs of kidney failure ). a fever ( which might be a sign of an infection with low levels of white blood cells ). chest pain
your doctor , pharmacist or nurse knows how to store azacitidine betapharm properly . they are responsible for the correct storage of any unused azaccitidine betabarm . this medicine is for single use only . keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . the azacituidine betafarm suspension for single - use use is stable for up
what azacitidine betapharm contains - the active substance is azacitonidine . each vial contains 100 mg azaccitidine . after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / ml azaciticidine . - the other ingredient is mannitol ( e421 ). what azacituidine betabarm looks like and contents of the pack azac citidine betafarm is a white to off - white powder supplied in a glass vial containing 100 mg of azacitoidine .
ceberdelga contains the active substance eliglustat . it is used for the long term treatment of gaucher disease type 1 in adults . gaucher dementia type 1 is inherited condition in which a substance called glucosylceramide is not removed from your body . this substance is mainly produced by the spleen , liver and bones . when eliglustate is taken with glucoslceramide , it can cause your affected organs to relax . your doctor will test for this before you start using this medicine . if you have any further questions on the use of this medicine , ask your doctor or pharmacist . if any of
do not take cerdelga if you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). if you take medicines known as moderate cyp2d6 inhibitors ( e . g . quinidine , terbinafine ) 31 if you have moderate cyc3a inhibitors ( such as erythromycin or itraconazole ). these medicines are used to improve your body ' s ability to absorb nutrients . warnings and precautions talk to your doctor before taking cerdelg . cerdeleg should not be used in patients with medicines that have a poor metabolism or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet twice a day with food . the amount of metaboliser that you need to take varies depending on your condition and the amount you need . the dose of metabolizer that you have to take is one 84 mg tablet twice daily . swallow the tablet whole with water . do not divide , crush or chew the tablet . the maximum recommended dose for adults is one 82 mg tablet once daily . if you take more cerdelga than you should if you accidentally take too many tablets , contact
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): headache dizziness change in taste ( dysgeusia ) palpitations throat irritation heartburn ( dyspepsia ) feeling sick ( nausea ) diarrhoea constipation abdominal pain stomach ache ( upper abdominal pain ) acid reflux disease ( gastrooesophageal reflux diseases ) bloating ( abdominal distension ) inflammation of the stomach ( gastritis ) 34 difficulty swallowing ( dysphagia ) vomiting dry mouth gas ( flatulence ) dry skin hives ( ur
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and sleeve after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what cerdelga contains - the active substance is eliglustat . each capsule contains 84 mg of eliglustate . - the other ingredients are : capsule content : microcrystalline cellulose , lactose monohydrate ( see section 2 ' cerdelaga contains lactose '), hypromellose , glycerol dibehenate , gelatin , potassium aluminium silicate , titanium dioxide ( e171 ), yellow iron oxide ( e172 ), indigotine ( e132 ). capsule shell : shellac , black iron oxide , propylene glycol and ammonia solution . what cerdelg looks like and contents of the pack
the active substance in zoledronic acid hospira is zoledron acid , which belongs to a group of substances called bisphosphonates . zoledor acid works by attaching itself to the bone and slowing down the rate of bone change . it is used : to prevent bone complications , e . g . fractures , in adult patients with bone metastases ( spread of cancer from primary site to the original bone ). to reduce the amount of calcium in the blood in adult people where it is too high due to the presence of a tumour . tumours can accelerate normal bone change in such a way that the release of calcium
your doctor will carry out blood tests before you start treatment with zoledronic acid hospira and will check your response to treatment regularly during treatment . do not use zoledron acid hospir if you are allergic ( hypersensitive ) to zoledor acid , another bisphosphonate ( the substance to which zoledoral acid belongs ). warnings and precautions talk to your doctor or pharmacist before using zoledric acid hospiral . if you think any of the above applies to you , or if you have been in close contact with someone who has used zoledic acid hospiar before , tell your doctor . if any
zoledronic acid hospira must only be given by healthcare professionals trained in administering bisphosphonates intravenously ( into a vein ). ' iv ' administration is recommended in order to reduce dehydration . how much zoledronic acidic hospira is given the recommended dose is 4 mg . if you have a kidney problem , your doctor may decide to lower the dose depending on your kidney problem . how zoledron acid hospir is given in hospital , patients at risk of bone complications due to bone metastases will be given one infusion of zoledic acid hospire . the amount of calcium in your blood will be checked by your
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . the most common ones are usually mild to moderate . the following side effects may happen with zoledron acid hospir : common ( may affect up to 1 in 10 people ): severe kidney impairment ( will be determined by your doctor with certain specific blood tests ). low level of calcium in the blood . uncommon ( may effect up to1 in 100 people ): pain in the mouth , teeth and / or jaw , swelling or non - healing sores inside the mouth . jaw discharge , numbness or a feeling of heaviness , or
keep out of the reach and sight of children . do not use zoledronic acid hospira after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what zoledronic acid hospira contains the active substance is zoledron acid . one vial of zoledic acid contains 4 mg zoledicle acid . the other ingredients are monohydrate , mannitol , sodium citrate and water for injections . what zoledico acid hospir looks like and contents of the pack zoledable acid hospire is a liquid concentrate for solution for infusion ' s use . it is a clear , colourless to pale yellow to yellow concentrate . each pack contains one vials of concentrate .
what varuby is varubky contains rolapitant which is used to treat adults with cancer feeling sick ( nauseous ) or being sick ( vomiting ) when cancer treatment chemotherapy is used . how varubiy works rolapitin stops the growth of nerve cells in the brain that help to fight nausea and vomiting . this can make you feel sick or be sick . how rolapnit works varubey stops the production of these nerve cells , which help to prevent nausea and / or vomiting from occurring .
do not take varuby if you are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). if you take an herbal medicine called st john ' s wort ( hypericum performatum ) for depression and difficulty sleeping ( see section 2 " warnings and precautions "). if you have taken this medicine for 27 days or more . if you suffer from severe liver or kidney problems . if taking certain medicines ( e . g . rifampicin ). if your doctor has told you that you have tuberculosis or other infections . if your dose of carbamazepine is too low
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 180 mg once a day for up to 90 days . swallow the tablet whole with water . you can take varuby with or without food . you may take it with or just after food . it may be taken with or with a meal . you should take varubsy for 2 days before your chemotherapy cycle . you will usually take it at the same time each day . if you take more varubys than you should if you have taken more tablets than you have been told to
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with varuby : very rare ( may affect up to 1 in 1 , 000 people ): symptoms of an allergic reaction may include sudden shortness of breath , swelling of the lips or tongue , change in taste , swelling or skin or tissue , sudden rash , fever and faster heartbeats . tell your doctor immediately , as this may indicate that you may need appropriate treatment . other side effects include : very common ( may affects more than 1 in 10 people ): headache constipation feeling tired uncommon ( may effect up to
what varuby contains - the active substance is rolapitant . each tablet contains 90 mg rolapit . - the other ingredients are lactose monohydrate ( see section 2 under ' varubiy contains lactose '), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide , magnesium stearate . - film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , polysorbate 80 . what varubey looks like and contents of the pack varubdy is
what enerzair breezhaler is enerz air breez inhaler contains two active substances : indacaterol and glycopyrronium - mometasone furoate indacterol and the active substance glycopyronium belong to a group of medicines called bronchodilators . they relax the muscles in the small airways in the lungs and help to open the airways . they help to keep the air in the smaller airways open . what enerzAIR breezer is used for enerzAir breezker is used to treat asthma in adults . asthma is a serious
do not use enerzair breezhaler if you are allergic to indacaterol , glycopyrronium , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before using enerzir if you have : heart problems if you get an irregular or fast heartbeat if you suffer from thyroid gland problems if your family has diabetes , high blood sugar , seizures if you drink alcohol if you smoke if you know that you have severe kidney problems if any of these
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhaler twice a day . the medicine should be inhaled once a day at about the same time each day . use enerzair breezhaler every day , at the same times of the day . this will help control your asthma and will help you to stop your symptoms getting worse . how to use enerzeair breezyhaler use enertzair breezehaler as an inhaler and capsules . the inhaler is for inhalation use only . the capsules
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious stop using enerzair breezhaler and see a doctor immediately if you notice any of the following : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching , hives . allergic reaction other side effects other side side effects include the following side effects : very commonly ( may affects more than one in 10 users ): sore throat , runny nose , sudden difficulty breathing , feeling of tightness , wheezing or
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store in the original package in order to protect from moisture . the capsules should be used immediately after first opening . do this if you notice any change in the appearance of the capsules . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what enerzair breezhaler contains the active substances are indacaterol ( as acetate ), glycopyrronium ( as bromide ), and mometasone furoate . each capsule contains 150 micrograms of indacatersol (as acetate ) and 63 microgram of glycopreyronium bromides . each delivered dose contains 50 microgram ( 3 . 5 microgram ) of glyopyrronia and 160 microgram( 3 . 4 microgram) of mometsone furuate . the delivered dose ( the dose that leaves the mouthpiece of the
clopidogrel acino pharma gmbh contains the active ingredient clopidougrel which belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopidineogrelacino pharmÃ¡ gmbhs is taken by adults to prevent blood clubs ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events , which
do not take clopidogrel acino pharma gmbh if you are allergic ( hypersensitive ) to clopipidogl or any of the other ingredients of clopidineogrel macroglurea gbh ; if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain ; if your doctor has told you that you suffer from severe liver disease ; if any of these apply to you , tell your doctor before taking clopidiogrelacino pharmara gmb h . warnings and precautions talk to your doctor or pharmacist before taking
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is one 75 mg tablet of clopidiogrel a gmb h per day to be taken orally with or without food . you can take cloclidogl acino pi gmbH with or just after food . if you take more clopidoogrel agmbh than you should contact your doctor , pharmacist or the nearest hospital emergency department because of the increased risk of bleeding . if possible take clap
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the most common side effects are : very common ( affects more than 1 user in 10 ) uncommon ( affects 1 to 10 users in 100 ) rare ( affects less than 1 users in 1 , 000 ) very rare ( affecting less than1 user in 1, 000 ) not known ( frequency cannot be estimated from the available data ) very common : may affect more than1 in 10 people - very rare : may affects lessthan 1 in 10 , 000 people contact your doctor immediately if you experience : fever
store in the original blister in order to protect from moisture . keep out of the reach and sight of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . donot use cloplidogl acino pi gmbhl if you notice any visible sign of damage of blister or film - coated tablets . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will
what clopidogrel acino pharma gmbh contains the active substance is clopridogrel . each tablet contains 75 mg of clopidaogrel ( as besilate ). the other ingredients are : tablet core : macrogol 6000 cellulose , microcrystalline ( e460 ) crospovidone type a castor oil , hydrogenated film - coating : macromol 6000 ethylcellulose ( e462 ) titanium dioxide ( e 171 ) what clopIDogrelacino pharmÃ¡ gmb h looks like and contents of the pack clopidiogrel acc
delstrigo is used to treat hiv (' human immunodeficiency virus ') infection in adults . it is used in combination with medicines called ' antiretroviral medicines '. the active substances are doravirine ( a non - nucleoside reverse transcriptase inhibitor ( nnrti ) and lamivudine ( also a nucleosides analogue reverse transcriptases inhibitor ( tnrtis ). the other active substances in delstrigo are tenofovir disoproxil ( also known as a nucleositide analogue reverse transcriptase inhibitor [ nrti ]) and tenofova
do not take delstrigo if you are allergic to doravirine , lamivudine , tenofovir disoproxil or any of the other ingredients of this medicine listed in section 6 . if you take any of any of these , tell your doctor or pharmacist . if your doctor has told you that you are taking any of : - the following medicines : carbamazepine , oxcarbazepine ; phenobarbital ; phenytoin ( medicines to prevent seizure ); rifampicin and rifapentine ( medicines used to treat tuberculosis ); st . john '
always take delstrigo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is a complete regimen of one tablet a day . a single tablet is sufficient for you to complete the full course of treatment for hiv infection . the usual dose is 1 tablet a morning . if you take certain medicines ( such as doravirine ) your doctor may prescribe medicines that lower your dose . taking this medicine swallow the tablet whole with a glass of water . do not crush , chew or break the tablet . taking the tablet before or after food , drink , or other
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking this medicine and tell your doctor immediately if you notice any of the following : very common ( may affect more than 1 in 10 people ): abnormal dreams difficulty in sleeping ( insomnia ) headache dizziness sleepiness cough nasal symptoms feeling sick ( nausea ) diarrhoea stomach pain vomiting wind ( flatulence ) hair loss rash muscle symptoms ( including pain and stiffness ) feeling tired fever blood tests showing increased levels in liver enzymes uncommon ( may effect up to 1 in 100 people ): nightmares , depression , anxiety , irritability , confusion and suicidal thoughts 45 trouble
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and carton after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . keep the bottle tightly closed in order to protect from moisture . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what delstrigo contains the active substances are 100 mg doravirine , 300 mg lamivudine and 245 mg tenofovir disoproxil ( as fumarate ). the other ingredients are croscarmellose sodium e468 , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose e460 , silica , colloidal anhydrous , sodium stearyl fumar . a coating material containing carnauba wax e903 , hyprogellose , iron oxide yellow ( e172 ), lactose monohydrate , titanium dioxide e171
spravato contains esketamine . this belongs to a group of medicines called anti - depressants . this medicine helps to control your depression and decreases the symptoms of depression . these include feeling sad , anxious , worthless , sleeping difficulties , change in appetite , loss of interest in favourite activities and feeling of being slowed down . spravato is used in combination with another antidepressant , which is used every 2 weeks . it is important to keep following the advice about antidepressant medicines given to you by your doctor .
do not take spravato if you are allergic to esketamine or any of the other ingredients of ketamine ( listed in section 6 ). if you have an aneurysm ( a weak spot in a blood vessel wall that bulges out ) or bleeding in the brain . if you recently had a heart attack . within 6 weeks of starting treatment . spravat can cause a temporary increase in blood pressure , which can lead to serious complications in these conditions . tell your doctor before you take sprevato if any of these apply to you . if any or all of these applies to you , tell your medical professional before
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the spravato nasal spray should be used immediately after application . the nasal spray device should be connected to the nasal pump device for 1 to 2 hours . there are 3 nasal spray devices connected to one nasal spraydevice for 4 hours . use spravat every day for 2 hours after application and for at least 4 hours after preparation . do not use this product if you experience nausea or vomiting after 2 hours of treatment . do this every day until your doctor tells you otherwise . do use sprevato for
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with spravato : very common ( may affect more than 1 in 10 people ) feeling disconnected or having feelings and things around you feeling dizzy headache change in sense of taste feeling sleepy decreased feeling or sensitivity to touch in the mouth area spinning sensation vertigo vomiting nausea common ( might affect up to 1 in every 10 people ): feeling extremely happy ( euphoria ) feeling agitated feeling anxious feeling in the eyes or ears a crawling feeling or being irritable panic attacks change in perception 37 feeling , hearing , seeing or sensing things
what spravato contains - the active substance is esketamine . each nasal spray device contains esketam hydrochloride equivalent to 28 mg esketa . - the other ingredients are citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ) water for injections what spravat looks like and contents of the pack spravatos is a nasal spray solution . this medicine is a clear , colourless solution for use in children . spravata is available as a single - use nasal spraydevice . spreamato is available in packs containing 1 , 2 , 3 or 6 nasal spray devices
zerbboraf is an anticancer medicine that contains the active substance vemurafenib . it is used to treat melanoma that has spread to other parts of the body or cannot be removed by surgery . it can be used if you have a type of cancer that has a change ( mutation ) in a gene called ' melanoma ' ( tk ). zelboraf targets proteins that are involved in the growth of your cancer .
do not use zelboraf if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ) symptoms of allergic reactions may include swelling of the face , lips or tongue , difficulty breathing , rash and fainting sensation . if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor or pharmacist before using zelberaf . allergic reactions if allergic reactions occur while using zeloboraf , tell the doctor or nurse immediately if you have any symptoms of an allergic reaction such as swelling ofthe face , lip or tongue ), difficulty
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 4 capsules taken once a day for 8 days . your doctor may increase your dose to 4 capsules once a week if you experience side effects . your treatment will be continued until your doctor tells you otherwise . taking zelboraf with food you can take zelberaf with or without food . swallow the capsules whole with a glass of water . do not crush or chew the capsules . if you take more zelbaf than you should if you accidentally take too many capsules , contact
like all medicines , zelboraf can cause side effects , although not everybody gets them . serious allergic reactions may occur : swelling of the face , lips or tongue difficulty breathing rash fainting sensation stop taking zelberaf and tell your doctor immediately if you notice any of the following : radiation treatment side effects caused by radiation during zelbaraf treatment , the following may occur . radiation may affect the skin , esophagus , bladder , liver , rectum , and lungs . tell your physician immediately if your doctor notices any of these symptoms : skin rash , blistering , peeling , discoloration of the skin
keep out of the reach and sight of children . do not use zelboraf after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do this to avoid evaporation . do away with any medicines that are damaged or shows signs of tampering . these measures will help to protect the environment .
what zelboraf contains the active substance is vemurafenib . each film - coated tablet contains 240 mg of vemurabenib ( as a co - precipitate of veMurafenb ). the other ingredients are hypromellose acetate succinate , colloidal anhydrous silica , croscarmellose sodium , hydroxypropyl cellulose , magnesium stearate film - coating : iron oxide , macrogol 3350 , polyvinyl alcohol , talc and titanium dioxide ( e171 ). what zelberaf looks like and contents of the pack zelbouraf
duoplavin contains clopidogrel and acetylsalicylic acid ( saa ). saa belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood which clump together during blood clotting . by preventing this clumping , blood vessels relax and blood vessels expand . antiplatelets medicinal products reduce the chances of blood clots forming ( a process called atherothrombosis ). duoplavic is taken by adults to prevent blood cl clots from forming in hardened arteries , a process known as atherostrombotic events , which can
do not take duoplavin if you are allergic to clopidogrel , acetylsalicylic acid ( arsa ) or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic , but are not sure , ask your doctor . if you have been previously treated with other products called non - steroidal anti - inflammatory products . if your doctor has told you that you have painful and / or inflammatory conditions of muscles or joints . if this applies to you , tell your doctor before taking duoplin . if any of these apply to you ( or you are
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . you should take duoplavin at the same time each day . your doctor will tell you how many tablets of your medicine to take . if you take more duoplin than you should if you have accidentally taken too many tablets , or if someone else has taken your tablets , contact your doctor immediately . if possible , show the doctor your pack of tablets . if a person accidentally takes too many tablet ( s ) of duopllin , contact the
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine if you notice any visible sign of deterioration . do so immediately after opening . donot throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what duoplavin contains duoplin 75 mg film - coated tablets each tablet contains 46 of the active substances , clopidogrel , acetylsalicylic acid (asa ). each 75 mg tablet contains acetylSalicylic acids ( as hydroxypropylcellulose ). each maize starch , hydrogenated castor oil ( see section 2 ' duopllin contains hydrogenatedcastor oil '). the other ingredients are stearic acid and colloidal anhydrous silica . the tablet core contains lactose monohydrate ( see also section 2 " duopluin contains lactate '
simbrinza contains two active substances , brinzolamide and brimonidine tartrate . brin zolamide belongs to a group of medicines called carbonic anhydrase inhibitors . brimonidine tartrate belongs to the group of medicine called alpha - 2 adrenergic receptor agonists , which work by reducing pressure within the eye . simbrinz is used to treat pressure in the eyes in adults aged 18 years and older who have eye conditions such as glaucoma , ocular hypertension ( high pressure on the eyes ).
do not take simbrinza if you are allergic to brinzolamide , brimonidine tartrate or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic to sulphonamides if you have ever taken medicines for diabetes or infections if you take diuretics ( water tablets ) or a monoamine oxidase ( mao ) inhibitors if you do not take medicines for depression or parkinson ' s disease if you cannot take certain antidepressants if you stop taking any antidepressant medicines if you suffer from severe kidney problems if you develop too much acidity in your blood (
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . simbrinza should only be used in the eyes . avoid contact with the drops in your eyes . wash your hands thoroughly after using simbrine ( see section 1 , " how to use simbrinusza "). do not remove the cap or snap collar . before using the medicine , twist off the cap . hold the bottle with your fingers . tilt the bottle back . pull down the eyelid with a clean finger and insert a ' pocket ' between the eyelids and the eye . the drop
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : if you have a reaction to the medicine ( frequency not known ): signs of an allergic reaction include : severe skin reactions , rash , redness or itching all over your body and / or eyes trouble breathing , chest pain , or irregular heart beat tell your doctor immediately if you experience extreme tiredness or dizziness . the other side effects that may occur with simbrinza are : common side effects ( may affect up to 1 in 10 people ) effects affecting the eye ( allergic conjunctivitis
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . store the bottle tightly in order to protect from light . once opened , use within 4 weeks to prevent infections . do use a new bottle immediately after opening . do away with the bottle that is damaged or shows signs of tampering . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no
what simbrinza contains - the active substances are brinzolamide and brimonidine tartrate . each ml of suspension contains 10 mg of brinza and 2 mg of of brimonine tartrate equivalent to 1 . 3 mg of Brimonidine . - the other ingredients are benzalkonium chloride ( see section 2 " simbrinusza contains benzalkonaium chloride "), propylene glycol , carbomer 974p , boric acid , mannitol , sodium chloride , tyloxapol , hydrochloric acid and sodium hydroxide . - purified water contains hydrochlor
what filgrastim ratiopharm is filgrastaim ratisopharm contains the active substance filgrasterim . filgrasteim is a protein produced by biotechnology in bacteria called escherichia coli . it is very similar to a natural protein produced in your body called granulocyte - colony stimulating factor ( gcfr ). filgrateim stimulates the bone marrow to produce new blood cells . more blood cells are needed than white cells . white cells are important as they help your body fight infection . what filgrustim ratinopharm does filgraintim ratiotopharm works
do not use filgrastim ratiopharm - if you are allergic ( hypersensitive ) to filgrasteim or any of the other ingredients of filgraspim ratisopharm . warnings and precautions talk to your doctor or pharmacist before using filgrateim ratitopharm if you : - have a cough , fever or difficulty breathing - have or have had a pulmonary disorder . tell your doctor straight away if you get any of these side effects . sickle cell disease 57 - have left upper abdominal pain or pain at the tip of your shoulder - have had or have a spleen disorder . if
how much filgrastim ratiopharm is given your doctor will decide how much filgnastim ratiopharm you will receive . how much is given the amount of filgrateim ratisopharm given will depend on your condition . your doctor or nurse will calculate the dose of filgnate ratiophile and will tell you how many treatments you will need . filgrasterim raticoopharm treatment will be started by a doctor who is experienced in the use of chemotherapy . the recommended dose is 0 . 5 mg per kilogram body weight given every 60 days . your treatment will last approximately 14
you must not be given filgrastim ratiopharm if you have sickle cell disease 57 you should not be treated if you get left upper abdominal pain or pain at the tip of your shoulder . this may be a sign of a spleen disorder . see section 4 . if you experience side effects , your doctor may order regular blood tests before you are given filbrastim ratiopharm . this is to check that the number of neutrophils ( a type of white blood cells ) in your blood is normal . your doctor will also check your blood before and during treatment . other medicines and filgraste
keep out of the reach and sight of children . do not use filgrastim ratiopharm after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . donot use filgrimastim piriopham if the solution is cloudy or contains particles . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what filgrastim ratiopharm contains - the active substance is filgrasim . each ml of solution for infusion contains 60 mg of filgrateim . filgrasterim ratisopharm 30 mg / 0 . 5 ml : each pre - filled syringe contains 30 mg of filmgrastime in 0 . 05 ml solution . filgnastim ratiopharm 48 mg / 1 ml : one pre -filled syringe containing 48 mg of the active ingredient filgracyim in 0. 8 ml solution , the other ingredients are sodium hydroxide , glacial acetic acid , sor
what riluzole zentiva is riluxole zertiva contains rilu which belongs to a group of substances called cytokines . these are involved in the nervous system and play an important role in controlling your condition . what rilzole zsentiva is used for rilukole zENTiva is given to adults with amyotrophic lateral sclerosis ( amy )- motor neurone disease ( ms ) where the nerve cells that make muscles work are damaged and cause weakness , muscle waste and paralysis . ms is caused by the destruction of nerve cells . motor neurONE disease may also be caused by too
do not take riluzole zentiva if you are allergic to rilizole or any of the other ingredients of this medicine ( listed in section 6 ). if you have any liver disease . if you experience increased blood levels of some enzymes of the liver called transaminases . if this applies to you , tell your doctor before taking rilzole zenta . warnings and precautions talk to your doctor or pharmacist before taking this medicine if you : have anyiver problems . if any of these apply to you ( or you are not sure ), tell your physician or pharmaceutist before taking it . if your
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet taken once a day . the tablets should be taken by mouth at about the same time each day . your doctor may prescribe a lower dose if necessary . the maximum recommended dose for adults is 12 tablets . if you take more riluzole zentiva than you should contact your doctor , pharmacist or your nearest hospital emergency department immediately . if possible take rilzole zsentiva with food . if a child swallows some tablets , contact your physician immediately . do
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : fever ( increase in temperature ). during treatment with riluzole zentiva there may be a decrease in the number of white blood cells . this is seen in a blood sample . white blood cell counts are important for fighting infections . if you have any of the following symptoms : yellowing of your skin or the whites of your eyes ( jaundice ), itching , feeling sick or being sick . these may be signs of liver disease ( hepatitis ). your doctor will do regular blood tests before and during treatment
what riluzole zentiva contains the active substance is rilusole . the other ingredients are : anhydrous dibasic calcium phosphate , micro crystalline cellulose , anhydrated colloidal silica , magnesium stearate , croscarmellose sodium , hypromellose , macrogol 6000 , titanium dioxide ( e171 ). what rilizole zenta looks like and contents of the pack the tablets are white to off - white , round and marked with " 50 " on one side and " ril " on the other side . the tablets have a diameter of 202 mm
emgality contains the active substance galcanezumab , a medicine that blocks the activity of calcitonin gene , a protein involved in migraine . increased levels of cgrp in the blood can lead to an increased risk of migraine . emgality is used to treat migraine in adults , adolescents and children aged 4 years and older who have migraines . emigality can reduce the frequency and severity of migraine headache and improve your quality of life .
do not use emgality if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious cardiovascular disease . serious cardiovascular diseases can cause allergic reactions emgally can cause serious allergic reactions . these reactions may occur up to 40 minutes after you have had a serious allergic reaction . you should see your doctor immediately if you notice such signs or possible side effects . see section 4 . children and adolescents emgali is not recommended for children and teenagers under 18 years of age . other medicines and emgalis tell your doctor or pharmacist if you
always use emgality exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg once daily . emgally is given under your skin ( subcutaneous injection ). you may receive your emgalis injection with or without proper training . if you miss a dose of emgal 240 mg , do not inject a double dose to make up for a forgotten dose . if your next dose is due in two weeks , skip the missed dose . use emegality as soon as possible after the missed doses . if it is not , your doctor may decide
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions to emgality may include rash and itching . serious allergic reactions ( rare , may affect up to 1 in 1 , 000 people ) may include : difficulty breathing or swallowing , low blood pressure , dizziness or light - headedness , swelling of the neck , face , mouth , lips , tongue or throat , severe itching of the skin , a red rash , raised bumps . other side effects very common side effects ( may affect more than 1 in 10 people ) injection site pain injection site reactions may include red skin , itching
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store the blister in the original package in order to protect from light . after first opening , the product may be stored for up to 8 days in a freezer at 2 8 or up to 7 days in the refrigerator at 30 . do this once a month . do away with this medicine if you notice it is discoloured or there are particles
what emgality contains - the active substance is galcanezumab . each pre - filled pen contains 120 mg of galcaneszumb in 1 ml solution . - the other ingredients are l - histidine , l - ethidine hydrochloride monohydrate , polysorbate 80 , sodium chloride and water for injections . what emgalis looks like and contents of the pack emgally is a solution for injection in a clear glass syringe . the solution is colourless to slightly yellow . the syringe is provided in a pack containing one single - dose pen . pack sizes of 1 , 2
defitelio is a medicine that contains the active substance defibrotide . it is used to treat a condition called hepatic veno - occlusive disease ( ha - occlusive ) in which the blood vessels in the liver become damaged and blood clots are formed . it can be used in patients who have not received medicines prior to a stem cell transplantation . defibroide works by helping the blood vessel to open and close , so that the blood clasts can be removed . if you have any further questions on the use of this medicine , ask your doctor or pharmacist .
do not use defitelio if you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ) if you have been taking other medicines to prevent blood clots ( tissue plasminogen activator warnings and precautions ) if any of these apply to you , tell your doctor before using this medicine . warnings and measures talk to your doctor or pharmacist before using defitgelio if : you have a history of bleeding if you experience heavy bleeding if your doctor thinks that you may need a blood transfusion or surgery if you suffer from problems with blood circulation ( a constant blood
the treatment with defitelio will be started by a doctor who is experienced in the care of patients who have received stem cells transplantation . it will be given into one of your veins as an ' intravenous infusion ' ( drip ). you will be monitored during this treatment for 21 days until your symptoms improve . if you have any further questions on the use of this medicine , ask your doctor or nurse . if more than 18 days have passed since you received defiteloio , tell your doctor , nurse or pharmacist . if possible , take the next dose at the usual time . do not take a double dose to make
like all medicines , defitelio can cause side effects , although not everybody gets them . stop taking defiteloio and see a doctor immediately if you notice any of the following side effects : very common ( may affect more than 1 in 10 people ): low blood pressure common ( might affect up to 1 in every 10 people ) bleeding in general bleeding including the nose bleeding from the brain bleeding from inside the gut vomiting blood bleeding from around the lungs bleeding from blood in the urine and the mouth bleeding from under the skin coagulopathy ( disturbance of blood clotting ) nausea vomiting diarrhoea rash itching fever uncommon ( may
keep this medicine out of the sight and reach of children . do not use defitelio after the expiry date which is stated on the outer carton and on the vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do do not shake defiteloio if you notice that the solution is cloudy or contains particles . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what defitelio contains the active substance is defibrotide . each ml of 2 . 5 ml solution contains 200 mg of defibrorotide ( as mesilate ). each ml solution provides 80 mg of the active substances in defibotide . the other ingredients are sodium citrate dihydrate , hydrochloric acid , sodium hydroxide ( for ph - adjustment ), water for injections ( see section 2 " defitelsio contains sodium "). what defitELio looks like and contents of the pack defiteloio is a clear , colourless to pale yellow concentrate for solution for infusion
daklinza contains the active ingredient daclatasvir . hepatitis c is an infectious disease that affects the liver caused by the hepatitis c virus . this medicine works by stopping the hepatitisc virus from multiplying in your body . it reduces the amount of the virus in your blood . daklinz is used in combination with other medicines to treat hepatitis c infection . the other medicines that you will be taking with daklineza are : - oral , single use , with or without food . - combination with a medicine containing other medicines for hepatitis c . your doctor will discuss with you which combination of the other treatments is best
do not take daklinza if you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 ) or to any of those substances by mouth . if you take any of these medicines : phenytoin , carbamazepine , oxcarbazepine and phenobarbital ( used to prevent epileptic seizures ) rifampicin , rifabutin and rifapentine ( antibiotics used to treat tuberculosis ) dexamethasone , a steroid ( used for allergic and inflammatory diseases ) medicines containing st . john ' s wort
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of daklinza is 60 mg once a day . do not take more than this dose once a week . do this if you notice that the medicine has a very unpleasant taste . your doctor may tell you to take dakinza with some other medicines . if you take more daklineza than you should if you have taken more dailinza than your doctor tells you to , talk to your doctor . if possible , take these medicines with a meal or snack . your
like all medicines , this medicine can cause side effects , although not everybody gets them . when daklinza is used in combination with sofosbuvir or ribavirin , the following side effects have been reported : very common ( may affect more than 1 in 10 people ): headache fatigue common ( might affect up to 1 in every 10 people ) difficulty sleeping dizziness migraine nausea ( feeling sick ) diarrhoea abdominal pain joint pain aching or tender muscles when dailinza in combination of sofosebuvir and ribavir the following other side effects are reported : common ( likely to affect up in every
what daklinza contains - the active substance is daclatasvir . each film - coated tablet contains 30 mg or 60 mg of daclasvir ( as dihydrochloride ). - the other ingredients are : tablet core : anhydrous lactose , microcrystalline cellulose , croscarmellose sodium , silicon dioxide , magnesium stearate . tablet coating : hypromellose , titanium dioxide , macrogol 400 , indigo carmine aluminum lake ( e132 ), yellow iron oxide ( e172 ) 51 what daklineza looks like and contents of the pack 30
proquad is a vaccine that helps protect against measles , mumps , rubella and chickenpox ( varicella ) viruses . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will produce antibodies against the measles , rubles , rubell and varicelluses . the antibodies help to prevent diseases caused by these viruses . proquad is used to prevent measles , measles , and rubella in adults who have already been vaccinated against chickenpox . the vaccine is given to infants 12 months of age and older . pro quad is used in children and adolescents ( 3 months to 9 years
do not receive proquad if you are allergic to any varicella vaccine , measles , mumps or rubella vaccine , or any of the other ingredients of this vaccine ( listed in section 6 ) if you have a blood disorder or type of cancer that affects the immune system ( including treatment with medications that weaken the immunesystem ), if you receive low - dose corticosteroid therapy ( for asthma ) or replacement therapy if you suffer from a weakened immune system , if you know you have or have had a disease ( including aids ), if your immune system is weakened , if your doctor determines that you have congenital or hereditary immun
proquad is given by injection into the muscle or under the skin ( usually in the thigh or upper arm ). injections will be given into the upper muscle ( usually the thigh area ) or upper upper arm . if you have a blood clotting disorder or low levels of platelets , the vaccine should not be given under the sun . bleeding may occur after injection into a muscle . proquad is injected into a blood vessel . pro quad is given as an injection into 9 to 12 months of age . it is recommended that the first dose is given in a hospital or clinic because of the risk of bleeding into a hard muscle . if the
like all vaccines and medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions such as hives may occur . if these reactions occur , you may have difficulty in breathing or swallowing . if you have an allergic reaction , contact your doctor immediately . other side effects that have been reported with proquad include : uncommon ( may affect up to 1 in 100 people ): seizures with a fever rare ( may effect up to1 in 1 , 000 people ): bronchiolitis ( difficulty breathing , cough , unsteadiness with walking ). other side side effects reported with the use of proquad are : very common (
what proquad contains the active substances are : measles virus1 , edmonston strain , 3 . 00 mg mumps virus1 ( jeryllynnâ¢ level b ) strain , 4 . 30 mg rubella virus2 , strain , equivalent to 3 .00 mg varicella virus3 , merck strain , strain 3 . 99 mg mrc . the other ingredients are : tissue culture : plaque - forming units 1 , chickembryo cells ( fibroblasts ) mrc , powder sucrose , hydrolysed gelatin , urea , sodium chloride , sorbitol ( e420 ), monosodium glutamate ,
jylamvo is a substance produced by the body . it is an anticancer medicine which reduces unwanted reactions . it acts as an immunosuppressive agent . jylamve is used to treat rheumatic and skin diseases : active rheumatoid arthritis ( for example , polyarthritic forms of joints ) severe juvenile idiopathic arthritis ( jia ) in children and adolescents 3 years of age and older . it may be used alone or in combination with non - steroidal anti - inflammatory drugs ( nsaids ) to treat inadequate o severe or disabling psoriasis in adults who have not responded to
do not use jylamvo if you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ) if you have a severe kidney impairment if you suffer from a liver impairment if your doctor has told you that you have blood disorders such as bone marrow hypoplasia , leukopenia or thrombocytopenia if you know that you are suffering from significant anaemia 34 if you think you may have a weakened immune system if you already have a serious infection such as tuberculosis or hiv if you develop ulcers in the stomach or intestines if you experience an
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of jylamvo is one tablet once a day . if you use more jylimvo than you should severe side effects , including even death , may occur . your doctor will discuss this with you and will adjust the dose and duration of the treatment . rheumatoid arthritis and severe juvenile idiopathic arthritis with severe psoriasis if you have severe psoriatic arthritis , jylemvo is used as a long - term treatment . jyamelvo is also
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : wheeziness , difficulty in breathing , swelling of the eyelids , face or lips , rash or itching on your whole body . other side effects include breathing problems , feeling of illness , dry , irritating cough , shortness of breath , difficulty or breathing , chest pain ( fever ), spitting or coughing blood , serious peeling or blistering of the skin unusual bleeding ( vomiting blood ), bruising , nose bleeds , nausea , vomiting , abdominal discomfort , severe diarrhoea mouth ulcers , black or tarry
keep this medicine out of the sight and reach of children . do not use the medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . do store below 25 . store in the original package in order to protect from light . the medicine should be administered immediately after preparation . in order for accidental spillage , the product should be used within 3 hours . any unused medicine or waste material should be disposed of in accordance with local requirements for cytotoxic products .
what jylamvo contains - the active substance is methotrexate . each ml of solution contains 2 mg of methotroxybenzoate . - the other ingredients are macrogol 400 , glycerol , orange flavour , sucralose , ethyl parahydroxybenzzoate ( e218 ), sodium methyl parahhydroxybenziate (e218 ), citric acid , tri - sodium citrate , purified water ( see section 2 " jylimvo contains ethyl paraahydrobenzoates and sodium methyl paraahhydrobenzate "). what jyarm
what enurev breezhaler is this medicine contains the active substance glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . what enurevo breez inhaler is used for this medicine is used to make breathing easier for adult patients who have breathing difficulties due to a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten , making breathing difficult . this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the lungs . this helps to reduce the effects
do not use enurev breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have kidney problems . - if the doctor has given you an eye problem called narrow - angle glaucoma ( difficulty passing urine ). warnings and precautions talk to your doctor or pharmacist before treatment with enurevo breez inhaler : if you have any of these conditions while taking this medicine : - tightness of the chest , coughing , wheezing or breathlessness immediately after using
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhaler once a day . you should use this this medicine for 24 hours at a temperature of 75 to 75 Âºc . you can use this when you are exercising or at home . do not change your daily dose without talking to your doctor . how to use this medicinal product this medicine is for inhalation use . you will find an inhaler and capsules ( in blisters ) that contain the medicine as inhalation powder . the capsules are for inhal use only . do this
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious : uncommon ( may affect up to 1 in 100 people ) irregular heart beat high level of blood sugar ( hyperglycaemia ) typical symptoms are excessive thirst , hunger and frequent urination ) rash , itching , hives difficulty breathing , swallowing or dizziness allergic reaction ( swelling mainly of the tongue , lips , face or throat ) angioedema ( see section 2 ). if any of the side effects gets serious , tell your doctor . some other side effects ( frequency cannot be estimated from the available data ) common
what enurev breezhaler contains the active substance is glycopyrronium bromide . each capsule contains 63 micrograms glycopyroniumbromide equivalent to 50 microgram glycopierronium . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram of glycopirronium per inhalation dose . the other ingredients are lactose monohydrate and magnesium stearate . what enurevo breez inhaler looks like and contents of the pack enurevan breezker 44 microliters are white to off - white
what riximyo is riximusimyo contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to a target in a type called a white blood cell called " b - lymphocyte ". when ritukimab sticks to the target of this protein , it stops the cell from growing and dividing . what rixima is used for the treatment of rixibyo is used to treat : a ) non - hodgkin ' s lymphoma this is an disease of the lymph tissue that affects the immune system . it
do not use riximyo if you are allergic to rituximab , other proteins that are derived from ritukimab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe active infection at the moment . if you suffer from a weak immune system . if your doctor has told you that you have severe heart failure or severe uncontrolled heart disease ( granulomatosis , polyangiitis , microscopic polyangitis or pemphigus vulgaris ). warnings and precautions talk to your doctor or pharmacist before using riximeryo . if any of
your doctor will decide how much riximyo you will receive and how often you will need this treatment . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you have any side effects , your doctor may decide to change your dose . riximusyo is given as a drip ( intra - venous infusion ). medicines given before each riximeyo administration you will be given riximeryo together with other medicines ( premedication ) to reduce the risk of side effects . your doctor will determine the dose you need and will adjust your dose
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy or runny nose , vomiting , flushing or palpitations , heart attack , low number of plate
what riximyo contains the active substance is rituximab . each 10 ml vial contains 100 mg of ritukimab ( 10 mg / ml ). each 50 ml vials contains 500 mg of the active ingredient in ritiximab , 10 mg/ ml . the other ingredients are sodium citrate , polysorbate 80 , sodium chloride , sodium hydroxide and hydrochloric acid ( see section 2 " rixima contains sodium "). what rixamyo looks like and contents of the pack riximusyo is a clear to slightly yellowish solution for infusion . it
topotecan actavis contains the active substance topotecin . topotecaan activ is used to treat small cell lung cancer that has come back after chemotherapy . it is also used to prevent advanced cervical cancer that cannot be removed by surgery or radiotherapy . in this case topotican actv treatment is combined with medicines containing cisplatin .
do not use topotecan actavis - if you are allergic to topotecaan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using topotocan activ . your doctor may check your blood cell counts if they are too low . this is because topotican actez may affect your ability to carry out daily activities . talk to a doctor or nurse if you have any kidney problems . your dose of topotchean actrix may need to be adjusted . talk with your doctor if any of these apply to you .
your doctor will determine the dose of topotecan actavis you will receive based on the results of blood tests carried out before treatment and on your response to treatment . adults small cell lung cancer : the usual dose is 1 . 5 mg per square metre of body surface area for the first 5 days of this treatment cycle . cervical cancer : this dose is 0 . 75 mg per sq metre of surface area , for the second 3 days of the treatment cycle and will be given to you by your doctor . if you have cervical cancer , your doctor may give you another anticancer medicines containing cisplatin . if cisplin is
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious sideeffects : infections ( very common , may affect more than 1 in 10 people ): fever . this may be due to your general condition . local symptoms such as sore throat , burning sensation , severe stomach pain , fever , diarrhoea and bowel inflammation ( neutropenic colitis ). topotecan actavis may reduce your ability to fight infections . lung inflammation ( rare , may affects up to 1 in 1 , 000 people ): difficulty in breathing , cough and
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . keep the vials in the outer carton in order to protect from light . reconstitution and dilution chemical and physical in - use stability has been demonstrated for 24 hours at 25 and 2 hours at 2 to 8 , when stored in a refrigerator ( 2 to 9 ). the drug product solution for dilution in solutions for infusion ( nacl 0 . 9 %) and glucose
what topotecan actavis contains - the active substance is topotecaan . each vial contains 1 mg or 4 mg topototecin ( as hydrochloride ). after reconstitution , each 1 ml vial of solution contains 1mg topotican . - the other ingredients are mannitol ( e421 ), tartaric acid , hydrochloric acid and sodium hydroxide . what topotECan actis looks like and contents of the pack topotan acti is supplied in glass vials with grey bromobutylic stopper and aluminium seals with plastic flip -
the active substance of rivastigmine hexal is rivustigmine . rivasta belongs to a class of substances called cholinesterase inhibitors . in patients with alzheimer ' s dementia or dementia due to parkinson ' s disease , certain nerve cells die in the brain , resulting in low levels of the neurotransmitter acetylcholine ( a substance that allows nerve cells to communicate with each other ). rivasterigmine works by blocking the enzymes that break down acetyl acetylCHoline : acetylchlorolinescerase and butyrylcholinestersterase .
do not take rivastigmine hexal - if you are allergic to rivasta , the active substance in rivostigminehexal , or any of the other ingredients of this medicine ( listed in section 6 ). - if a previous skin reaction ( allergic contact dermatitis ) has been severe . warnings and precautions talk to your doctor or pharmacist before taking rivstigmine Hexal . if any of these apply to you , tell your doctor before taking the medicine . if you have : - irregular or slow heartbeat - an active stomach ulcer - difficulties in passing urine - seizures - asthma - severe respiratory
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to start treatment your doctor will tell you what dose of rivastigmine hexal to take . treatment usually starts with a low dose . depending on how you respond to treatment , the highest dose that should be taken is 6 . 0 mg per kg of body weight . your doctor may increase your dose depending on your response to this medicine . if you take more rivasta hexal than you should if you have taken more r rivasteigminehexal than your doctor tells you to
like all medicines , this medicine can cause side effects , although not everybody gets them . you may experience side effects more often when you start your medicine or when your dose is increased . the side effects are usually mild to moderate . very common ( may affect more than 1 in 10 people ) feeling dizzy loss of appetite stomach problems such as feeling sick ( nausea ) or being sick ( vomiting ) diarrhoea common ( might affect up to 1 in every 10 people ): anxiety sweating headache heartburn weight loss stomach pain feeling agitated feeling tired or weak generally feeling unwell trembling or feeling confused decreased appetite nightmares uncommon ( may affects up to1
keep out of the reach and sight of children . do not use rivastigmine hexal after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store above 30 . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what rivastigmine hexal contains 64 the active substance is rivastaigmine hydrogen tartrate . the other ingredients are hypromellose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica , gelatin , yellow iron oxide red iron oxide ( e172 ), titanium dioxide ( e171 ), shellac . each rivastsigminehexal 1 . 5 mg capsule contains 1 . 25 mg of rivostigmine . each vial of each riastigme hexal 3 mg capsule releases 3 mg of the active ingredient rivasigmine (
cabometyx is a cancer medicine that contains the active substance cabozantinib . it is used to treat kidney cancer ( renal cell carcinoma ) or liver cancer that has spread to other organs . it can be given alone or in combination with a specific anticancer medicine containing sorafenib . how cabometyx works cabomety blocks the action of proteins called receptor tyrosine kinases ( rtks ), which are involved in the development of new blood vessels . by blocking the action , these proteins can help to prevent high amounts in cancer cells . cabometx is used in adults .
do not take cabometyx 45 if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking cabomety if you have high blood pressure , have had an aneurysm ( enlargement or weakening of a blood vessel wall ) or a tear in a blood valve wall , have diarrhoea , have recent had significant bleeding , have recently had surgery or have had a recent dental surgery , have inflammatory bowel disease , crohn ' s disease , ulcerative colitis , diverticulitis or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . you should take this tablet at the same time each day . your doctor may increase your dose or stop your treatment if you experience serious side effects . your treatment will be overseen by a doctor who is experienced in the treatment of patients with dementia . the usual starting dose of cabometyx is 60 mg once a day taken with cabomety . you may take cabometometyx for 2 - 3 consecutive days . you must take cabostyx for 1 hour before
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with cabometyx and other medicines . tell your doctor or pharmacist if your side effects become severe or persistent . tell the doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : symptoms include pain in the abdomen ( nausea ), vomiting , constipation , fever . these may be signs of a gastrointestinal perforation ( a hole that develops in the stomach or intestine ). severe or uncontrollable bleeding . symptoms include vomiting blood , black stolls , bloody urine , headache , coughing
what cabometyx contains the active substances are cabozantinib and malate . cabometx 20 mg film - coated tablets : each tablet contains cabozatinib ( s )- malate equivalent to 20 mg cabozinib . cabobometyx 40 mg film coated tablets ): each tablet contain cabozutinib_( s ) - malateivalent to 40 mg caboyantinip . cabostyx 60 mg film coating tablets : all tablet strengths contain cab ozantin ib ( s ), malate , and 60 mg caboxantininib the other ingredients are microcrystalline
pemetrexed hospira is a medicine used in the treatment of cancer . pemetrexED hospira in combination with cisplatin , another anti - cancer medicine , is used for treatment of malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , in adults who have not received prior chemotherapy . pemdesed hospir in combinationwith cisplin is also used for the initial treatment of patients with advanced stage of lung cancer . when pemetreed hospiera is used , you may be diagnosed with lung cancer at an advanced stage if your disease has responded to
do not use pemetrexed hospira - if you are allergic ( hypersensitive ) to pemetreed or any of the other ingredients of this medicine ( listed in section 6 ). - if breast - feeding is not recommended during treatment with pemetemetrexED hospira . - if your child has recently received or is about to receive a vaccine against yellow fever . warnings and precautions talk to your doctor or pharmacist before using pemetretted hospir if you have or have ever had problems with your kidneys . before you receive pemetreted hospire , your doctor will check before each infusion that the amount of
the dose of pemetrexed hospira is 500 milligrams for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your entire body . your doctor will use this body surface area to work in exactly the right way . your dose may be adjusted , or treatment may be delayed depending on your blood cell counts and on your general condition . your healthcare professional will have mixed the pemetreed hospir powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution before it is given to you . pemetresed hospire will be given
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : fever or infection ( common ): if you have a temperature of 38Âºc or greater , sweating or other signs of infection ( since you may have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if you get chest pain ( common ) or a fast heart rate ( uncommon ). if you develop pain , redness , swelling or sores in your mouth ( very common ) allergic reaction : if you notice skin rash ( common ),
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . reconstituted and infusion solution : the product should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2Âºc - 8Âºc . the reconstituuted solution should be administered immediately after preparation . p
what pemetrexed hospira contains the active substance is pemetreed . pemetxed hospir 100 mg : each vial contains 100 milligrams of pemetereed ( as pemetrhyd disodium hemipentahydrate ). pemetoxed hospiry 500 mg : one vial of 500 milligram of pemphrexed (as pemetirhyd dis sodium hemipertahydrates ). pemperexedospira 1 , 000 mg : the active ingredient is pemf1 . each vials of 1 ,000 milliggram of pere
ganfort contains two active substances called bimatoprost and timolol which work together to reduce pressure in the eye . bimatra belongs to a group of medicines called prostamides , which work by interfering with a prostaglandin analogue . timolole belongs to medicines called beta - blockers . what ganfort is used for ganart is used to lower pressure in your eye . it is a clear , watery liquid that is injected into the eye by your eye specialist . ganat is used in adults , adolescents and children aged one year and above . the eye specialist has prescribed gan
do not use ganfort eye drops if you are allergic to bimatoprost , timolol or beta - blockers or any of the other ingredients of this medicine ( listed in section 6 ) if you have respiratory problems such as asthma or severe chronic obstructive bronchitis if you suffer from severe lung disease ( signs include wheeziness , difficulty in breathing , or long - standing cough ) if any of these apply to you , tell your doctor before using ganf . warnings and precautions talk to your doctor or pharmacist before using this medicine if you : have coronary heart disease ( symptoms include chest pain , tight
always use ganfort exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to use treatment use the bottle and the bottle . - twist your neck ( picture 1 ). - hold your hands up to your head . - pull down your eyelid , which is closed by a small pocket . - do not touch your eye during treatment . - hold the bottle tightly closed . - gently squeeze the lid of your eye ( picture 2 ). - gently pull down the front of your coloured eye . - tilt your head back and look at the ceiling . - you can see the drops floating
like all medicines , ganfort can cause side effects , although not everybody gets them . the drops can cause some side effects . ganart ( multi - dose or single - dose ) may cause very common side effects ( may affect more than 1 in 10 people ) the eye redness . common side effect ( may affects up to 1 in 9 people ) 100 the eye burning , itching , stinging or irritation of the conjunctiva ( the transparent layer at the back of the eye which increases sensitivity to light ), eye pain , sticky eyes , dry eyes , feeling of something in the eye , small breaks in the surface of
keep this medicine out of the sight and reach of children . do not use ganfort after the expiry date which is stated on the carton and on the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what ganfort contains - the active substance is bimatoprost ( 0 . 3 mg / ml ). - the other ingredients are timolol ( 5 mg / l ), timolole maleate ( 6 . 8 mg / kg ), benzalkonium chloride ( a preservative ), sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate , purified water , hydrochloric acid and sodium hydroxide . what ganFort looks like and contents of the pack gan fort is a clear to slightly opalescent , colourless to slightly yellow solution for injection in
gefitinib mylan contains the active substance gefitinib . this protein is designed to kill cancer cells by stopping them from growing . gefitoninib melan is used to treat adults with non - small cell lung cancer . this cancer is a disease in which malignant ( cancer ) cells form in the tissues of the lung .
do not take gefitinib mylan if you are allergic to gefitoninib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking gefnitinibmylan if : you have any other lung problems . some lung problems may be serious . gefinib melan should not be used if you have problems with your liver . gifitin ib mylan should be used in children and adolescents under 18 years of age . other medicines and gefilitinib tell your doctor or pharmacist if you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 250 mg antacids taken once daily on an empty stomach ( see section 2 , " gefitinib mylan contains sodium "). take gefnitinib melan at about the same time each day . if you have trouble swallowing the tablets , you can take them with or without food . do not split , crush or split the tablets . if your doctor recommends that you take gifitin ib mylan with food , drink or other non - alcoholic drink ,
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects you may need urgent medical treatment : allergic reaction ( symptoms include swollen face , lips , tongue or throat , difficulty to swallow , hives , nettle rash , difficulty breathing , serious breathlessness , sudden worsening breathlessness with a cough or fever ). this may be due to an inflammation of the lungs called ' interstitial lung disease '. uncommon ( may affect up to 1 in 100 people ) gefitinib may cause severe skin reactions which affect your body . the signs may
what gefitinib mylan contains - the active substance is gefinib . each film - coated tablet contains 250 mg of gefib . - the other ingredients are lactose monohydrate , microcrystalline cellulose , crospovidone ( type a ), povidon ( k30 ), sodium laurilsulfate , magnesium stearate . - in the tablet core : polyvinyl alcohol , macrogol 4000 , titanium dioxide ( e171 ), red iron oxide ( e172 ) and yellow iron oxide red ( e 172 ). what gefitoninib melan looks like
reblozyl contains the active substance luspatercept which is used to treat myelodysplastic syndromes ( mds ). mds is a consequence of many different blood and bone marrow disorders in which red blood cells become abnormal . signs and symptoms include a low red blood cell count and anaemia . red blood infusion is usually given to patients with mds who cannot receive red bloodcell transfusions . reblozey is used : to treat anaemia in patients with a history of mds when red blood tissue transfusions are not readily available or are not suitable , in patients who have responded to 
do not take reblozyl if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be pregnant , ask your doctor for advice before taking this medicine . warnings and precautions talk to your doctor , pharmacist or nurse before taking rebluzyl if : you have thalassaemia ( your spleen removed ) you have had a blood clot , or you are undergoing hormone replacement therapy . you have a previous blood clot . preventive measures are needed to prevent medicines from causing a blood clot . you suffer from high blood pressure . re
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will carry out blood tests before you start using reblozyl . reblzyl is given as an injection under the skin . the dose given is based on how much you weigh . the injections should be given in increments of 1 . 0 mg / kg of body weight . your dose will be adjusted by your doctor . your blood pressure will be checked before and during treatment with rebluzyl . in certain patients with myelodysplastic syndromes the maximum single dose is
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor immediately if you experience : difficulty in walking or speaking , dizziness , loss of balance and coordination , numbness or paralysis in the face , leg or arm , or blurred vision . these may be symptoms of a stroke . blood clots swelling in the area around the eyes , face , lips , mouth or tongue throat allergic reactions , rashes 36 reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . very common side
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after reconstitution , reblozyl may be stored at room temperature ( up to 8 ) for up to 25 days when stored at 2 8 . do away with any unused medicinal product or waste material . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what reblozyl contains - the active substance is luspatercept . each ml of solution contains 25 mg or 75 mg of luspaterscept . after reconstitution , each mlof solution contains 50 mg of the active ingredient luspormcept . - the other ingredients are excipients , citric acid monohydrate , sodium citrate 80 , sucrose , hydrochloric acid ( for ph adjustment ), sodium hydroxide ( for pct adjustment ). what rebl ozyl looks like and contents of the pack rebloxyl is a white to off - white powder . rebloyyl 25 mg
fotivda contains the active substance tivozanib , a protein kinase inhibitor . tiv ozanib works by stopping the growth of the cancer by stopping cancer cells from growing and attaching to new blood vessels . fotivd is used in adults with advanced kidney cancer when other treatments ( alpha or interleukin - 2 ) have not helped to stop your disease or have not worked .
do not take fotivda if you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). if you have been told that you have a problem with your heart . if you take st . john ' s wort ( hypericum perforatum ), a herbal remedy used for depression and anxiety . warnings and precautions talk to your doctor before taking fotiveda if any of these apply to you . high blood pressure you should not take more fotiva than your doctor tells you to . your doctor will check your blood pressure before you start taking fotala .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of fotivda is 1340 mg once a day for 21 days , taken as 7 capsules in the morning and 7 capsules once a morning for 4 days . fotvda may be stopped if you experience unacceptable side effects or if severe side effects occur after stopping fotrevda therapy . the usual daily dose of the fotive medicine is 890 mg once daily for 21 day , taken in the mornings and 7 days , taking as 1 capsule in the evening and 7 times
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure ( this side effect can occur in more than 1 in 10 people ) tell your doctor immediately if you experience high bloodpressure with symptoms such as severe headaches , blurred vision , shortness of breath , changes in your mental state ( e . g . feeling anxious , confused or disorientated ). your doctor may want to monitor your blood pressure more closely . fotivda is not a cure for high blood hypertension , but it is a medicine that you can take to control your high blood blood pressure . if you take
what fotivda contains the active substance of fotivex is tivozanib . each tablet contains 890 mg of tivzanib ( as tiv ozanib hydrochloride monohydrate ). the other ingredients are : capsule content : 890mg tivuzanib , mannitol ( e421 ), magnesium stearate capsule shell : gelatin , titanium dioxide ( e171 ), indigo carmine ( e132 ), yellow iron oxide ( e172 ) printing ink : shellac , propylene glycol ( for strong ammonia solution ), titanium dioxide , tartrazine aluminium lake ( e
stribild contains two active substances : elvitegravir , an antiretroviral medicine known as an integrase inhibitor cobicistat , which is a booster ( pharmacokinetic enhancer ) of elvitesgravira emtricitabine , an antiviral medicine called a nucleoside reverse transcriptase inhibitor ( nrti ) tenofovir disoproxil , an antitroviral medication called aucleotide reverse transcriptases inhibitor ( rtti ). stribild is given as a single tablet regimen for the treatment of human immunodeficiency virus ( hiv
do not take stribild if you are allergic to elvitegravir , cobicistat , emtricitabine , tenofovir , ten ofovir disoproxil or any of the other ingredients of this medicine ( listed in section 6 ). during treatment , you should not take any medicine containing tenofovegravira disoproflide . your doctor will monitor your kidney function and may change your dose of these medicines . if you have been told by your doctor that you have an increased risk of developing an enlarged prostate gland , amiodarone , quinidine (
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults and adolescents 12 to less than 18 years of age : take the tablet once a day at about the same time each day . the recommended dose is 35 mg taken by mouth once a morning . you should take your tablet at about about the time each morning . your doctor may change the dose of your medicine or stop the treatment if you take medicines ( oral supplements , antacids , laxatives containing minerals , magnesium , aluminium , calcium , iron , zinc ) at least 4 hours apart . take strib
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . when treating hiv infection , it is not always possible to tell whether the unwanted effects of stribild are caused by the hiva disease itself or by its underlying causes . serious side effects tell your doctor immediately lactic acidosis ( excess lacticacid in the
what stribild contains the active substances are elvitegravir , cobicistat , emtricitabine and tenofovir disoproxil . each stribil film - coated tablet contains 150 mg elvitesgravira , 150 mg cobicista , 200 mg emtrititabrine , 245 mg tenofvir disopicroxil and 300 mg ten ofovir desoproxel fumarate . each tablet contains 136 mg tenorovir . the other ingredients are : tablet core : croscarmellose sodium , hydroxypropyl cellulose
zyprexa contains the active substance olanzapine . zyprexa belongs to a group of medicines called antipsychotics and is used to treat the following conditions : schizophrenia , a disease with symptoms such as hearing , seeing or sensing things which are not there , mistaken beliefs , unusual suspiciousness , and becoming withdrawn . people with this disease may also feel depressed , anxious or tense . moderate to severe manic episodes , a condition with symptoms of excitement or euphoria . zzyprex has been shown to prevent recurrence of these symptoms in patients with bipolar disorder whose manic episode has responded to olan zapine treatment
do not take zyprexa - if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). an allergic reaction may be recognised as a rash , itching , a swollen face , swollen lips or shortness of breath . - if your doctor has told you that you have eye problems such as certain kinds of glaucoma ( increased pressure in the eye ). warnings and precautions talk to your doctor or pharmacist before taking zypoxa . zypitxa is not recommended for use in elderly patients with dementia because it may have serious side
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . zyprexa tablets should be taken once a day . you should take zypxa 5 to 20 mg once a morning . if your symptoms return , you should continue taking zypyxa until your doctor tells you otherwise . if you take more zypoxa than you should if you accidentally take too many zypitxa tablets , contact your doctor immediately . if possible , take your tablets and this leaflet with you . zzyprexa coated tablets are for oral use . swallow the
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience : unusual movement ( a common side effect that may affect up to 1 in 10 people ) mainly of the face or tongue ; blood clots in the veins ( an uncommon side effect which may affect upto 1 in 100 people ) especially in the legs ( symptoms include swelling , pain , and redness in the leg ), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing . if you notice any of these symptoms seek medical advice immediately ; a combination of fever , faster breathing , sweating
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . zyprexa may pose a risk to the environment . do this by interfering with the administration of zyprixa . these measures will help to protect the environment
what zyprexa contains - the active substance is olanzapine . each zypxa tablet contains 2 . 5 mg , 5 mg or 7 . 5mg , 10 mg , 15 mg or 20 mg of olanza . - the other ingredients are lactose monohydrate , hyprolose , crospovidone , microcrystalline cellulose , magnesium stearate , hypromellose , titanium dioxide ( e171 ), carnauba wax . the different zypyxa tablet strengths are marked with the following symbols : - zypoxa 2 . 0 mg ,
what prolia is prolia contains denosumab , a protein ( monoclonal antibody ) that attaches to a target in the body . attaching to another protein can cause bone loss in osteoporosis , and may improve the quality of life for patients . treatment with prolia helps to make bone stronger and keeps it free of oestrogen . it reduces the amount of bone that makes oestrogens , which helps to keep bones healthy . after the menopause , oest nitrogen level drops , making bones become thin and fragile . what osteopORosis is osteoporeosis is caused by the lack of
do not use prolia if you have low calcium levels in the blood ( hypocalcaemia ) if you are allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using prolia . if you think any of these apply to you , tell your doctor straight away . if any of them apply to your child , tell them straight away before using this medicine . if they do not , tell the doctor straightaway . warnings and symptoms talk to the doctor or nurse before using the product : if your child has a skin infection with
what prolia is prolia contains one pre - filled syringe of 60 ml . it is given to you by your doctor or nurse , as a single injection under the skin ( subcutaneous ) in the front of your thighs , abdomen or upper arm . your doctor will decide how much prolia you need and how often you need to receive it . your dose will be decided by your healthcare professional . it may be up to 6 months before you receive your first dose . your treatment will be started with a single dose . you will be given injections every 6 months after the last injection . if you miss a dose of prolia
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking prolia and tell your doctor straight away if you develop skin infections ( cellulitis ). if you have any of these symptoms while taking prolium : swollen , red area of skin , usually in the leg , which feels hot and tender . symptoms may include fever . if you experience any of the following while taking this medicine , stop taking it and tell a doctor straightaway : pain in the mouth and / or jaw , swelling or non - healing of sores in themouth or jaw ( discharge , numbness , feeling of heaviness or
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . you may remove your pre - filled syringe from the refrigerator and store it at room temperature ( not above 25 ) for a single period of maximum one month . after the injection , you may store it either at room temperatures ( not below 25 ) or at room
what prolia contains - the active substance is denosumab . each ml of solution contains 1 mg or 60 mg of denosumaab in 60 ml . - the other ingredients are acetic acid , glacial , sodium hydroxide , sorbitol ( e420 ), polysorbate 20 and water for injections . what prolia looks like and contents of the pack prolia is a clear to slightly yellow solution for injection in a pre - filled syringe with a needle guard .
what ambirix is ambirux is a vaccine used to protect adults and children from 1 to 15 years of age against two diseases : hepatitis a and hepatitis b . infection with the hepatitis a virus causes the liver to become swollen and inflamed . the virus can also infect faeces , serum or saliva . symptoms are usually mild to moderate . in 3 to 6 weeks of infection , you may feel sick , have a fever , aches and pains , feel very tired , dark urine , pale faececes or yellowish skin or eyes ( jaundice ). the severity and type of symptoms can vary from person to
do not use ambirix if you are allergic to ambirax or any of the other ingredients of this vaccine ( listed in section 6 ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of your face or tongue . if you have an allergic response to any vaccine used to treat hepatitis a or hepatitis b diseases , tell your doctor straight away . if a severe infection with a high temperature has been reported , the vaccine should be given at the earliest . a minor infection such as a cold should not be given , but talk to your doctor first . warnings and precautions talk to the doctor before
your doctor or nurse will give you ambirix as an injection into a muscle in the upper arm . ambirux will be given into a vein . the injection will be injected into the thigh muscle . you will receive a total of two injections . the injections will be administered within 12 months . the first injection will usually be given at least 6 months after the second injection . you may be given between 6 and 12 months after your first injection . extra doses may be used to prevent future booster dosing . if you are given more ambirx than you should if you have been given more than two injections , your doctor will decide
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects you may need urgent medical treatment : allergic and anaphylactic reactions . the signs may include a rash , itchy , blistering , swelling of the eyes and face , difficulty in breathing or swallowing , a sudden drop in blood pressure and loss of consciousness . other side effects reported in clinical trials with ambirix were : very common ( may affect more than 1 in 10 people ): headache loss of appetite feeling tired or irritable pain or redness
what ambirix contains 26 the active substance is hepatitis a virus . 1 ml solution contains 720 micrograms of elisa units ( equivalent to 0 . 5 mg / ml ). the other ingredients are : hepatitis b surface antigen 20 , human diploid ( mrc ), cells , aluminium hydroxide ( hydrated 0 . 05 %) and saccharomyces cerevisiae ( e570 ). aluminium phosphate ( 0 . 4 %) in the solvent and sodium chloride and water for injections . what ambirax looks like and contents of the pack suspension for injection in a pre - filled syringe . ambirood is
what bexsero is bex sero is a meningococcal group b vaccine . bex serumo is given to adults , adolescents and children from 2 years of age with disease caused by the neisseria meningitidis group b bacteria . these bacteria are responsible for many types of infections , including meningitis ( inflammation of the brain and spinal cord ) and sepsis ( blood poisoning ). the vaccine works by helping your body to produce its own protection ( antibodies ) against the disease .
do not use bexsero if you are allergic to any of the ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor or nurse before using bex serumo if : you have a severe infection with a high temperature . vaccination should be postponed until you have recovered from a minor infection such as a cold . your doctor may decide to postpone vaccination if you have haemophilia or any other problem that may prevent your blood from clotting properly . you are taking blood thinners ( anticoagulants ) as part of treatment for the immune system ( eculizumab ). if
your doctor or nurse will give you bexsero at the recommended dose . the recommended doses are 5 micrograms given into a muscle ( usually in the thigh or upper arm ). injections will be given at least 2 weeks apart . the first dose will be administered at least 5 days apart . after three injections , the vaccine may be given as an additional injection ( booster ). the first injection will be made at least 1 month apart . if the interval between injections is longer than 2 months , your doctor may give you a booster . children and adolescents from 12 years of age and above 15 years of old : the first booster will be
like all vaccines , this vaccine can cause side effects , although not everybody gets them . stop using bexsero and tell your doctor straight away if you notice any of the following side effects : very common ( may affect more than 1 in 10 people ): pain / tenderness at the injection site , redness of the skin at the site of injection , swelling of theskin at the place of injection site hardness at the area of injection at the time of injection . other side effects may occur with this vaccine : common ( might affect up to 1 in every 10 people ) fever , loss of appetite , tenderness around the injection area
what bexsero contains the active substances are recombinant neisseria meningitidis group b nhba fusion protein 1 , 2 , 3 and 50 micrograms recombinant nisseria maningitidi group b noada protein 1 and 2 , 2 and 3 50 microgene recombinant neoisseria meingitis group b fhbp fusion protein 3 and 3 , 50 micromgene recombinating neissia meningitsidis groupb fhbhbp fusionprotein 1 , 3 , and 50 micromole recombinant dna technology 2 the other ingredients are : aluminium hydroxide
what nitisinone mdk is nitisinfone is a medicine used to treat a rare disease called hereditary tyrosinemia ( hty ) in adults , adolescents and children from 1 year of age . in this disease your body does not make enough of the amino acid tyrosine ( amino acids are substances that are naturally present in the body ). nitisinnone works by reducing the amount of tyrosino and the harmful substances that can be produced by your body . this medicine helps to reduce the amount tyrosrine in the blood and helps to lower the level of low tyrosin and phenylalanine
do not take nitisinone if you are allergic to nitisine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking this medicine . pregnancy and breast - feeding nitis inone mdk is not recommended for use in children . your doctor will check your eyes before and during nitisinfone treatment if you have red eyes . if you notice any change in the appearance of your eyes , tell your doctor immediately . your physician may recommend an eye examination . if possible , your doctor may recommend a lower dose . you should not take this medicine
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . treatment with this medicine will be started by a doctor who is experienced in the treatment of the disease ( hereditary tyrosinemia type 1 ). the recommended dose is 1 capsule for every kg of body weight taken orally once a day . the dose may be increased to 20 capsules once a daily . in this patient population , the dose is based on body weight . swallow the capsules whole with a small amount of water or formula diet . if you take more nitisinone mdk than you should if you accidentally
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store below 2 8 . store at a temperature not above 25 . do away with the blister . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what nitisinone mdk contains the active substance is nitisinoone . nitisinnone md k 2 mg capsules : each capsule contains 2 mg nitisine . nisinonemdk 5 mg capsules: each capsule contain 5 mg nisine . each capsule of nitishinone mdks 10 mg capsules contains 10 mg ninone . the other ingredients are gelatin , titanium dioxide ( e171 ), black iron oxide ( e172 ), shellac glaze . what nitisinsone mdke looks like and contents of the pack nitisinfone mdky capsules are 15 . 7 mm long ,
docetaxel accord contains the active substance docetaxal . docetxel belongs to the group of anti - cancer medicines called taxoids . docel accord has been prescribed by your doctor for the treatment of breast cancer , special forms of lung cancer ( non - small cell lung cancer ), prostate cancer , gastric cancer and head and neck cancer : - for the diagnosis of advanced breast cancer : docetacel could be administered either alone or in combination with doxorubicin , or trastuzumab , or capecitabine . - for early breast cancer with or without lymph node involvement ,
do not use docetaxel accord - if you are allergic ( hypersensitive ) to docetxel or any of the other ingredients of docetixel accord ( listed in section 6 ) - if your number of white blood cells is too low - if there is a severe liver disease warnings and precautions before you are given docetAXel accord , you will have blood tests to check that you have enough blood cells and sufficient liver function to receive docetacord . in case of whiteblood cells disturbances , you may experience fever and infections . tell your doctor immediately if you have abdominal pain , tenderness , diarrhoe
docetaxel accord will be given to you by a healthcare professional . the dose will depend on your weight and your general condition . your doctor will calculate your body surface area in square meters ( mÂ² ) and will determine the dose you should receive . method and route of administration docetaxal accord will usually be given by infusion into one of your veins . the infusion will last approximately one hour during which you will be in the hospital . frequency of administration you should usually receive your infusion once every 3 weeks . your blood tests will be taken at regular intervals to check your generalcondition . docetacel accord should be administered
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these with you and will explain the potential risks and benefits of your treatment . the most commonly reported adverse reactions of docetaxel accord are reduction in the number of red blood cells and white blood cells , alopecia , nausea , vomiting , sores in the mouth , diarrhoea and tiredness . the severity of adverse events of docelaxel alone may be higher when docetacel is given in combination with other chemotherapeutic agents . during the infusion , allergic reactions ( may affect up to
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . store below 25 . store in the original package in order to protect from light . after dilution , the medicine should be transferred from the infusion bag to the infusion vial and used within 6 hours ( up to 25 hours ). for infusion , the infusion solution should be used immediately . non - pvc bags may be stored for 48 hours at 2 to 8 . if the infusion solutions are not clear
what docetaxel accord contains - the active substance is docetacel . each ml of concentrate for solution for infusion contains 20 mg doceta . each 1 ml of the concentrate contains 20mg docetea . each 4 ml of each concentrate contains 80 mg docelaxel . one 8 ml vial of concentrate contains 160 mg docnetaxel - the other ingredients are polysorbate 80 , ethanol anhydrous ( see section 2 " docetel accord is a concentrate for solvent "), citric acid anhydrated ( see also section 2 ) and an orange flip - off cap . what doc
intuniv contains the active substance guanfacine . this medicine belongs to a group of medicines that affect the brain . this medicines helps to stop people becoming impulsive , hyperactive . this medication is used to treat ' attention deficit hyperactivity disorder ' ( adhd ) in adults who are not adequately responsive to current stimulation or who are unable to tolerate current medication . the medicine is used in combination with a treatment programme consisting of psychological therapy , educational therapy and social therapy . it is used 38 in adults with adhd . what intuniv is used for intunib is used on its own in adults whose adhd symptoms
do not take intuniv if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking this medicine if you have low or high blood pressure . heart problems tell your doctor if you suffer from heart problems . you have ever fainted or have recently had thoughts or feelings of suicide . tell your physician if you know or have any other psychiatric conditions or withdrawal symptoms . increased heart rate or highblood pressure tell your dentist if you take this medicine at any time during the day or night . stop taking this medication and tell
your treatment will be supervised by a doctor experienced in the treatment of adolescent behavioural disorders . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . your doctor will determine the dose that is right for you . your treatment will start with 1 tablet once daily . your dose will be gradually increased depending on how you respond to treatment . the starting dose is 0 . 05 mg / kg of bodyweight once daily for the first 7 days . your daily dose of intuniv will be increased every 7 days until your daily maintenance
like all medicines , this medicine can cause side effects , although not everybody gets them . if you feel unwell , talk to your doctor or pharmacist straight away . your doctor may need to change your medicine . serious side effects tell your doctor straight away if you notice any of the following serious side side effects : feeling drowsy ( feeling dizzy ) hypotension ( slow heart beat ( bradycardia ), feeling faint and loss of concentration ( syncope ), a serious withdrawal side effect from high blood pressure . symptoms may include headaches , feeling confused , nervousness , agitation and tremors ( hypertensive encephalopathy ). tell
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister pack after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . the tablets should be used within one month after first opening of blister pack . do this to protect from moisture . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what intuniv contains the active substance is guanfacine hydrochloride . each prolonged - release tablet contains 1 mg of guanFacine . each extended - release dose contains 2 mg of the active substances guanfuine and 3 mg of of gufacine hydrochloride ( see section 3 for further information on guanfaine ). each extended prolonged -release dose contains 4 mg of Guanfacrine and 4 mg guanjuine . the other ingredients are hypromellose 2208 , methacrylic acid - ethyl acrylate copolymer , lactose monohydrate , pov
ecalta contains the active substance anidulafungin and is used to treat adults and children from 1 to 18 years old with a type of fungal infection affecting the blood or other internal organs called invasive candidiasis . the infection is caused by fungal cells called candida . ecalta belongs to a group of medicines called echinocandins . these medicines are used to prevent serious fungal infections caused by the breakdown of fungo - fungal cell walls . ecalda works by preventing the formation of these cells . if fungalcells have incomplete or defective cell walls , it makes them fragile and unable
do not use ecalta if you are allergic to anidulafungin , other echinocandins , caspofungin acetate or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or nurse before using ecaltra if you have liver function problems . your doctor may decide to reduce the dose you receive , stop your treatment , or give you anaesthetics . your treatment with ecaltfa may need to be delayed or stopped . if you experience an allergic reaction , such as itching , wheezing , blotchy skin , you should contact
the treatment will be given to you by a doctor or nurse . the recommended dose is 200 mg / 100 mg given once a week . the dose is 1 dose in the morning and 1 dose after the evening . adults ( 18 years of age and older ) the recommended starting dose is 3 . 0 mg / 200 mg given twice a week , given 1 . 5 to 100 mg once a day . the doctor will decide the dose that is right for you based on the patient ' s weight . ecalta is given as a slow infusion ( a drip into a vein ) lasting 1 . 4 to 3 hours . the loading dose will
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with ecalta : serious and potentially life - threatening allergic reactions , including difficulty breathing or wheezing or an existing rash , have been reported in patients taking ecaltra . serious side effects including convulsion ( seizure ), flushing , rash , pruritis , itching , hot flush , hives , sudden contraction of the muscles , wheezezing , coughing or difficulty of breathing other side effects very common side effects ( may affect more than 1 in 10 people ): low blood potassium ( hypokalaemia
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiratory date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . the reconstituted solution should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 8 . if the infusion solution is not used within 25 hours it should be stored in a refrigerated unit
what ecalta contains - the active substance is anidulafungin . each vial of powder contains 100 mg of anidulinafungan . - the other ingredients are mannitol , polysorbate 80 , tartaric acid , sodium hydroxide and hydrochloric acid 30 . what ecaltas looks like and contents of the pack ecaltfa is supplied as a box containing 1 vial containing 100 mg concentrate for solution for infusion . the powder is white to off - white .
adenovi contains the active substance rurioctocog alfa pegol , which is a copy of pegylated human coagulation factor viii ( hcviii ). the human coaggulation factor iii is produced naturally in the body . factor v iii is necessary for the blood to form clots and stop bleedings . in patients with haemophilia a , factor v viii is not produced in the laboratory . adynovi is used for the treatment and prevention of bleeding in adults and adolescents 12 years of age and older with haemaophilia b , an inherited bleeding disorder caused by lack of
do not use adynovi if you are allergic to rurioctocog alfa pegol or octocog aluminium or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using adynov : if you have had an anaphylactic reaction ( a severe , sudden allergic reaction ) to adyno or any other ingredients in this medicine . allergic reactions may include rash 95 , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in
treatment with adynovi will be started by a doctor experienced in the treatment of haemophilia . always use adynov exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . treatment of bleeding the recommended dose of adynova is one tablet once a day . the replacement therapy should be started at the same time each day . adynoc is a life - long treatment . always take this medicine exactly as described in this leaflet and as your healthcare professional has told your doctor . prevention of bleeding your doctor will calculate your dose of adsynovi according to your body weight
like all medicines , this medicine can cause side effects , although not everybody gets them . sudden allergic reactions ( anaphylactic ) may occur within minutes of the injection . early symptoms of allergic reactions may include rash , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , wheezing , tightness in the chest , feeling of being unwell , dizziness and loss of consciousness . if severe symptoms of difficulty in breath or fainting occur , prompt emergency treatment is needed . patients who have received previous treatment with factor viii ( more than 150 days of treatment ) inhibitor antibodies (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . the powder vial may be stored at room temperature ( up to 30 ) for a maximum of 3 days . do this medicine if it is not used within 3 days or if it has been stored at a room temperature not above 30 for a total of 3 weeks
what adynovi contains the active substance is rurioctocog alfa pegol ( pegylated human coagulation factor viii produced by recombinant dna technology ). each powder vial contains 250 , 500 , 1000 or 2000 iu of ruriorioctog ala pegol . the solvent vial is made up of 5 ml sterilised water for injections . the other ingredients are mannitol , trehalose dihydrate , histidine , glutathion , sodium chloride , calcium chloride dihydrates , tris ( hydroxymethyl ) aminomethane , poly
rekovelle contains follitropin delta , a follicle stimulating hormone that belongs to a group of hormones called gonadotropins . gonadotropicins are involved in female fertility and are present in assisted reproduction programs , in vitro fertilisation ( ivf ) and intracytoplasmic sperm injection . they are produced by the ovaries and are involved with the development of many eggacs .
do not use this medicine if any of the above apply to you . if you are not sure , talk to your doctor or pharmacist before using rekovelle . warnings and precautions talk to the doctor or nurse before using this medicine : if you have a problem with your fertility problems . if your doctor thinks you may be allergic to follicle stimulating hormone or any of those other ingredients of this medicine ( listed in section 6 ). if you develop a tumour in your uterus ( ovaries , breasts , pituitary gland or hypothalamus ). if your ovaries have enlarged ovaries . if there are cysts on your ov
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the rekovelle dose will be given to you at the start of your first treatment cycle . your doctor will prescribe anti - mÃ¼llerian hormone to stimulate your ovaries to produce more stimulation with gonadotropins . the dose will depend on your blood weight . your dose will also be calculated from a blood sample taken every 12 months . the duration of treatment depends on your body weight . the first dose of treatment will be administered as a single injection . the rkovelLE dose will usually
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects caused by hormones in the ovaries ( infertility ) this medicine may cause a high level of activity in the ovarian tissues ( ovarian hyperstimulation syndrome ). symptoms include pain , discomfort and swelling of the abdomen . nausea , vomiting , diarrhoea , weight gain and difficulty breathing . if you notice any of these symptoms , seek medical advice straight away . a side effect that may affect up to 1 in 10 people is headache . nausea ( ovarianhyperstimulation syndrome ) pelvic pain and discomfort ( ovarian origin tiredness ( fatigue )
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store the vials in the original carton in order to protect from light . after reconstitution , the solution may be stored at room temperature ( up to 25 ) for a maximum of 3 days . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would
what rekovelle contains the active substance is follitropin delta . each multidose cartridge contains 12 mg of follitroin delta in 0 . 36 millilitre of solution . after dilution , each ml of solution contains 33 . 3 mg of of folliotropin delta in each millilitere of solution ( corresponding to 0 . 35 mg / ml ). the other ingredients are phenol , polysorbate 20 , l - methionine , sodium sulphate decahydrate , disodium phosphate dodecahydrates , concentrated phosphoric acid , sodium hydroxide and water for
the active substances of revinty ellipta are fluticasone furoate and vilanterol . each inhalation of revminty elliptoe contains flutic asone firoate 92 mg and vilterol 22 mg . each inhale of fluticastone fioate 184 mg and / or vilancerol 22mg is equivalent to 92 / 22 mg of the active substances . chronic obstructive pulmonary disease ( copd ) in adults and adolescents ( 12 years of age and older ) weighing 184 kg or more . asthma in adults ( 12 to 22 years of old ) weighing less than 184
do not use ellipta - if you are allergic to fluticasone furoate , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using ellipta . ellipta should not be used if you have liver disease . this is because it may increase the risk of side effects . if you suffer from moderate or severe liver disease , the lower strength of revinty ellipta 92 / 22 mg may be appropriate for you . talk to a doctor or nurse before using this medicine if you : have heart problems , have high blood
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . asthma the recommended dose for asthma is one inhalation twice a day ( one inhaler each day ). the recommended starting dose for fluticasone furoate 22 mg / m2 body weight ( vilanterol ) is one tablet twice a morning . for severe asthma the dose for the higher strength inhaler is one spray twice a daily ( one spray each day ) ( one tablet each day ), with or without flutic asone firoate 22mg / m4
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to ellipta are rare ( may affect up to 1 in 1 , 000 people ). if you experience any of the following symptoms while taking ellipta stop taking this medicine and contact your doctor immediately : skin rash , hives , redness swelling , especially of the face or mouth ( angioedema ), becoming very wheezy or coughing , having difficulty in breathing , feeling weak or light headed ( which may lead to collapse or loss of consciousness ). immediate breathing difficulties immediate breathing problems stop taking revinty ellipta and contact
what revinty ellipta contains the active substances are fluticasone furoate and vilanterol . each 92 micrograms inhalation delivers 92 microlitres of flutic asone firoate and 22 microlitre of vilancerol and trifenatate . each 184 microgram / 22 microgram inhalation provides 184 microliters of flilitasonefuroate , 22 micrometre of Vilanterl and triffenatatate respectively . the other ingredients are lactose monohydrate ( see section 2 " revintchy ellipta is for inhalation use
atripla contains three active substances that are used to treat human immunodeficiency virus ( hiv ) infection : efavirenz , a non - nucleoside reverse transcriptase inhibitor ( nnrti ) emtricitabine , a nucleosides reverse transcriptases inhibitor ( tnrtis ) tenofovir , a nucleotide reverse transcriptatase inhibitor . these active substances are all given together with antiretroviral medicines . they work by interfering with the activity of an enzyme ( reverse transcriptasing ) that is essential for the virus to multiply and reproduce itself . at
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet taken by mouth once a day . atripla should be taken on an empty stomach at least 1 hour before or 2 hours after food . some side effects may be more common ( dizziness and drowsiness ). if you take more atripola than you should if you accidentally take too many tablets , contact your doctor immediately . if you forget to take atriplea if you miss a dose of atriblea , take it as soon as you remember
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects lactic acidosis ( excess lacticacid in the blood ) is rare ( may affect up to 1 in 1 , 000 people ). if you experience any of the following serious side effect , stop taking atripla and seek medical help immediately :
what atripla contains the active substances are efavirenz , emtricitabine and tenofovir disoproxil . each atripera film - coated tablet contains 600 mg eflavirenz and 200 mg emtritabine , 245 mg tenofvir disopicroxil ( as fumarate ). the other ingredients are croscarmellose sodium , hyprolose , magnesium stearate , microcrystalline cellulose , sodium laurilsulfate ( see section 2 " atriplea contains sodium "). the tablet film coating contains
orgalutran contains the active substance ganirelix . it belongs to a group of medicines called anti - gonadotrophin - the natural gonadonadotrophicin releasing hormone ( gnrh ). release of gonadotroprophins is a natural hormone that stimulates the growth and release ofgonadotocytes in the ovaries . follicles are small round sacs that contain the egg cells . they are then grown in the laboratory to release the immature egg cells that are needed for the development of follicles in the ovarian tissue . the follicles may be small round sacs that contain eggs . the
do not use orgalutran if you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be hypersensitive to gonadotrophin releasing hormone ( gnrh ), a gnrh analogue . if you have a moderate or severe kidney or liver disease . if your doctor thinks you may have an increased risk of becoming pregnant . warnings and precautions talk to your doctor or pharmacist before using orgaluchran allergic reactions . if this is the case , you should tell your doctor immediately . if there is an active allergic condition , your doctor may
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . orgalutran is intended for use in adults only . the treatment should be supervised by a doctor who is experienced in assisted reproduction techniques ( i . e . in vitro fertilisation ( ivf ), ovarian stimulation , follicle stimulating hormone ( corifollitropin ), and is given on day 2 or day 3 of each cycle . orgdalutran should be injected under the skin ( subcutaneously ) every 5 to 6 weeks . your doctor will decide how long you should be treated with org
like all medicines , this medicine can cause side effects , although not everybody gets them . a side effect that may affect more than 1 in 10 people is local skin reactions ( redness and swelling ). the local reaction usually disappears after a few days . this is uncommon ( may affect up to 4 in 1 , 100 people ). other side effects are headache , nausea , malaise . this rare ( may effect up to 1 in every 10 , 000 people ) allergic reactions are rash facial swelling difficulty breathing ( dyspnoea ) swelling of face , lips , tongue , and / or throat that may cause difficulty in breathing or swallowing (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and syringe after exp . the exp date refers to the last day of that month . syringes should be clear , liquid - free solutions . do away with any preservative after first opening . do this if you notice any particles in the solution . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what orgalutran contains - the active substance is ganirelix . each vial contains 0 . 5 ml of acetic acid . - the other ingredients are mannitol and water for injections ( for the ph ) and sodium hydroxide and acetic acids . what orgalUTran looks like and contents of the pack orgaluitran is a clear , colourless aqueous solution . the solution is prepared by adding water for subcutaneous administration . the needle is inserted into a dry natural rubber / latex . orgalustran is available in packs containing 1 or 5 vials . not all
what blitzima is blitzima contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to a specific target in a type in white blood cell called " b - lymphocyte ". when ritukimab sticks to this target , it stops the cell from growing and dividing . what blitzima used for blitzima has been prescribed for the treatment of : a ) non - hodgkin ' s lymphoma this is usually a disease of the lymph tissue . the immune system attacks a type a of white blood cells called b - cells . blitz
do not use blitzima if you are allergic to rituximab , other proteins that are derived from ritukimab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe active infection . if you suffer from a weak immune system . if your doctor has told you that you have severe heart failure or severe uncontrolled heart disease . warnings and precautions talk to your doctor or pharmacist before using blitzima : if you currently have granulomatosis , polyangiitis , microscopic polyangitis or pemphigus vulgaris . if any of these apply to
how blitzima is given the doctor will decide how much blitzima you will receive and for how long . always use this treatment exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will tell you exactly how many tablets of this medicine you will need and if you will have any side effects . how blitzima will be given blitzima comes as a drip ( intravenous infusion ). medicines given before each blitzima administration you will be treated with blitzima together with other medicines ( pre - medication ) to reduce the risk of side effects and to improve the course of your treatment .
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . rarely , some reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy or runny nose , vomiting , flushing or palpitations , heart attack , low number of plate
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what blitzima contains the active substance is rituximab . each 10 ml vial contains 100 mg of ritukimab in 10 ml . each 50 ml vials contains 500 mg of the active ingredient in ritiximab ( 10 mg / ml ). the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what blitzima looks like and contents of the pack blitzima is a clear , colourless solution for infusion . it is available in 2 strengths : 50 ml and 1 ml . not all pack sizes may be marketed .
roactemra contains the active substance toilizumab , a type of monoclonal antibody ( a type in the body ) that attaches to a specific target in the immune system . this target is found in the cells of the body and causes the inflammation in your body to decrease . roactemrea can cause symptoms such as pain and swelling in your joints . roactorra prevents the damage to the cartilage and bone in the joints caused by the disease . roacticemra is used to treat moderate to severe active rheumatoid arthritis , an autoimmune disease where previous therapies did not work well enough or
do not use roactemra if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active , severe infection . during the infusion with roactemnra , you may experience allergic reactions such as chest tightness , wheezing , severe dizziness , light - headedness , swelling of the lips and skin rash . tell your doctor immediately during the treatment . infection if you get infections , tell your physician immediately . if you feel unwell while being treated with roacticemra , your body ' s ability to fight infections may be reduced
the doctor or nurse will give you roactemra by infusion into a vein , usually by a nurse . the intravenous infusion will last about an hour . your doctor will decide on the treatment that you need . the recommended dose of roacterera is 8 mg / kg body weight . the dose is 4 mg /kg body weight given once a week . the usual dose of 8 mg is 4mg / kg ( body weight ) given once weekly . the maximum dose of 30 mg / kilograms body weight is 8mg /kg ( bodyweight ) given twice weekly . your dose of 1 mg / kilogram body weight will
like all medicines , roactemra can cause side effects , although not everybody gets them . the following side effects have been reported in the marketing of roactemnra ( see section 3 ): serious side effects ( may affect up to 1 in 10 people ) allergic reactions , including difficulty with breathing , chest tightness , light - headedness , rash , itching , hives , swelling of the lips , tongue or face . serious infections , including fever and chills , especially in the mouth and skin blisters and stomach ache signs and symptoms of liver toxicity ( may occur up to1 in 1000 people ) tiredness , abdominal
keep this medicine out of the sight and reach of children . do not use after the expiry date which is stated on the outer carton and the vial after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what roactemra contains the active substance is tocilizumab . each 4 ml vial contains 80 mg of tociluzumab in 20 mg . each 10 ml vials contains 200 mg of of tocizumumab ( 20 mg / ml ). each 20 ml vray contains 400 mg of the active substances in tocilixumab 20 mg ( 20mg / ml ) solution . the other ingredients are sucrose , polysorbate 80 , disodium phosphate dodecahydrate , sodium dihydrogen phosphate dihydrate and water for injections . what roactemetra looks like
what onbrez breezhaler is onbrezezhalers contains the active substance indacaterol which belongs to a group of medicines called bronchodilators . these relax the muscles in the walls of the small air passages in the lungs . what onbreez breez inhaler is used for onbrezer is used to make breathing easier in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways relax , making breathing difficult . this medicine works by relaxing these muscles in your lungs . this makes it easier for air to get in and out
do not use onbrez breezhaler - if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). - if your asthma is getting worse . warnings and precautions talk to your doctor or pharmacist before using onbreez breez inhaler - - if any of these apply to you , tell your doctor immediately . - if the following applies to you : - if this applies to your child : - heart problems - epilepsy - thyroid gland problems ( thyrotoxicosis ) - diabetes . treatment with onbrezer breezer should be stopped immediately if you get
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose is one 150 microgram capsule twice a day . your doctor may increase your dose to 300 microgram twice a week depending on how you respond to the treatment . you should use your inhaler every 24 hours . how onbrez breezhaler is used onbreez breez inhaler comes as an inhaler and capsules ( in blisters ) are provided with each inhaler . the medicine is inhalation powder . the onbrex breezhilder inhaler contains the
what onbrez breezhaler contains - each onbrex breez inhaler 150 micrograms inhaler contains 150 microliters of indacaterol ( as indacareol maleate ). - the other ingredients are lactose and the capsule is made of gelatin . - eachonbrez bronzhalER 300 microgramsis inhaler 300 microlitre inhaler includes 300 micrometers of Indacaterols ( as exacaterola maleate ), lactoseand the capsule contains gelatin . what onbreez breezeler looks like and contents of the pack onbrezy breez
clopidogrel hcs contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopIDogrel clcs is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( such as stroke , heart attack , or death ). you
do not take clopidogrel hcs : if you are allergic to clopidineogrel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , tell your doctor before taking clopridogrel ccs . warnings and precautions take special care with clopIDogrel clcs : - if you think you may be at an increased risk of bleeding - if any member of your family has a medical
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel hcs per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clubidogl hcs ( 4 tablets of 75 mg ) once at the start
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel hcs contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopidaogrel ( as hydrochloride ). the other ingredients are ( see section 2 " clopide hcs contain hydrogenated castor oil "): tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenatedcastor oil . tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc
febcroja contains the active substance cefiderocol . it is an antibiotic medicine that belongs to a group of antibiotics called " cephalosporins ". antibiotics are used to fight bacteria that cause infections . fetcroja is used to treat infections caused by bacteria that you have not previously been able to fight with other antibiotics .
do not use fetcroja if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using fetcroj if you have had a severe allergic reaction to certain antibiotics ( e . g . penicillins or carbapenems ). if severe skin peeling or swelling of the hands , face , feet , lips , tongue or throat that may cause difficulty swallowing or breathing , stop using fetroja and contact your doctor immediately . if you
this medicine is given to you by a doctor or nurse as an infusion ( a drip ) into a vein . it is usually given every 3 weeks . it may be given every 2 weeks . your doctor will decide how much fetcroja treatment you need . your dose will depend on how you respond to infection . your infection will be treated and you will be monitored for any pain during the fetcroJA infusion . your vein will be checked regularly . if you have kidney problems tell your doctor . if kidney problems are not treated , your doctor may decide to reduce your dose of fetcroje . if your dose is reduced , your dose
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects you may need urgent medical treatment : severe allergic reaction : sudden swelling of your lips , face , throat or tongue , a severe rash or other severe skin reactions , difficulty swallowing or breathing . this reaction may be life - threatening . diarrhoea , stools , blood or mucus may occur during treatment with medicines that slow bowel movement . other side effects include : very common side effects ( may affect more than 1 in 10 people ): feeling sick ( nausea
what fetcroja contains the active substance is cefiderocol sulfate tosylate . each vial contains 1 mg of cefithocol . the other ingredients are sucrose , sodium chloride and sodium hydroxide . what fetcroJA looks like and contents of the pack fetcrojia is a white to off - white powder for concentrate for solution for infusion . it is supplied in packs containing 10 vials .
depocyte is used to treat lymphomatous meningitis in adults . lymphomatinous menenitis is a condition in which tumour cells accumulate in the membranes of the brain and spinal cord . depocyte is prepared by biotechnology and is used in adults to destroy lymphoma tumour cell cells .
do not take depocyte if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ). if you have a meningeal infection . warnings and precautions severe neurological side effects have been reported with depocyte . symptoms of the nervous system may include convulsions , pain , numbness , tingling , blindness , visual disturbances . if you experience any of these symptoms , stop taking depocyte and contact your doctor immediately . taking any dexamethasone tablets may increase the risk of unwanted effects . if your side effects are not well controlled , tell your doctor or pharmacist
treatment of cancer in the lumber sac is supervised by a doctor who is experienced in the use of depocyte . depocyte is prepared and given to you by a healthcare professional . the recommended dose of depocytes is 1 to 5 g of dexamethasone 5 mg / ml . each depocyte dose will be diluted to reduce any side effects . the amount of depecutable solution that is prepared is based on the body surface area ( temperature 22 to 30 ). before withdrawing depocyte from the vial , proper precautions should be taken . depecatable solution is a cytotoxic drug . proper handling technique is used
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may occur with your treatment : very common side effects ( may affect more than 1 in 10 people ): common ( may affects up to 1 in 100 people ): uncommon ( may affecting up to1 in 10 , 000 people ): very common ( frequency cannot be estimated from the available data ): very rare ( may effect up to one in 10 ), very rare : very rare (> 1 in 1000 people ): not known ( frequency can cannot be determined from the availability of depocyte in the clinical data ): uncommon : very rarely ( may show up
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . depocyte should be stored in a refrigerator ( 2 - 8 ). do not freeze . depocytes should be used within 4 hours after preparation . do this to protect from light . do do not store depocyte above 25c . do away with this medicine if you notice severe discolouration or a changed appearance . do discard the vials if you suspect that they contain a defective
what depocyte contains - the active substance is cytarabine . one ml of suspension contains 10 mg cytarbine . each vial of depocyte 5 ml solution contains 50 mg cytabine ( as cholesterol , triolein ). - the other ingredients are dioleoylphosphatidylcholine , dipalmitoylophosphatidoylglycerol , sodium chloride and water for injections . what depocyte looks like and contents of the pack depocyte is a solution for injection . depocyte comes in a 5 ml glass vial as a single injection . it is available in
what bemrist breezhaler is bemist breez inhaler contains two active substances , indacaterol and mometasone furoate . indacatersol belongs to a group of medicines called bronchodilators . it relaxes the muscles in the lungs , making it easier for air to get in and out of the lungs . mometsone fruate belongs to the group of medicine called corticosteroids ( steroids ). corticostromes reduce the swelling and irritation ( inflammation ) in the small airways in the lung , which can lead to breathing problems . cortic
do not use bemrist breezhaler if you are allergic to indacaterol , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before using bemrid breez inhaler if : you have heart problems , such as an irregular or fast heartbeat . you have thyroid gland problems . you are suffering from diabetes . you suffer from high blood sugar . you experience seizures . you know that you have a low level of potassium in your blood . you smoke
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . bemrist breezhaler capsules should be swallowed whole with water . you should use the medicine every day , at the same time of the day . do not change the dose unless your doctor tells you to . if your asthma is getting worse or your symptoms get worse , your doctor may prescribe bemrid breez inhaler . how bemist breezhhaler is used bemrit breezhaner is an inhaler and capsules are for inhalation use . the medicine is for
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious . tell your doctor immediately if you experience any of the following : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips , or face , skin rash , itching and hives . allergic reaction uncommon ( may affects up to 1 in 100 people ): swelling of either the tongue or lips , face or throat ( angioedema ). other side effects other sideeffects include : very commonly ( may effect more than one in 10 users ): sore throat , runny
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store in the original blister in order to protect from light . do this after first opening of the blister . do away with the blister after this period . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what bemrist breezhaler contains the active substances are indacaterol ( as acetate ) and mometasone furoate . bemist breez inhaler 125 micrograms / 62 . 5 microgram inhaled in a single inhalation each contains 173 microgram of indacate and 150 microgram indacatedol ( corresponding to 80 microgram mometsone furuate ). the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is 125 microlitres ( equivalent to 173 microlitre ) of indiacaterol acetate and 160 microgram
zyllt contains clopidogrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). zyllt is taken to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( such as stroke , heart attack , or death ). zllt is also taken to reduce the risk of
do not take zyllt if you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . warnings and precautions before taking zylltt , tell your doctor if any of these apply to you . if any part of you is not sure , talk to your doctor or pharmacist before taking this medicine . warnings , precautions and precautions talk to the doctor or nurse before taking any of your zyllts : if you :
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of zyllt per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of zllt ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended daily
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what zyllt contains - the active substance is clopidogrel . each film - coated tablet contains 75 mg of clopridogrel ( as hydrogen sulphate ). - the other ingredients are lactose ( see section 2 under ' zylltic contains lactose '), microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil in the film - coating , hypromellose , titanium dioxide ( e171 ), red iron oxide ( e172 ), talc and propylene glycol in thefilm - coating . what zyllts looks like and contents
lamivudine teva contains the active substance lamivudin . lamivudaine tev is used to treat long term ( chronic ) hepatitis b infection in adults . lamvudineteva is an antiviral medicine that works by stopping the hepatitis b virus from multiplying . it belongs to a group of medicines called nucleoside analogue reverse transcriptase inhibitors ( nrtis ). hepatitis b is a virus that infects the liver . long term (" chronic ") infection can lead to liver damage . lamlivudine treament reduces the amount of hepatitis b in your liver and so reduces the risk of compensated
do not take lamivudine teva - if you are allergic to lamivuda or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 28 lamivuxine tevas , like other similar medicines , can cause serious side effects , especially if you have liver disease ( such as hepatitis c . if you become overweight ). your doctor will do blood tests before you start your medication ( see section 4 " warnings and risks "). if you take more lamivuine tev than you should if you accidentally take too many tablets , contact your doctor . if possible , show them the pack of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage your doctor lamivudine teva is used to treat your hepatitis b infection . it is important that you keep taking it every day until your infection is gone . this will help control your illness . you should continue to take lamivodine tevas every day as long as your health is benefiting from it . if you have the impression that lamivuda teva does not work as well as it should , talk to your doctor . lamivuine tev can be used in some cases
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with lamivudine teva in patients with other conditions linked to hepatitis b . the most serious side effects reported during therapy for hepatitis b are listed below . the side effects that have been observed during lamivuine clinical trials include tiredness , respiratory tract infections , throat discomfort , headache , stomach discomfort , pain , nausea , vomiting , diarrhoea and increases in liver enzymes . these are signs that the liver is not working properly and that the enzymes build up in the muscles . allergic reaction ( rare ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . lamivudine teva should be used immediately after first opening . do this to protect from light . donot throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what lamivudine teva contains - the active substance is lamivuine . each film - coated tablet contains 100 mg of lamivue . - the other ingredients are microcrystalline cellulose , sodium starch glycolate ( type a ), magnesium stearate . tablet film - coating : hypromellose , titanium dioxide ( e171 ), macrogol , polysorbate 80 , iron oxide yellow ( e172 ), iron oxide red ( e 172 ). what lamivUDine teeva looks like and contents of the pack orange , biconvex film - - coated tablets , debossed
nespo ( an anti - anaemic ) is used to treat your anaemia . anaemia occurs when your blood does not contain enough red blood cells . the symptoms include fatigue , weakness and shortness of breath . it is caused by the lack of the natural hormone erythropoietin . erythroietin works by blocking the action of erythromycin . this helps your kidneys to produce more red blood cell cells . darbepoetin alfa is used for treating chronic renal failure . symptomatic anaemia is caused when chronic renal fail is not controlled . kidney failure is caused if kidney
do not use nespo : if you have high blood pressure or are taking other medicines if you are allergic to nesco ( darbepoetin alfa ) or r - huepo . if you suffer from high bloodpressure and are taking medicines to treat sickle cell anaemia . if your child has epileptic fits ( seizures ). if your baby has convulsions ( fits ). if you know that your child suffers from seizures . if he has liver disease . if any of the above applies to you , do not use drugs to treat anaemia and talk to your doctor . if the child has
your doctor will carry out blood tests before you start nespo . your doctor will check your haemoglobin level regularly . the usual starting dose is 10 mg . your dose may be increased to a haemogl level of 10 mg or 12 mg per kg body weight . the pre - filled syringe is for injection into a vein . in patients with chronic renal failure , a single injection is given under the skin or into a veins ( intravenous ). your doctor may decide to increase the dose if your anaemia is not controlled enough . your usual dose of nespos is based on your body weight and is usually 0 .
like all medicines , nespo can cause side effects , although not everybody gets them . the following side effects have been reported with nespos : 471 common ( may affect up to 10 in 100 people ): high blood pressure ( hypertension ) fluid retention ( oedema ) uncommon ( may effect up to 1 in 100 , 000 people ): blood clots ( thrombosis ) pain in the area injected rash , redness and swelling of the skin rare ( may affects up to one in 10 , 000 patients ): serious allergic reactions sudden life - threatening allergic reactions ( anaphylaxis ) swelling of any of the face
keep out of the reach and sight of children . do not use nespo after the expiry date which is stated on the carton and on the syringe label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep your syringe in the original package in order to protect from light . after first opening , you may remove your syringes from the refrigerator and store them at room temperature ( not above 30 ) for a single period of up to 7 days . do this every time you use nnespo . medicines should not be
what nespo contains the active substance is darbepoetin alfa . each ml of solution for injection contains 10 , 15 , 20 , 30 , 40 , 50 , 60 , 80 , 100 , 130 , 150 , 300 , 500 micrograms . the active substances darpepoeteetin aluminium are produced by recombinant dna technology . the other ingredients of nespos are sodium phosphate monobasic , sodium phosphate dibasic ( e487 ), sodium chloride , polysorbate 80 and water for injections . what nespol looks like and contents of the pack n
macugen is a solution for the treatment of macular degeneration in adults . this medicine prevents abnormal formation of new blood vessels in the eye . macugen is used for thetreatment of adults with macular dementia . in this disease , vision loss occurs due to damage to a part of the retina ( macula ) in the back of the eye called amd . abnormal blood vessels grow in the retina and become larger around the macula . these new blood structures can bleed and leak fluid causing the macular to bulge , distorting or destroying central vision . this can lead to vision loss . macug prevents these abnormal blood structures from
do not use macugen if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active or suspected infection in your eye . warnings and precautions talk to your doctor or pharmacist before using macugen . if you think you have or have ever had an infection or bleeding in the eye , stop using macug injection and contact your doctor immediately . if any of these happen , tell your doctor straight away . if the following symptoms occur , contact your ophthalmologist immediately : eye pain or increased discomfort worsening eye redness blurred or decreased vision increased sensitivity to
mrcu injections will be given to you by a doctor or nurse . your doctor or pharmacist will decide how much macugen you need . macugen is given as a single injection into the eye ( intraocular pressure ). it is given every 6 to 9 weeks . the injection will be injected into the vitreous part of the eye . your eye doctor will decide if you need to be treated with macugen . antibiotic eye drops will be applied to your eye . you will be treated by your doctor , nurse or pharma while you are being treated with this medicine . your eyes will be carefully monitored by your eye specialist .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious allergic reaction ( anaphylactic reaction ) angioedema of which symptoms may include breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting , rapid pulse , stomach cramps , nausea , vomiting and diarrhoea . the frequency of these side effects is not known . an infection in the internal portion of the eye has been reported following macugen treatment . the symptoms are described in section 2 . if you experience any of these symptoms , contact your doctor immediately . other side effects very
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do use the medicine immediately if you notice any change in the appearance of the capsules . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what macugen contains - the active substance is pegaptanib . each single dose pre - filled syringe contains 0 . 3 mg of pegaptaib in 90 ml solution . - the other ingredients are sodium chloride , monobasic sodium phosphate monohydrate , dibasicodium phosphate heptahydrate , sodium hydroxide , hydrochloric acid ( for ph adjustment ) and water for injections . see section 2 . what macugen looks like and contents of the pack macugen solution for injection is a single dose pack supplied in a pouch . each pack contains a pre -filled syringe of 0 .
palifermin belongs to a group of medicines called escherichia coli . palifermin works by stopping the growth of epithelial cells in the mouth and digestive tract and by blocking their growth in the tissues beneath the skin . palififermin is used to treat adults with oral mucositis ( soreness , dryness or inflammation of the mouth ), a common side effect that occurs during treatments for your blood cancer . if your bloodcancer is not treated with chemotherapy , radiotherapy or autologoushematopoietic stem cell transplantation ( cells that are collected from blood cells ) it may increase the risk of side
do not take kepivance if you are allergic to palifermin , escherichia coli derived proteins or any of the other ingredients of this medicine ( listed in section 6 ). children and adolescents do not give this medicine to children and teenagers under 18 years of age . other medicines and kepivalance tell your doctor or pharmacist if you have recently taken or might take any other medicines . kepvelance may be taken with heparin . if you recently taken heparrin , tell your physician . pregnancy and breast - feeding kepipivance is not recommended if you plan to become pregnant or if
before starting cancer treatment , kepivance will be given to you by a doctor or nurse . the recommended dose is 60 mg . kepvelance will usually be given by injection ( intravenous injection ) into a vein . you will be observed closely while you are given kepivalance . kempivance is given three days before chemotherapy ( chemotherapy and radiotherapy ) and three days after chemotherapy ( radiotherapy ). you will receive chemotherapy and radiationotherapy at least 24 to 48 hours after the chemotherapy . you may also receive radiotherapy at the end of radiotherapy unless you have agreed to be treated with radiotherapy . you
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ): side effects include skin rash , itching , redness ( pruritus and erythaema ), an increase in the thickness in the mouth or tongue , change in colour of the mouth , generalised swelling ( oedema ), swelling of hands , ankles or feet , pain , fever and aching joints ( arthralgia ), altered taste , raised levels of lipase and amylase levels in the blood , and increased levels of digestive enzymes in theblood . not known (
what kepivance contains - the active substance is palifermin . each vial contains 6 . 25 mg of paliferin . - the other ingredients are mannitol , sucrose , l - histidine , polysorbate 20 and diluted hydrochloric acid . what kepvelance looks like and contents of the pack kepiverance is a white powder supplied in a vial . each carton contains 6 vials .
cinacalcet accordpharma contains the active ingredient cinacalcitepine which reduces the levels of calcium and phosphorous in the blood . it is used to treat problems with organs called parathyroid glands . parathyroids are four small glands in the neck , which are connected to the thyroid gland . cinaconalcate accordphara is used : to treat secondary hyperparathyroidism in patients with serious kidney disease who are not on dialysis or who are unable to eliminate waste products that increase the amount of calcium in the bloodstream ( hypercalcaemia ). to treat parathyrot
do not take cinacalcet accordpharma - if you are allergic to cinacealcate or any of the other ingredients of this medicine ( listed in section 6 ). - if there are low levels of calcium in your blood . your doctor will check your blood calcium levels regularly before and during treatment with cinocalcut accordpha . warnings and precautions talk to your doctor or pharmacist before taking cinicalcvet accordphara : - if any of these apply to you , tell your doctor before taking this medicine . - if : you have ever had seizures ( fits or conv
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . cinacalcet accordpharma must be taken orally with or without food . cinnacalcitpharma should be taken once a day at about the same time each day . the tablets should be swallowed whole with water . your doctor will take regular blood samples during treatment to monitor your progress . for secondary hyperparathyroidism the recommended starting dose of cinacealcordpharma is 30 mg once a week . cincac
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : numbness or tingling around the mouth , muscle aches , cramps or seizures , as these may be signs that your calcium levels are too low ( hypocalcaemia ). swelling of the face , lips , mouth , tongue or throat , which may cause difficulty in swallowing or breathing ( angioedema ). very common ( may affect more than 1 in 10 people ): nausea and vomiting . if you notice any of these side effects seek medical advice immediately . common ( might affect up to 1 in
what cinacalcet accordpharma contains - the active substance is cinacealc . each film - coated tablet contains 30 mg , 60 mg or 90 mg of cinaconalcate ( as hydrochloride ). - the other ingredients are cellulose , microcrystalline - crospovidone - magnesium stearate , hypromellose , titanium dioxide ( e171 ), triacetin , indigo carmine aluminum lake ( e132 ), iron oxide yellow ( e172 ). what cinacyalcel accordpharmaceutical looks like and contents of the pack ciniac
jentadueto contains two active substances called linagliptin and metformin . linaglptin belongs to a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4 inhibitor ) metformined and belongs to the class of substances called biguanides . they work together to lower blood sugar levels in adult patients with diabetes called ' type 2 diabetes mellitus '. this medicine works by reducing the amount of sugar in the blood , which can be caused by diabetes . it is used in adult women with ' type 1 diabetes mellitis ' when this medicine is not used together with
do not take jentadueto if you are allergic to linagliptin , metformin or any of the other ingredients of this medicine ( listed in section 6 ). if you have severely reduced kidney function . if you suffer from uncontrolled diabetes with severe hyperglycaemia ( high blood glucose ), nausea , vomiting , diarrhoea , rapid weight loss . lactic acidosis ( see section " risk of lacticacidosis " below ) is a more serious form of ketoacidosis . keto acidosis is a condition in which substances called ' ketone bodies ' accumulate in the blood and which can lead to
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jentadueto should be taken with or without food . if you currently take metformin or individual tablets containing linagliptin or metforman , do not take this again until your doctor tells you otherwise . take this this medicine at the same time each day to reduce the chance of an upset stomach . the recommended dose is one 5 mg linaglptin tablet once a day with food . your doctor may prescribe a higher dose of 2 , 000 mg metforma hydrochloride once
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms may be serious and require immediate medical attention . stop taking jentadueto and contact a doctor immediately if you experience any of the following symptoms : low blood sugar ( hypoglycaemia ): trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change or confusion . hypoglycemia is a very rare ( may affect up to 1 in 10 , 000 people ) but very serious side effect . jentadaeto plus sulphonylurea may cause lactic acidosis ( coma ). if
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . store the blister in the original package in order to protect from light . do this medicine if you notice any visible sign of tampering . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what jentadueto contains - the active substances are linagliptin and metformin hydrochloride . each jentadinueto 2 . 5 mg / 850 mg film - coated tablet contains 2 . 25 mg linaglioptin and 850 mg metforma hydrochlorides . - each jentinueto 1 , 000 mg film film - coating contains 2. 5 mg linagoptin and 1 , 500 mg metin hydroxychloride ). - the other ingredients are arginine , copovidone , magnesium stearate , maize starch , silica , colloidal anhydrous , hyp
edurant contains the active substance rilpivirine . edurant is used to treat human immunodeficiency virus ( hiv ) infection in adults , adolescents and children . it belongs to a group of hiv medicines called non - nucleoside reverse transcriptase inhibitors ( nnrtis ). edurants works by reducing the amount of hla - b * 5701 in the body . it is used in combination with hiv medications in adults and adolescents 12 years of age and older and who are infected with hla b * 5801 . your doctor will discuss with you which combination of hl
do not take edurant if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking edurent if you : are taking any of any of : the following medicines : carbamazepine , oxcarbazepine or phenobarbital or phenytoin ( medicines used to treat epilepsy and prevent seizures ) rifampicin or rifapentine ( medicines to treat some bacterial infections such as tuberculosis ) omeprazole , esomeprazole or lans
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults and adolescents ( aged 18 years and over ) the recommended dose of edurant is one tablet once a day . do not take more than one tablet twice a day with food . do this if your doctor tells you to . do the following : - if you take rifabutin ( a medicine used to treat some bacterial infections ). if you have taken more edurent than you should if you accidentally take more rifabiutin than you were told to , talk to your doctor .
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you have : headache , nausea , difficulty falling asleep , insomnia , dizziness , or changes in your routine liver tests ( transaminase ), increase in cholesterol and pancreatic amylase in your blood , abnormal dreams , rash , stomach pain , depression , tiredness , vomiting , drowsiness , decreased appetite , sleep disorders , stomach discomfort , depressed mood , dry mouth 36 low white blood cell and / or platelet count , decrease in haemoglobin in your body ( triglycerides , lipase , bilirub
what edurant contains - the active substance is rilpivirine . each tablet contains rilpaline hydrochloride . each film - coated tablet contains 50 mg rilpitivirrine . - the other ingredients are : tablet core : lactose monohydrate , croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose , magnesium stearate . the film - coating : lactate monohydrate and hypromellose 2910 ( e464 ). tablet coating : 6 mm ( diameter ), titanium dioxide ( e171 ),
avandamet tablets contain two different medicines called rosiglitazone and metformin . these two medicines are used to treat type 2 diabetes in adults . type 2abetes is when your body does not make enough insulin to control blood sugar levels . insulin is a substance that helps your body make better use of its blood . rosigslitazONE and met formin work together by helping your body use the insulin it produces better . your blood sugar should be controlled by diet and exercise . avandamvet is also used in combination with a sulphonylurea ( type of diabetes ) medicine for adults .
follow all the doctor ' s instructions carefully . check with your doctor or pharmacist if you are not sure . your doctor may need to change your dose of avandamet . do not take avandamanet if you : are allergic ( hypersensitive ) to rosiglitazone , metformin or any of the other ingredients of avANDamet ( listed in section 6 ) have had a heart attack have severe angina have heart failure have had heart failure in the past have severe breathing difficulties have liver disease have diabetic ketoacidosis ( a complication of diabetes causing rapid weight loss , nausea or vomiting )
always take avandamet tablets exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is 2 tablets rosiglitazone ( 1000 mg ) metformin twice a day . this dose is taken once a day , at least 1 hour apart from meals . this is taken every 8 hours . the maximum dose is 4 tablets rosciglitayone ( 600 mg ) once a morning , at about the same time each day . your doctor will tell you the dose to take . your dose will depend on how much metformatin
like all medicines , avandamet can cause side effects , although not everybody gets them . allergic reactions to avandamanet may include raised and itchy rash ( hives ) swelling mainly of the face or mouth ( angioedema ), with difficulty in breathing collapse . if you get any of these symptoms , stop taking avandandamnet and seek medical advice straight away . lactic acidosis ( build up of lacticacid in the blood ( lactic acidsosis is a common side effect of metformin in patients with severe kidney disease ). symptoms of lact acidosis include rapid breathing , cold stomach pain
keep out of the reach and sight of children . do not use avandamet after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do this if you notice any change in the appearance of the tablets . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what avandamet contains the active substances are rosiglitazone and metformin . avandamanet tablets come in different strengths . each tablet contains 1 mg rosigllitazon ( 500 mg ) metforma . each film - coated tablet contains 2 mg rosciglitasone ( 500mg ) met formin . each 2 mg film - coating tablet contains rosigslitazome ( 1000 mg ) meetformin , each 4 mg film film - coat tablet contains 4 mg rossiglitazaone ( 1000mg ) meet formin , respectively . the other ingredients are sodium
clopidogrel mylan contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopIDogrel has been shown to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( such as stroke , heart attack , or death ). you have been prescribed
do not take clopidogrel mylan 31 if you are allergic to clopipidogl or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , tell your doctor before taking clopridogrelmylan . warnings and precautions talk to your doctor or pharmacist before taking : if you think any of this applies to you ( or you are not sure ), talk to the doctor or nurse before taking
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel mylan per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clubidogl mylan ( 4 tablets of 75 mg ) once at the start
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel mylan contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopidaogrel ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil ( see section 2 ' clopideogrelmylan contains hydrogenatedcastor oil '), polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc , macrogl 3000
doptelet belongs to a group of medicines called thrombopoietin receptor agonists . doptelet is used to treat chronic liver disease with low platelet count ( thromboocytopenia ), in adults , in a medical procedure to stop bleeding . it works by reducing the number of platelets in the blood . platelets are blood cells that help the blood to clot and stop bleeding from occurring .
do not use doptelet if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using doptelelet if : you have a history of blood clots ( especially in the veins or arteries ). this is because dopteel may increase the risk of bloodclots in patients with a history or a history with cancer . you are taking the contraceptive birth control pill or hormone replacement therapy . you have recently had surgery or are seriously injured . you weigh less than 23 kg . you may be overweight .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose for your procedure is one 5 mg tablet once a day . your doctor may increase your dose to one 8 mg tablet twice a day depending on your response to doptelet . your dose of dopteol may be increased by 20 mg , 40 mg or 60 mg once a week for up to 5 weeks . your platelet counts may be reduced by taking this medicine for 10 to 13 days . if you take more doptelets than you should if you have taken more tablets than you have
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with doptelet : very common ( may affect more than 1 in 10 people ): feeling tired uncommon ( may effect up to 1 in 100 people ): low red blood cell count ( anaemia ) blood clot in the portal vein ( a blood vessel that transports blood from the liver to the intestines ) upper abdominal pain , swelling bone pain muscle aches and fever reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet .
what doptelet contains - the active substance is avatrombopag . each film - coated tablet contains avatormbopog maleate equivalent to 20 mg avatrambopg . - the other ingredients are lactose monohydrate ( see section 2 ), microcrystalline cellulose , crospovidone type b [ e110 ], silica , colloidal anhydrous , magnesium stearate . - film - coating : vinyl alcohol , talc , macrogol 3350 , titanium dioxide ( e171 ), iron oxide yellow ( e172 ). what dopteel looks like and contents
rapiscan belongs to a group of medicines called ' coronary vasodilators '. it works by blocking the flow of blood from the heart arteries , thus increasing heart rate and helping to relax the muscles of the heart . rapiscan is used for the following types of heart scan : ' myocardial perfusion imaging '. the scan uses a radioactive substance called a ' radiopharmaceutical '. these images are taken onto the muscles in the heart using a readmill . a scan contains a small amount of radiopharma ( a substance that is injected into the body through a vein or hand ) to obtain images of the inside of
do not use rapiscan if you have slow heart rate , high degree heart block , sinus node disease or if you are using a pacemaker . if you experience chest pain ( unstable angina ) during treatment , please inform your doctor . if your doctor has prescribed rapiscin if you suffer from low blood pressure ( hypotension ) or heart failure . if allergic to regadenoson . warnings and precautions talk to your doctor or pharmacist before using rapiscen . if any of the situations mentioned below apply to you , your doctor may need to adjust your dose of rapiscon . if : you have a recent
rapiscan will be given to you by a doctor or nurse who is experienced in the treatment of your heart and blood pressure . it will be injected into a vein ( intravenously ) over a period of 400 minutes . the recommended dose is a 5 ml solution the injection will be administered over a minimum of 5 to 10 minutes depending on your weight . the dose may be administered as an injection of sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection ( intravenous ) over the same period of 5 minutes . rapiscan contains a radioactive substance ( radiopharmaceutical ). the dose of rapiscin given
like all medicines , rapiscan can cause side effects , although not everybody gets them . the side effects are usually mild to moderate and usually disappear after the rapiscin injection has been given within 30 minutes of any treatment . tell your doctor immediately if you notice any of the following side effects : sudden stopping of the heart , which may be due to damage to the heart ( heart block ), a disorder of theheart ' s electrical signal , rapid heart beat low blood pressure , fainting , ministrokes , weakness of the face and inability to speak . rapiscans may cause a stroke ( cerebrovascular accident )
viagra contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 ( pde5 ) inhibitors . it works by helping the blood vessels in your penis relax , allowing blood to flow into your penis when you get sexually excited . viagra will only help you to get an erection if you are sexually stimulated . viag is a treatment for adult men with erectile dysfunction ( impotence ), a condition where a man cannot get , or keep a hard , erect penis suitable for sexual activity .
do not take viagra - if you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has prescribed medicines containing nitrates , which could lead to a dangerous fall in your blood pressure . these medicines are used to treat angina pectoris ( " chest pain "). if you have not been prescribed any of these medicines , please contact your doctor . - if the doctor has recently prescribed nitric oxide donors such as amyl nitrite , which may lead to an increase in your risk of a dangerous drop in yourblood pressure . - when r
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 50 mg once a day . viagra film - coated tablets are for oral use . viag orodispersible tablets are also for oral . swallow the tablets whole with a glass of water . viaga can be taken with or without food . viampicin is for oral treatment . swallow your tablets whole . taking viagra with food viagra will help you to get an erection . if you get sexually stimulated while taking viampica , you may find it easier to take
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported with viagra are usually mild to moderate . if you experience any of the following side effects stop taking viagra and seek medical help immediately : an allergic reaction ( may affect up to 1 in 100 people ). symptoms include sudden wheeziness , difficulty in breathing , dizziness , swelling of the eyelids , face , lips or throat . if this happens , chest pains may be severe and you may need to be in a semi - sitting position . you may also be given nitrates to relieve your chest pain . prolonged and sometimes
what viagra contains - the active substance is sildenafil . each tablet contains 25 mg of sildenedafil ( as the citrate salt ). - the other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate , hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake ( e132 ). what viagra looks like and contents of the pack viagra film - coated tablets have a rounded - diamond shape and are engraved with "
sifrol contains the active substance pramipexole and belongs to a group of medicines known as dopamine agonists , which stimulate dopamine receptors in the brain . stimulation of the dopamine receptors triggers nerve impulses in thebrain that help to control body movements . sifrol is used to : : : treat the symptoms of primary parkinson ' s disease in adults ; - on its own , it can be used alone or in combination with levodopa . treat parkinson ', s disease is associated with the symptoms in moderate to severe primary restless legs syndrome in adults .
do not take sifrol if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking sifol if you have any medical conditions or symptoms , including kidney disease . hallucinations ( seeing , hearing or feeling things that are not there ). most hallucinations are visual . dyskinesia ( abnormal , uncontrolled movements of the limbs ). if you suffer from advanced parkinson ' s disease , you may be given levodopa to treat dyskineia . if any of these apply to you , tell your doctor . warnings and
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of sifrol for parkinson ' s disease is 3 tablets per day . during the first week , 1 tablet of sufrol 0 . 088 mg ( 0 . 264 mg ) will be taken . after 1 week , 2 tablets of sofrol 0. 088mg ( 0. 264 mg ), your symptoms should be controlled by taking tablets once a day . the usual starting dose is 1 tablet ( 0 , 088 ml ) of safrol 0 0 . 012
like all medicines , this medicine can cause side effects , although not everybody gets them . evaluation of these side effects is based on the following frequencies : very common : may affect more than 1 in 10 people common : might affect up to 1 in 100 people uncommon : may affects up to1 in 1 , 000 people rare : may effect up to one in 10 , 000 patients not known : frequency cannot be estimated from the available data - parkinson ' s disease the following side effects have been reported : - dyskinesia ( abnormal , uncontrolled movements of the limbs ), dizziness , nausea ( sickness ), urge to behave in an unusual
what sifrol contains the active substance is pramipexole . each tablet contains 0 . 088 mg , 0 . 18 mg , or 0 . 35 mg , corresponding to 0 . 7 mg pramipxole as 0 . 125 mg , 1 mg , 3 mg , and 0 . 5 mg pramsipexol dihydrochloride monohydrate . the other ingredients are mannitol , maize starch , anhydrous colloidal silica , povidone k 25 , magnesium stearate . what sifroll looks like and contents of the pack sifol 0 . 019 mg
emadine is a medicine used for the treatment of seasonal allergic conjunctivitis of the eye in adults . allergic conditions may occur in some parts of the body , especially around the eye . the allergic reaction to allergic conjutivitis may be caused by exposure to some materials ( allergens ) that may cause allergic reactions such as itching , redness and swelling . if you notice any of these on the surface of your eye , tell your doctor immediately . do not try to cover them up . if any of the signs of allergic conjuritis get worse , tell the doctor straight away .
do not use emadine - if you are allergic to emedastine or any of the other ingredients of this medicine ( listed in section 6 ). - if your child is more than 3 years old . warnings and precautions talk to your doctor or pharmacist before using benzalkonium chloride in emadade . see section 6 . clinical trials should be performed before and during treatment with emadrine . if you have kidney or liver problems , your doctor may decide to reduce the dose of emadadine . other medicines and emadines tell your doctor if you use , have recently used or might use any other medicines
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use adults use one drop twice a day ( morning and evening ). use in children and adolescents use in adults ( 12 years of age and older ) the recommended dose is one drop in each eye twice a week . use this tip in children ( 12 to 17 years of old ) and adolescents ( 12 - 17 years old ) using the emadine bottle . wash your hands after using the bottle . remove the cap . remove cap and snap collar . hold the bottle ,
like all medicines , this medicine can cause side effects , although not everybody gets them . the drops can cause some of these effects . common side effects ( may affect up to 10 in 100 people ) effects in the eye : eye pain , itchy eye and eye redness . uncommon side effects : ( may effect up to 1 in 100people ) effects affecting the eye ( corneal disorder ): abnormal eye sensation , increased tear production , tired eyes , eye irritation , blurred vision , corneel staining and dry eye . general side effects include headache , difficulty sleeping , sinus headache , bad taste , rash . generalside effects
keep out of the reach and sight of children . do not use emadine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do this to protect from infections .
what emadine contains - the active substance is emadastine 0 . 5 mg / ml . - the other ingredients are difumarate , benzalkonium chloride , trometamol , sodium chloride , hypromellose , purified water , hydrochloric acid , sodium hydroxide to maintain acidity levels and ph levels . what emadrine looks like and contents of the pack emadINE is a liquid ( a solution ) supplied in a 5 ml or 10 ml plastic ( drop - bottle ) bottle with a screw cap . each bottle contains one bottle .
levetiracetam is an antiepileptic medicine ( a medicine used to treat seizures in epilepsy ). levetir acetam actavis is used : on its own in adults and adolescents from 16 years of age with newly diagnosed epilepsy , to treat a certain form of epilepsy . epilepsy is a condition where the patients have repeated fits ( seizures ). levevetirateam is used for the epilepsy form in which the fits initially affect only one side of the brain , but could thereafter extend to larger areas on both sides of the body ( partial onset seizure with or without secondary generalisation ). levantiracetamer has
do not take levetiracetam actavis - if you are allergic to levetiraacetam , pyrrolidone derivatives or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking leveturacetamactavis - tell your doctor if you have kidney problems - tell the doctor if any slow down in the growth or unexpected puberty has been reported in patients taking anti - epileptics . levetiralacetam actsavis may cause thoughts of harming or killing themselves . tell your physician if you or your family / carer notices any
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet of levetiracetam actavis in the morning and one tablet in the evening . monotherapy dose in adults and adolescents from 16 years of age and older : one tablet ( 1 , 000 mg ) once daily . the usual starting dose is 3 , 000 micrograms once daily ( two tablets of levevetiratam acta in the afternoon and one half tablet of 1 , 500 mg ). after therapy dose in children and adolescents ( 12 to 17 years of
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor or the nearest emergency department immediately if you experience : weakness , feel light - headed or dizzy or have difficulty breathing , as these may be signs of a serious allergic ( anaphylactic ) reaction . swelling of the face , lips , tongue and throat ( quincke ' s oedema ). flu - like symptoms and a rash on the face followed by an extended rash with a high temperature . increased levels of liver enzymes seen in blood tests ( increase in a type of white blood cell ) 56 in patients with eos
what levetiracetam actavis contains the active substance is levetiraacetam . levetairam activ 250 mg : each tablet contains 250 mg of levetirusacetam ( as levetoracetam ). levetouracetamactavis 500 mg : one tablet contains 500 mg of the active ingredient levetieracetam. leveturacetam actingavis 750 mg : every tablet contains 750 mg of of leveriracetamine ( as velvetir acetam ). what levetmiracetam effectavis looks like and contents of the pack 1 , 000 mg film - coated tablets :
celemetha contains the active substance umeclidinium bromide which belongs to a group of bronchodilators . incruse ellipta is used to treat adults with chronic obstructive pulmonary disease ( copd ). copd is a long - term condition in which the airways in the lungs become blocked , leading to breathing difficulties . difficulties in breathing can also result in tightening of the muscles around the airway . this medicine blocks the tightening of these muscles , making it easier for air to get in and out of the lungs . this helps to control your breathing difficulties and helps to stop copd from
do not use incruse ellipta 27 if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine if you have asthma . incruruse ellipta should not be used if you suffer from asthma . if you smoke . if your doctor has told you that you have heart problems . if any of these apply to you , tell your doctor . if this applies to you . if it does not apply to any of your medical conditions , tell the doctor . tell your physician if you
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at the same time each day . use incruse ellipta every day . if you use more incrupe ellipta than you should if you have used more inculse elliptas than you have been told to , contact your doctor immediately . symptoms of using too much of this medicine may include a sudden attack of breathlessness or wheezing . if this attack occurs , you may need to use
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions are uncommon ( may affect up to 1 in 100 people ). if you experience any of the following symptoms while taking incruse ellipta , stop taking this medicine and seek medical help immediately : itching skin rash , hives and redness 29 common side effects ( may effect up to1 in 10 people ): faster heart beat painful and frequent urination . these may be signs of a urinary tract infection . common cold infection of nose or throat cough feeling of pressure or pain in the cheeks and forehead . these could be signs for inflammation
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the inhaler after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the inhal inhaler in the sealed tray in order to protect from light . after first opening of the tray , the inhal should be used within 6 months . once the tray has been opened , the active substance of the medicine should be transferred to the inhalere and used within 30 . once opened , use the
what incruse ellipta contains - the active substance is umeclidinium bromide . each single inhalation provides a delivered dose of 55 micrograms umechinium ( equivalent to 65 microgram ) umecylidinIUM bromides . - the other ingredients are lactose monohydrate ( see section 2 under ' incrusemipta contains lactose '), magnesium stearate . what incrusey ellipta looks like and contents of the pack incruere ellipta is an inhalation powder . the ellipta inhaler consists of a grey plastic body , a light green mouth
what nucala is nucal contains the active substance mepolizumab , a monoclonal antibody . this type of protein is used to treat severe asthma in adults , adolescents and children from 6 years of age . severe asthma affects many eosinophils ( a type of white blood cell that helps the lungs breathe ) in patients with eosynophilic asthma . what nucalan is used for asthma nucalo is used in adults to prevent asthma attacks when you are taking medicines called high dose inhalers . it helps control your asthma when you first start taking these medicines . it is also used
do not use nucala if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine if you have worsening asthma 58 if you experience asthma - related side effects , your doctor may decide to reduce the dose of nucal or stop your nuca treatment . if you think you may be allergic , ask your doctor for advice . injection site reactions medicines of this type ( monoclonal antibodies ) cause severe allergic reactions to parts of your body , which can be life threatening ( see section
nucala is given under the skin ( subcutaneous injection ). adults and adolescents 12 years of age and older : the recommended dose is 100 mg given once a week for 1 week . the pre - filled pen may be used for up to four weeks . your doctor will decide how long you should receive nucala . duration of treatment your doctor may decide to continue to give nucal for as long as your doctor continues to prescribe it . your physician will monitor your condition during the treatment . if you miss a dose of nucale , do not stop the treatment without talking to your doctor first . if your asthma symptoms
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with nucala : allergic reactions allergic or allergic - like reactions may occur very commonly ( may affect more than 1 in 10 people ) after the injection . sometimes symptoms may be severe . symptoms may include chest tightness , cough , difficulty breathing fainting , dizziness or feeling lightheaded ( due to a drop in blood pressure ), swelling of eyelids , face , lips , tongue or mouth hives rash tell your doctor immediately if you have a reaction similar reaction to nucal . other side effects include :
keep out of the reach and sight of children . do not use nucala after the expiry date which is stated on the carton and on the pre - filled pen after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after first opening , the nucalo pre -filled pen may be stored for up to 7 days in the refrigerator ( 4 8 ). discard if the pen has been stored for more than 7 days . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use
what nucala contains - the active substance is mepolizumab . each 1 ml vial contains 100 mg of mepolzumab ( as besilate ). - the other ingredients are sucrose , sodium phosphate dibasic heptahydrate , citric acid monohydrate , polysorbate 80 , edta disodium dihydrate and water for injections . what nucal looks like and contents of the pack nucalo 1 mg is supplied as a pack containing 1 vial , a multipack containing 3 vials and 1 vials . not all pack sizes may be marketed .
what ninlaro is ninlar is a cancer medicine that contains the active substance ixazomib , a ' proteasome inhibitor '. what it is used for ninlara is used to treat a cancer of the bone marrow called multiple myeloma . ixezomib works by stopping cell survival . myelomas cells have a lot of proteins called proteasomes . how ninlalo works ninlAR works by blocking the action of a protein called ' protease '. what is multiple myelin ? when multiple myelooma is first diagnosed , your doctor will give you a combination of two different medicines
do not take ninlaro if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking ninlar if any of these apply to you . if you have any of those conditions : if you think you may be taking this medicine , tell your doctor . warnings and symptoms talk to the doctor or nurse before taking the tablets . if any part of the tablet gets cut or damaged , tell the doctor . if the tablet does not appear clear , tell them immediately . if there is bleeding or persistent nausea , vomiting
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one capsule twice a day . if you have multiple myeloma , your doctor may prescribe a different dose of this medicine . the dose of ninlaro that you take will depend on how you respond to lenalidomide and dexamethasone . the 4 - week treatment with ninlar is divided into two doses : once on the same day of the week . once on day 4 of each cycle . lenalidomeide 25 mg capsules once on same dayof the
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects ( may affect more than 1 in 10 people ): low platelet counts ( thrombocytopenia ) nose bleeds that can easily bruise nausea , vomiting , diarrhoea numbness , tingling or burning of the hands or feet ( peripheral neuropathy ) swelling of the legs or feet (> peripheral oedema ) skin rash ( itchy , often on the surface of the body ). rare side effects these may affect up to 1 in 1 , 000 people : severe skin rashes , red to
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the blister and carton after exp . the exp date refers to the last day of that month . do store above 30 . store in the original package in order to protect from moisture . once the capsule has been opened , use this medicinal product immediately . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what ninlaro contains the active substance of ninlar is ixazomib . each capsule contains 2 . 3 mg ixezomib and 3 . 3mg ixzomib citrate . the other ingredients are microcrystalline cellulose , magnesium stearate , talc . the capsule shell contains gelatin , titanium dioxide ( e171 ), red iron oxide ( e172 ), shellac , propylene glycol , potassium hydroxide , black iron oxide . the printing ink contains : - the capsule content contains : ixar 3 mg / ixabine ( 4 . 3 microgram
do not use palforzia if you are allergic to peanuts or arachis hypogaea . warnings and precautions talk to your doctor , pharmacist or nurse before using palfORzia . children and adolescents from 4 to 17 years of age should not receive treatment for peanut allergy because the medicine contains traces of peanut ( desensitisation ). palfiorzia should be used in children and young children who have not experienced allergic reactions before . palforszia is not indicated for the treatment of food allergies . pforzial should not be used for children and children under the age of 18
do not take palforzia if you are allergic to peanut or soya or any of the other ingredients of palforsia . if your asthma is getting worse or you have a problem swallowing , especially if you have long term problems with your digestive system . if you suffer from a severe mast cell disorder . if severe or life - threatening anaphylaxis occurs within 60 days of starting treatment . if this happens , stop taking palfourzia and contact your doctor . warnings and precautions talk to your doctor or pharmacist before taking palorzias . the symptoms of peanut allergy may occur with palf
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage and frequency of administration if you have been diagnosed with allergy , allergic reactions ( anaphylaxis ) and are not responding to treatment with palforzia , your doctor will prescribe the dose that is right for you . initial doseescalation and up - dosing steps are available . your doctor may prescribe a lower or higher dose depending on your response to treatment . your physician will prescribe palfourzia as an initial dose and follow - up doses . these treatment steps will be given to
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with palforzia : severe allergic reactions : if you have any of the following symptoms after taking palfORzia , stop taking the medicine and seek medical help immediately : trouble breathing , throat tightness , feeling offulness , trouble swallowing or speaking - changes in voice , dizziness or fainting severe stomach cramps , pain , vomiting , diarrhoea , severe flushing and itching of the skin palforsia may cause problems with the stomach and digestive system ( eosinophilic
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine if you notice any hard lumps of powder or if the seal is broken . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what palforzia contains the active substance is palforbzia . each 0 . 5 mg capsule contains 1 , 10 or 20 mg of the active substances . the other ingredients are microcrystalline cellulose , colloidal anhydrous silica and magnesium stearate palfiorzia 100 mg oral powder in capsules with opening microcry crystalline celluloses , colloid anhydrated silica , magnesium stareate paforzias 300 mg oralpowder in sachet microcrycrystallose cellulose, colloidal Anhydroussilica and calcium stearates , beige oral
zerne belongs to a group of substances called benzodiazepine - related medicinal products . it contains hypnotic actions . zerene is used to treat sleeping problems in adults . it is used during treatment . it should be used during the first week of treatment to help you sleep . if you have problems sleeping , it should not be used .
do not take zerene : if you have hypersensitivity ( an allergy ) to zaleplon or any of the other ingredients of zerenea sleep apnoea syndrome ( which may occur for short periods ) if you suffer from severe kidney or liver problems if you are suffering from myasthenia gravis ( which causes you to feel very weak and tired muscles , severe breathing or chest problems ) if any of these apply to you , tell your doctor . children and adolescents do not give this medicine to children under 18 years of age because it has not been studied in this age group . other medicines and zere
always take zerene exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 10 mg capsule per day to help you sleep . if you have difficulty falling asleep , you should take the capsule with you . if your doctor tells you to stop taking zeren : if you ( or your child ) are 65 years of age or older with mild to moderate liver problems , the recommended starting dose is two 5 mg capsules per day . if the capsule is cloudy , you may feel that an overdose has been given . if this happens , you will become increasingly d
like all medicines , zerene can cause side effects , although not everybody gets them . tell your doctor or nurse if you notice any other changes in your health . the frequency of possible side effects listed below is defined using the following convention : 36 very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to 5 users in 1 , 000 ) very rare ( affects less than 1 users in 10 , 000 ). very rare : very rare (> affects lessthan 1 user per 10 ,000 ) not known ( frequency cannot be estimated from the available data ) very common :
what zerene contains - the active substance is zaleplon 5 mg . - the other ingredients are : capsule contents : microcrystalline cellulose , pregelatinised starch , silicon dioxide ( e171 ), sodium lauryl sulphate , magnesium stearate . capsule shell : lactose monohydrate , indigo carmine ( e132 ), titanium dioxide ( c171 ). capsule shell printing ink : gelatin , titanium dioxide , red iron oxide ( e172 ), yellow iron oxide , black iron oxide (< e172 ) and sodium laurel sulphates ( e133 ), silicon dioxide . printing ink ( s -
